# EDGAR Filing Document

**Accession Number:** 0001201792
**File Stem:** 0001140361-26-013996
**Filing Date:** 2026-4
**Character Count:** 297668
**Document Hash:** fe9f019e301b17ce069120830472247d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-013996.hdr.sgml**: 20260409

**ACCESSION NUMBER**: 0001140361-26-013996

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 39

**CONFORMED PERIOD OF REPORT**: 20260522

**FILED AS OF DATE**: 20260409

**DATE AS OF CHANGE**: 20260409

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMERICAN PUBLIC EDUCATION INC
- **CENTRAL INDEX KEY:** 0001201792
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-EDUCATIONAL SERVICES [8200]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 010724376
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33810
- **FILM NUMBER:** 26851528

**BUSINESS ADDRESS:**
- **STREET 1:** 111 W CONGRESS STREET
- **CITY:** CHARLES TOWN
- **STATE:** WV
- **ZIP:** 25414
- **BUSINESS PHONE:** (304) 724-3700

**MAIL ADDRESS:**
- **STREET 1:** 303 W.3RD. STREET
- **CITY:** RANSON
- **STATE:** WV
- **ZIP:** 25438

?xml version='1.0' encoding='ASCII'?

#### **TABLE OF CONTENTS**

#### UNITED STATES

#### &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

#### SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

#### SCHEDULE 14A
(Rule 14a-101)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

INFORMATION REQUIRED IN PROXY STATEMENT

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

SCHEDULE 14A INFORMATION

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Proxy Statement Pursuant to Section 14(a) of the Securities

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Exchange Act of 1934

(Amendment No.)

Filed by the Registrant ☒

Filed by a party other than the Registrant ☐

Check the appropriate box:

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Preliminary Proxy Statement 

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) 

☒ Definitive Proxy Statement 

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Definitive Additional Materials 

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Soliciting Material under § 240.14a-12

---

| |
|:---|
| **American Public Education, Inc.**  |
| (Name of Registrant as Specified In Its Charter)  |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |

---

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required. 

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Fee paid previously with preliminary materials. 

&nbsp;&nbsp;&nbsp;&nbsp; ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. 

------

#### **TABLE OF CONTENTS**
![](ny20064163x1_fcvx1.jpg)

------

### Message from our Board Chair
![](ny20064163x1_danielpianko.jpg)

April 9, 2026

Dear Stockholders:

We cordially invite you to join us for the 2026 Annual Meeting of Stockholders of American Public Education, Inc., which we will hold virtually on Friday, May 22, 2026, at 8:30 a.m. EDT at http://www.virtualshareholdermeeting.com/APEI2026. This format not only includes enhanced opportunities for engagement and interaction through the Q&A forum and other platform features but also accommodates those unable to attend in person, ensuring accessibility for all stakeholders.

Across APEI and its institutions, the staff and faculty work every day to ensure that the Company's work and our students' work reflect our vision for education that transforms lives, advances careers, and improves communities. As a Board, we focus on ensuring that APEI's key strategic initiatives align with that vision.

As examples of the successes achieved by our students and their commitments to service, I wish to recognize our APUS Lunar Pathfinders team, a student-led initiative that gained national recognition when it was named a top 10 finalist in NASA's prestigious Lunar Autonomy Challenge. Competing against 30 other teams from top-tier institutions in March 2025, our Pathfinders team created autonomous rover software capable of navigating lunar terrain, mapping surfaces, managing energy, and detecting obstacles.

During 2025, our management team worked to simplify and strengthen APEI by delivering on the commitments they established at the start of the year, and our 2025 performance reflects their efforts. We redeemed all outstanding shares of preferred stock, sold certain corporate buildings, divested Graduate School USA, and made meaningful progress on the planned combination of American Public University System, Rasmussen University, and Hondros College of Nursing. We believe completion of the combination will position us to expand our campus footprint, provide greater programmatic and academic choice, reinforce student and alumni support, more effectively meet the growing demand for nursing and other healthcare professionals, and accelerate enrollment growth among non-military, military, military family, and veteran student. We are also proud of our financial results in 2025, which included increases in revenue, net income available to common stockholders, adjusted EBITDA, and fully diluted earnings per share available to common stockholders.

While appreciative of APEI's successes in 2025, the Board remains focused on effective oversight, accountability, long term value creation, and supporting management in pursuing key strategic initiatives. We approach our responsibilities with a focus on ensuring that management executes the Company's strategy responsibly, allocates capital prudently, and operates with integrity in service of our students, employees, and stockholders.

------

#### **TABLE OF CONTENTS**
In its work, the Board continues to emphasize strong governance practices, including independent oversight, rigorous risk management, and thoughtful executive compensation design aligned with performance and stockholder interests. We also regularly review the composition and effectiveness of the Board and its committees to ensure that we bring the appropriate mix of experience, skills, and perspectives to our oversight role.

At the Annual Meeting, we will ask you to elect six director nominees to the Board of Directors, as detailed in the attached proxy statement. You can find details about the qualifications of our director nominees and the reasons we believe they are the right individuals to represent your interests starting on page [26](#tPROP1). We believe the nominees collectively bring the skills and experience necessary to oversee APEI's strategy and risk profile and embody our commitment to strong governance.

As discussed in the Compensation Discussion and Analysis section, which begins on page [33](#tCDA), in 2025, we continued our commitment to compensation practices designed to attract, incentivize, retain, and reward the talent needed to maintain and strengthen our position in career-minded adult education and to achieve our business objectives. At the Annual Meeting, we will ask for approval, on a non-binding advisory basis, of the compensation paid to our named executive officers.

Our Audit Committee, as discussed beginning on page [75](#tACR), has again selected Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026, and we will ask you to ratify that appointment.

The members of our Board, just like those who work across APEI and at our institutions, are drawn to APEI because of its mission of powering purpose, potential and prosperity for those in service to others. It is our honor to serve APEI, its institutions and students, and we value the opportunity to do so on your behalf.

Sincerely,

![](sig_danielspianko.jpg)

#### Daniel S. Pianko

#### Board Chair, APEI Board of Directors

------

#### **TABLE OF CONTENTS**
![](logo_apeiv5.jpg)

111 W. Congress Street

Charles Town, West Virginia 25414

### NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
![](ny20064163x1_boxes.jpg)

The 2026 Annual Meeting of Stockholders of American Public Education, Inc. (the "Annual Meeting") will be held on May 22, 2026, at 8:30 a.m. Eastern Daylight Time as a virtual meeting of stockholders held over the Internet. Stockholders will be able to attend the Annual Meeting, vote, and submit questions during the Annual Meeting at *www.virtualshareholdermeeting.com/APEI2026*. The Annual Meeting will be held for our stockholders to consider and vote on the following proposals:

&nbsp;&nbsp;&nbsp;&nbsp;•  ***Proposal No. 1:*** To elect to the Board, the six nominees set forth in the accompanying proxy materials, each of whom will hold office until the next annual meeting of stockholders and until such director's successor is elected and qualified or until such director's earlier death, resignation, or removal.

&nbsp;&nbsp;&nbsp;&nbsp;•  ***Proposal No. 2:*** To approve, on an advisory basis, the compensation paid to our named executive officers as disclosed in the accompanying proxy materials.

&nbsp;&nbsp;&nbsp;&nbsp;•  ***Proposal No. 3:*** To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

In addition, any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof will be considered. Management is presently aware of no other business to come before the Annual Meeting.

Each outstanding share of American Public Education, Inc. common stock (Nasdaq: APEI) entitles the holder of record at the close of business on March 26, 2026, to receive notice of and to vote at the Annual Meeting or any adjournment or postponement of the Annual Meeting. We are pleased to take advantage of Securities and Exchange Commission rules that allow us to post these materials on the Internet, which enables us to provide stockholders with the information that they need more quickly, while lowering our costs of printing and delivery and reducing the environmental impact of our Annual Meeting.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>1</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
Whether or not you expect to attend the meeting, we urge you to vote your shares before the meeting by Internet, telephone, or by signing, dating, and returning the proxy card you will receive if you request printed materials. If you choose to attend the virtual Annual Meeting, you may still vote your shares online at the meeting, even though you have previously voted or returned your proxy by any of the methods described in this Proxy Statement. If your shares are held in a bank or brokerage account, please refer to the materials provided by your bank or broker for voting instructions.

All stockholders are extended a cordial invitation to attend the meeting.

---

| |
|:---|
| By Order of the Board of Directors,  |
| ![](sig_tbeckett.jpg)<br>|
| **Thomas A. Beckett** <br>**Senior Vice President, General Counsel and Secretary** <br>**April 9, 2026** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>2</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

---

| | |
|:---|:---|
| **[PROXY STATEMENT SUMMARY](#tPSS)** | **[5](#tPSS)** |
| &nbsp;&nbsp;&nbsp;[Powering Purpose, Potential and Prosperity for Those Who Serve](#tPMP) | [5](#tPMP) |
| &nbsp;&nbsp;&nbsp;[Overview of Proposals](#tOVER) | [5](#tOVER) |
| &nbsp;&nbsp;&nbsp;[Corporate Governance and Stockholder Engagement Highlights](#tCGS) | [7](#tCGS) |
| &nbsp;&nbsp;&nbsp;[Executive Compensation Highlights](#tECH) | [8](#tECH) |
| **[ABOUT THE ANNUAL MEETING](#tATAM)** | **[9](#tATAM)** |
| &nbsp;&nbsp;&nbsp;[Purpose of the Annual Meeting](#tPAM) | [9](#tPAM) |
| &nbsp;&nbsp;&nbsp;[Proposals to be Voted Upon at the Annual Meeting](#tPVAM) | [9](#tPVAM) |
| &nbsp;&nbsp;&nbsp;[Recommendation of the Board](#tRB) | [9](#tRB) |
| &nbsp;&nbsp;&nbsp;[Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held Virtually on May 22, 2026](#tIRAP) | [9](#tIRAP) |
| &nbsp;&nbsp;&nbsp;[Attending the Annual Meeting](#tAAM) | [10](#tAAM) |
| &nbsp;&nbsp;&nbsp;[Voting at the Annual Meeting](#tVAM) | [10](#tVAM) |
| &nbsp;&nbsp;&nbsp;[Quorum Requirement for the Annual Meeting](#tQRAM) | [11](#tQRAM) |
| &nbsp;&nbsp;&nbsp;[Broker Non-Votes](#tBNV) | [12](#tBNV) |
| &nbsp;&nbsp;&nbsp;[Required Votes](#tRV) | [12](#tRV) |
| &nbsp;&nbsp;&nbsp;[Solicitation of Proxies](#tSP) | [12](#tSP) |
| **[CORPORATE GOVERNANCE](#tCG)** | **[13](#tCG)** |
| &nbsp;&nbsp;&nbsp;[Corporate Governance Guidelines and Codes of Ethics](#tCGG) | [13](#tCGG) |
| &nbsp;&nbsp;&nbsp;[Certain Relationships and Related Person Transactions](#tCRR) | [13](#tCRR) |
| &nbsp;&nbsp;&nbsp;[Stock Ownership Guidelines](#tSOG) | [14](#tSOG) |
| &nbsp;&nbsp;&nbsp;[Insider Trading Policy](#tITP) | [15](#tITP) |
| &nbsp;&nbsp;&nbsp;[Restrictions on "Hedging"](#tRH) | [15](#tRH) |
| &nbsp;&nbsp;&nbsp;[Restrictions on "Pledging"](#tRP) | [15](#tRP) |
| &nbsp;&nbsp;&nbsp;[Stockholder Engagement](#tSE) | [15](#tSE) |
| &nbsp;&nbsp;&nbsp;[Corporate Governance Best Practices](#tCGB) | [16](#tCGB) |
| &nbsp;&nbsp;&nbsp;[Board's Role in Risk Oversight](#tBRR) | [17](#tBRR) |
| **[COMPOSITION AND MEETINGS OF THE BOARD AND ITS COMMITTEES](#tCMB)** | **[20](#tCMB)** |
| &nbsp;&nbsp;&nbsp;[Board Independence and Leadership Structure](#tBIL1) | [20](#tBIL1) |
| &nbsp;&nbsp;&nbsp;[The Board of Directors and its Committees](#tTBD2) | [21](#tTBD2) |
| **[DIRECTOR NOMINATIONS AND COMMUNICATION WITH DIRECTORS](#tDNC)** | **[24](#tDNC)** |
| &nbsp;&nbsp;&nbsp;[Director Nomination Process](#tDNP) | [24](#tDNP) |
| &nbsp;&nbsp;&nbsp;[Contacting the Board of Directors](#tCDB2) | [25](#tCDB2) |
| ***[PROPOSAL NO. 1 – ELECTION OF DIRECTORS](#tPROP1)*** | **[26](#tPROP1)** |
| &nbsp;&nbsp;&nbsp;[Criteria for Evaluating Director Nominees](#tCED) | [26](#tCED) |
| **[2025 DIRECTOR COMPENSATION](#t2025)** | **[31](#t2025)** |
| **[EXECUTIVE COMPENSATION](#t12DC)** | **[33](#t12DC)** |
| &nbsp;&nbsp;&nbsp;[Compensation Discussion and Analysis](#tCDA) | [33](#tCDA) |
| **[MANAGEMENT DEVELOPMENT & COMPENSATION COMMITTEE REPORT](#tMDCC)** | **[51](#tMDCC)** |
| **[COMPENSATION TABLES AND DISCLOSURES](#tCTD)** | **[52](#tCTD)** |
| &nbsp;&nbsp;&nbsp;[Summary Compensation Table](#tSCT) | [52](#tSCT) |
| &nbsp;&nbsp;&nbsp;[2025 Grants of Plan-Based Awards](#tGPB) | [53](#tGPB) |
| &nbsp;&nbsp;&nbsp;[2025 Outstanding Equity Awards at Fiscal Year-End](#tOEA) | [55](#tOEA) |
| &nbsp;&nbsp;&nbsp;[Option Exercises and Stock Vested](#tOESV) | [57](#tOESV) |
| &nbsp;&nbsp;&nbsp;[Non-qualified Deferred Compensation](#tNQD) | [57](#tNQD) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>3</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;[Potential Payments Upon Termination or Change in Control](#tPPU) | [57](#tPPU) |
| &nbsp;&nbsp;&nbsp;[CEO Pay Ratio](#tCEO) | [65](#tCEO) |
| &nbsp;&nbsp;&nbsp;[Pay Versus Performance](#tPVP) | [66](#tPVP) |
| &nbsp;&nbsp;&nbsp;[Equity Compensation Plan Information](#tECP) | [70](#tECP) |
| ***[PROPOSAL NO. 2 – ADVISORY VOTE ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS](#tPROP2)*** | **[71](#tPROP2)** |
| ***[PROPOSAL NO. 3 – RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM](#tPROP3)*** | **[73](#tPROP3)** |
| &nbsp;&nbsp;&nbsp;[Principal Accountant Fees and Services](#tPAF) | [73](#tPAF) |
| &nbsp;&nbsp;&nbsp;[Audit Committee's Pre-Approval Policies and Procedures](#tACP) | [74](#tACP) |
| **[AUDIT COMMITTEE REPORT](#tACR)** | **[75](#tACR)** |
| **[BENEFICIAL OWNERSHIP OF COMMON STOCK](#tBOC)** | **[76](#tBOC)** |
| **[GENERAL MATTERS](#tGM)** | **[78](#tGM)** |
| &nbsp;&nbsp;&nbsp;[Availability of Certain Documents](#tACD) | [78](#tACD) |
| &nbsp;&nbsp;&nbsp;[Stockholder Proposals and Nominations](#tSPN) | [78](#tSPN) |
| &nbsp;&nbsp;&nbsp;[Other Matters](#tOM) | [79](#tOM) |
| **[CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS](#tANNXB)** | **[A-1](#tANNXB)** |
| **[GAAP NET INCOME AVAILABLE TO COMMON STOCKHOLDERS TO ADJUSTED EBITDA](#tANNXBB)** | **[B-1](#tANNXBB)** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>4</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

### PROXY STATEMENT SUMMARY
This summary highlights information that is contained elsewhere in this Proxy Statement. It does not include all information necessary to make a voting decision and you should read this Proxy Statement in its entirety before casting your vote.

#### Powering Purpose, Potential and Prosperity for Those Who Serve
*American Public Education, Inc. ("APEI") provides online and on-campus postsecondary education through American Public University System ("APUS"), Rasmussen University ("RU"), and Hondros College of Nursing ("HCN"). In March 2026, we combined the legal entities of these three institutions into one consolidated institution, operating under two divisions: APU Global, comprising American Military University and American Public University; and RU Health+, comprising Rasmussen University and Hondros College of Nursing. Our vision is for education that transforms lives, advances careers, and improves communities — by educating those who serve. Our institutions are purpose-built for the service-minded student, offering programs designed to prepare individuals for meaningful contributions to their profession and society, whether advancing in their current career or preparing for their next. In this Proxy Statement, "we," "our," "us," "the Company," and similar terms refer to APEI and its educational institutions collectively unless the context indicates otherwise.*

![](ny20064163x1_boxes1ax1.jpg)

#### Overview of Proposals

#### Item 1: Election of Directors
Our director nominees bring a mix of experience, backgrounds, and perspectives to the Board. The Board recommends a vote FOR each nominee. See page [26](#tPROP1).

#### Nominee Highlights
• *100% have strategy, risk management, and operational experience* 

• *Average tenure of independent director nominees: 4.5 years* 

• *Average age of nominees: 58 years old* 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>5</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Director Nominees

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Current**<br>**Committee**<br>**Memberships**  | **Current**<br>**Committee**<br>**Memberships**  | **Current**<br>**Committee**<br>**Memberships**  |
| <br>**Nominee** | <br>**Age** | <br>**Director**<br>**Since** | **AUD** | **MDC** | **NCG**  |
| **Granetta B. Blevins, *Independent<sup>(1)</sup>***<br>***Independent Consultant*** | 67 | 2020 | C |  | C  |
| **Michael D. Braner, *Independent*** <br>**Managing Member and Chief Compliance Officer, 325 Capital LLC** | 56 | 2023 | X | X |  |
| **Anna M. Fabrega, *Independent*** <br>**Former Chief Executive Officer, Local Bounti Corp.** | 47 | 2022 | X | C |  |
| **Daniel S. Pianko, *Independent*<sup>(</sup><sup>2</sup><sup>)</sup>** <br>**Co-Founder and Managing Director, Achieve Partners** | 49 | 2020 |  |  | X  |
| **Angela K. Selden** <br>**President and Chief Executive Officer of the Company** | 60 | 2019 |  |  |  |
| **Richard J. Statuto, *Independent*** <br>**Former President and Chief Executive Officer of Bon Secours Health System**  | 69 | 2025 |  | X | X |

---

---

| | | | |
|:---|:---|:---|:---|
| AUD | Audit Committee | (1) | Audit Committee Financial Expert  |
| MDC | Management Development & Compensation Committee | (2) | Board Chair  |
| NCG | Nominating and Corporate Governance Committee |  |  |
| C | Committee Chair |  |  |
| X | Committee Member |  |  |

---

#### Item 2: Compensation Paid to our Named Executive Officers
We are holding a non-binding advisory vote on the compensation paid to our named executive officers as disclosed in our Proxy Statement for the Annual Meeting. The Board recommends a vote FOR this proposal. See page [71](#tPROP2).

#### Item 3: Ratification of Independent Auditors
We are asking our stockholders to ratify the appointment of Deloitte & Touche LLP ("Deloitte") as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. The Board recommends a vote FOR this proposal. See page [73](#tPROP3).

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>6</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Corporate Governance and Stockholder Engagement Highlights

#### Best Practices

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **✔** | **Highly independent board** <br>▪ <br>Five of our six director nominees are independent <br>▪ <br>All Board committees are 100% independent <br>▪ <br>Active Board refreshment; four of our six non-employee directors joined the Board within the last five years | **✔** | **Board oversight of corporate responsibility efforts** |  |  |
| **✔** | **Highly independent board** <br>▪ <br>Five of our six director nominees are independent <br>▪ <br>All Board committees are 100% independent <br>▪ <br>Active Board refreshment; four of our six non-employee directors joined the Board within the last five years | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR))  |  |  |
| **✔**  | **Annual elections of all directors** | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR))  |  |  |
| **✔** | **Independent Board Chair** | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR))  |  |  |
| **✔** | **Restrictions on hedging and pledging** | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR))  |  |  |
| **✔** | **Equity ownership guidelines**<br>▪ 6x annual base salary for our CEO <br>▪ <br>3x annual base salary for our CFO and 2x for all other executive officers <br>▪ <br>3x annual base retainer for non-employee directors | **Equity ownership guidelines**<br>▪ 6x annual base salary for our CEO <br>▪ <br>3x annual base salary for our CFO and 2x for all other executive officers <br>▪ <br>3x annual base retainer for non-employee directors | **Equity ownership guidelines**<br>▪ 6x annual base salary for our CEO <br>▪ <br>3x annual base salary for our CFO and 2x for all other executive officers <br>▪ <br>3x annual base retainer for non-employee directors | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR))  |

---

#### Stockholder Engagement
We believe regular communication with our stockholders and the financial community is essential for both transparency and long-term value creation. Throughout 2025, our Chief Executive Officer, Chief Financial Officer, and Chief Strategy and Growth Officer actively engaged with investors across conferences, non-deal roadshows, and one-on-one meetings. In November 2025, we hosted our inaugural Investor Day, providing a detailed overview of our multi-year growth framework and the strategic and financial rationale for the planned institutional combination. Following earnings releases and other material company developments, we conducted timely meetings with investors and analysts to ensure ongoing transparency. These interactions covered a range of topics, including our long-term strategy, planned institutional combination progress and new segment structure, healthcare campus expansion, recent operating and financial performance, capital allocation actions, and regulatory profile.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>7</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Executive Compensation Highlights
Our executive compensation program is designed to attract, incentivize, retain, and reward the talent that we need to maintain and strengthen our position in career-minded adult education and to achieve our business objectives. We tie executive compensation to objective performance metrics to hold our executives accountable for our actual business performance.

Below is a breakdown of the components of Ms. Selden's target compensation opportunity for 2025. Approximately 82% of her total compensation opportunity was performance-based or variable and at risk.

![](ny20064163x1_piechart05.jpg)

\* Due to rounding, sums may not equal 100% or the totals indicated.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>8</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### ABOUT THE ANNUAL MEETING

#### Purpose of the Annual Meeting
The purpose of the Annual Meeting is for our stockholders to consider and act upon the proposals described in this Proxy Statement and any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof. In addition, management will report on the performance of the Company and respond to questions from stockholders.

#### Proposals to be Voted Upon at the Annual Meeting
At the Annual Meeting, our stockholders will be asked to consider and vote upon the following three proposals:

&nbsp;&nbsp;&nbsp;&nbsp;•  ***Proposal No. 1*** : To elect to the Board the six nominees set forth in this Proxy Statement, each of whom will hold office until the next annual meeting of stockholders and until such nominee's successor is elected and qualified or until such nominee's earlier death, resignation, or removal.

&nbsp;&nbsp;&nbsp;&nbsp;•  ***Proposal No. 2*** : To approve, on a non-binding, advisory basis, the compensation paid to our named executive officers as disclosed in this Proxy Statement.

&nbsp;&nbsp;&nbsp;&nbsp;•  ***Proposal No. 3*** : To ratify the appointment of Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

In addition, any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof will be considered. Management is presently aware of no other business to come before the Annual Meeting.

#### Recommendation of the Board
The Board recommends that you vote FOR each of the nominees to the Board (Proposal No. 1), FOR approval of the compensation paid to our named executive officers (Proposal No. 2), and FOR ratification of the appointment of Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2026 (Proposal No. 3).

#### Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held Virtually on May 22, 2026
Pursuant to the "notice and access" rules of the Securities and Exchange Commission (the "SEC"), we have elected to provide stockholders access to our proxy materials over the Internet. Accordingly, we sent a Notice of Internet Availability of Proxy Materials (the "Notice") on or about April 9, 2026, to all of our stockholders as of the close of business on March 26, 2026 (the "Record Date"). The Notice includes instructions on how to access our proxy materials over the Internet and how to request a printed copy of these materials. In addition, by following the instructions in the Notice, stockholders may request to receive proxy materials in printed form by mail or electronically by e-mail on an ongoing basis.

Choosing to receive your future proxy materials by e-mail will save us the cost of printing and mailing documents to you and will reduce the impact of our annual meetings on the environment. If you choose to receive future proxy materials by e-mail, you will receive an e-mail next year with instructions containing a link to those materials and a link to the proxy voting site. Your election to receive proxy materials by e-mail will remain in effect until you terminate it.

Our Annual Report to Stockholders and this Proxy Statement are available at *www.proxyvote.com*.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>9</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Attending the Annual Meeting
The Annual Meeting will be a completely virtual meeting to be held over the Internet. The virtual meeting will enable expanded stockholder participation for those who might not otherwise attend in person.

Whether you are a stockholder of record or hold your shares in "street name," you may participate in and vote online at the Annual Meeting by visiting *www.virtualshareholdermeeting.com/APEI2026* and using the 16-digit control number included on your Notice, on your proxy card, or on the instructions that accompanied your proxy materials to enter the Annual Meeting.

The virtual meeting platform is fully supported across common browsers (Microsoft Edge, Firefox, Chrome, and Safari) and devices (desktops, laptops, tablets, and cell phones) running the most updated version of applicable software. Participants should ensure that they have a strong internet or Wi-Fi connection to participate in the Annual Meeting. Participants should also give themselves plenty of time to dial-in to the conference call or log in and ensure that they can hear audio prior to the start of the Annual Meeting. We encourage stockholders wishing to attend the Annual Meeting to visit *www.virtualshareholdermeeting.com/APEI2026* in advance of the meeting to verify their internet connection.

If you have questions regarding how to attend and participate in the Annual Meeting or encounter any technical difficulties with the virtual meeting platform on the meeting day, please call 844-986-0822 (Toll Free) or 303-562-9302 (International Toll). Technical support will be available starting at 8:15 a.m. EDT on May 22, 2026.

If you wish to submit a question, you may do so in a few ways. If you want to submit a question before the meeting, then beginning April 16, 2026, and until 11:59 p.m. EDT on May 21, 2026, you may log into *www.proxyvote.com* and enter your 16-digit control number. Once past the login screen, click on "Question for Management," type in your question or comment, and click "Submit." Alternatively, if you want to submit your question or make a comment during the meeting, log into the virtual meeting platform at *www.virtualshareholdermeeting.com/APEI2026*, type your question into the "Ask a Question" field, and click "Submit". Any e-mailed questions or comments will need to include your 16-digit control number in order to be addressed at the meeting.

Questions and comments submitted via the virtual meeting platform that are pertinent to meeting matters will be addressed during the meeting. Consistent with our approach when the annual meetings were held in person, questions or comments that are not related to the proposals under discussion, are about personal concerns not shared by stockholders generally, or use blatantly offensive language may be ruled out of order. In the unlikely event that the volume of questions increases to the point that time constraints prohibit us from answering all pertinent questions, the remaining pertinent questions will be answered on our Investor Relations site.

A webcast of the Annual Meeting will be archived and accessible through May 21, 2027.

#### Voting at the Annual Meeting
The Board is soliciting your vote at the Annual Meeting or at any later meeting should the scheduled annual meeting be adjourned or postponed for any reason. Stockholders will be entitled to vote at the Annual Meeting on the basis of each share held of record at the close of business on the Record Date.

If on the Record Date you hold shares of our common stock that are represented by stock certificates or registered directly in your name with our transfer agent, Equiniti Trust Company, LLC ("Equiniti"), you are considered the stockholder of record with respect to those shares, and Equiniti is sending these proxy materials directly to you on our behalf. As a stockholder of record, you may vote online at the meeting or by proxy via Internet, mail, or telephone. Whether or not you plan to attend the Annual Meeting online, you may vote over the Internet by following the instructions in the Notice. If you request printed copies of the proxy

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>10</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
materials by mail, you may also vote by submitting your vote by telephone or by signing and submitting your proxy card. Whether or not you plan to attend the Annual Meeting, we urge you to vote by way of the Internet, by telephone, or by filling out and returning the proxy card you will receive upon request of printed materials. If you submit a proxy but do not give voting instructions as to how your shares should be voted on a particular proposal at the Annual Meeting, your shares will be voted in accordance with the recommendations of the Board stated in this Proxy Statement.

Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time before its use by (1) delivering a written notice of revocation addressed to American Public Education, Inc., Attn: Corporate Secretary, 303 West 3<sup>rd</sup> Avenue, Ranson, West Virginia 25438, (2) submitting a duly executed proxy bearing a later date, (3) voting again by Internet or by telephone, or (4) attending the Annual Meeting and voting online. Your last vote or proxy will be the vote or proxy that is counted. Attendance at the Annual Meeting will not cause your previously granted proxy to be revoked unless you vote at the Annual Meeting or specifically so request.

If on the Record Date you hold shares of our common stock in an account with a brokerage firm, bank, or other nominee, then you are a beneficial owner of the shares and hold such shares in street name, and these proxy materials will be forwarded to you by that organization or person. As a beneficial owner, you have the right to direct your broker, bank, or other nominee on how to vote the shares held in its account, and the nominee has enclosed or provided voting instructions for you to use in directing it how to vote your shares. The nominee that holds your shares, however, is considered the stockholder of record for purposes of voting at the Annual Meeting. Because you are not the stockholder of record, you may not vote your shares online at the Annual Meeting unless you use your 16-digit control number to enter the meeting.

Whether or not you plan to attend the Annual Meeting, we urge you to vote by following the voting instructions provided to you to ensure that your vote is counted should you later decide not to attend the Annual Meeting.

If you are a beneficial owner and do not vote, and your broker, bank or other nominee does not have discretionary power to vote your shares, your unvoted shares may constitute "broker non-votes." Unvoted shares that constitute broker non-votes will be counted for the purpose of establishing a quorum at the Annual Meeting. Voting results will be tabulated and certified by the inspector of elections appointed for the Annual Meeting. If you receive more than one Notice, it is because your shares are registered in more than one name or are registered in different accounts. Please follow the instructions on each Notice received to ensure that all of your shares are voted.

A list of stockholders of record as of the Record Date will be available for inspection during ordinary business hours at our offices located at 111 W. Congress Street, Charles Town, West Virginia 25414, for ten days immediately preceding the day before the date of our Annual Meeting to the date of our Annual Meeting. Stockholders may contact our Corporate Secretary and arrangements will be made to review the records in person.

#### Quorum Requirement for the Annual Meeting
The presence at the Annual Meeting, whether online or by valid proxy, of the persons holding a majority of shares of common stock entitled to vote at the meeting will constitute a quorum, permitting us to conduct our business at the Annual Meeting. On the Record Date, there were 18,411,154 shares of common stock outstanding, held by 386 stockholders of record. Abstentions (*i.e.*, if you or your broker mark "ABSTAIN" on a proxy) and "broker non-votes" will be considered to be shares present at the meeting for purposes of a quorum.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>11</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Broker Non-Votes
Broker non-votes occur when shares held by a broker for a beneficial owner are not voted with respect to a particular proposal and generally occur because the broker (1) does not receive voting instructions from the beneficial owner and (2) lacks discretionary authority to vote the shares. Brokers and other nominees have discretionary authority to vote on routine matters, such as the ratification of an independent public accounting firm, for clients who have not provided voting instructions. However, without voting instructions from their clients, they cannot vote on "non-routine" proposals, including the election of directors, approval of amendments to stock plans, and matters related to executive compensation.

#### Required Votes
***Election of directors. Each director will be elected by the vote of the majority of the votes cast with respect to that director's election. For purposes of electing directors, a majority of the votes cast means that the number of shares voted "FOR" a director's election exceeds the number of the votes cast against that director's election. Abstentions and broker non-votes are not taken into account in determining the outcome of the election of directors.***

***The advisory vote on executive compensation, and the ratification of our independent public accounting firm. The advisory vote on compensation paid to our named executive officers, and ratification of the Audit Committee's appointment of Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2026 each requires the affirmative vote of the holders of at least a majority of the shares of common stock present or represented by proxy at the Annual Meeting and entitled to vote. Broker non-votes are not taken into account in determining the outcome of these proposals, and abstentions will have the effect of a vote against each of these proposals.***

#### Solicitation of Proxies
We will bear the cost of solicitation of proxies. This includes the charges and expenses of brokerage firms and others for forwarding solicitation material to beneficial owners of our outstanding common stock. We have retained Georgeson LLC to assist in the distribution of proxy materials and the solicitation of proxies from brokerage firms, fiduciaries, custodians, and other similar organizations representing beneficial owners of shares for the Annual Meeting. We have agreed to pay Georgeson LLC a fee of approximately $13,000 plus out-of-pocket expenses. We may solicit proxies by mail, personal interview, telephone, or via the Internet through our officers, directors, and other management employees, who will receive no additional compensation for their services.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>12</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### CORPORATE GOVERNANCE
The Board has adopted Corporate Governance Guidelines (the "Guidelines"), a Code of Business Conduct and Ethics (the "Code of Conduct"), a Policy for Related Person Transactions and other policies as part of our corporate governance practices and in accordance with rules of the SEC and the listing standards of The Nasdaq Stock Market ("Nasdaq").

The Guidelines, Code of Conduct, and Policy for Related Person Transactions are reviewed periodically by our Nominating and Corporate Governance Committee (the "NCG Committee"), and changes are recommended to the Board for approval as appropriate.

#### Corporate Governance Guidelines and Codes of Ethics
The Guidelines set forth a framework to assist the Board in the exercise of its responsibilities. The Guidelines cover, among other things, the composition and certain functions of the Board, director independence, stock ownership by our non-employee directors, management succession and review, Board committees, the selection of new directors, and director expectations.

The Code covers, among other things, compliance with laws, rules and regulations, conflicts of interest, corporate opportunities, confidentiality, protection and proper use of Company assets, cybersecurity, and the reporting process for any illegal or unethical conduct. The Code of Conduct is applicable to all of our officers, directors, and employees. We also have a separate code of ethics (together with the Code of Conduct, the "Codes of Ethics") that is specifically applicable to our Chief Executive Officer, Chief Financial Officer, and other Principal Officers (as defined therein).

Any waiver of either Code of Ethics for our directors, executive officers, or Principal Officers may be made only by the Board and will be promptly disclosed as may be required by law, regulation, or rule of the SEC, or Nasdaq listing standards. If we further amend either Code of Ethics or waive any provision of either Code of Ethics with respect to our Chief Executive Officer, Chief Financial Officer, or other Principal Officers, we will post the amendment or waiver on our corporate website, *www.apei.com*. The information on our corporate website is not incorporated by reference into this Proxy Statement.

The Guidelines and Codes of Ethics are available in the Governance section of our corporate website.

#### Certain Relationships and Related Person Transactions

#### Policies and Procedures for Related Person Transactions
As a supplement to and extension of our Codes of Ethics, the Board has adopted a Policy for Related Person Transactions pursuant to which our Audit Committee, another independent committee of the Board consisting of independent directors, or the full Board must give prior consent before we may enter into a related person transaction with our executive officers, directors, nominees for director and principal stockholders, including their immediate family members and affiliates. Any request for us to enter into a related person transaction with an executive officer, director, nominee for director, principal stockholder or any of such persons' immediate family members or affiliates must first be presented to our Audit Committee for review, consideration, and approval. A related person transaction is a transaction in which the Company is or will be a participant and in which a related person has or will have a direct or indirect material interest, other than (i) a transaction involving $120,000 or less when aggregated with all related transactions, (ii) a transaction involving compensation to an executive officer that is approved by the Board or the Management Development and Compensation Committee (the "MDC Committee"), (iii) a transaction involving compensation to a director or director nominee that is approved by the Board or the MDC Committee, and (iv) any other transaction that is not required to be reported pursuant to Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All of our directors, executive officers, and employees are required to report to our Audit Committee any such related person transaction.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>13</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
In approving or rejecting a proposed related person transaction, our Audit Committee considers the facts and circumstances available and deemed relevant to the Audit Committee, including, but not limited to, the risks, costs and benefits to us, the terms of the transaction, the availability of other sources for comparable services or products, and, if applicable, the impact on a director's independence. Our Audit Committee approves only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our Audit Committee determines in the good faith exercise of its discretion. Under the policy, if we discover related person transactions that have not been approved, the Audit Committee will be notified and will determine the appropriate action, including ratification, rescission, or amendment of the transaction.

#### Related Person Transactions
There have been no related person transactions since the beginning of 2025, and there are no currently proposed related person transactions.

#### Stock Ownership Guidelines
To further align the interests of our executive officers and directors with the interests of our stockholders, and after evaluation of best practices and consultation by the MDC Committee with Willis Towers Watson, its independent consultant, the Board has implemented stock ownership guidelines applicable to our executive officers and directors.

Each executive officer is expected to hold shares of common stock with an aggregate value greater than or equal to a multiple of the executive officer's base salary as set forth below:

&nbsp;&nbsp;&nbsp;&nbsp;• our Chief Executive Officer — six times base salary;

&nbsp;&nbsp;&nbsp;&nbsp;• our Chief Financial Officer — three times base salary; and

&nbsp;&nbsp;&nbsp;&nbsp;• all other executive officers — two times base salary.

Each of our non-employee directors is expected to hold shares of common stock with an aggregate value greater than or equal to at least three times the amount of the annual retainer paid to non-employee directors for service on the Board, excluding additional committee retainers, if any.

Under the stock ownership guidelines, common stock held directly, including shares of common stock held in a separate brokerage account or in a 401(k) account, and common stock held indirectly (*e.g.*, by a spouse, minor dependent, or a trust for the benefit of the executive or director, or the executive's or director's spouse or minor dependent), count toward satisfaction of the levels set forth in the guidelines including shares of Common Stock underlying restricted stock awards subject to time-based vesting that are not, or are no longer, also subject to performance conditions. For purposes of the guidelines, the "value" of the common stock is based on the 60-day trailing average closing stock price on the day on which a determination under the guidelines is being made, which is annually on the last business day of each year.

Each of our executive officers is expected to satisfy the requisite stock ownership level within five years of the date the person first became an executive officer. Executive officers are required to retain seventy-five percent (75%) of the net shares of common stock acquired pursuant to restricted stock or option awards made after the adoption of these guidelines until the requisite stock ownership level is achieved. "Net shares" are those shares that remain after shares are sold or withheld to pay withholding taxes and/or the exercise price of stock options, if applicable. Each of our non-employee directors is expected to achieve the stock ownership level within five years of the date such person first becomes a non-employee director. As of December 31, 2025, all of our executive officers and continuing directors were in compliance with the stock ownership guidelines, to the extent required.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>14</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Insider Trading Policy
The Company has adopted an insider trading policy that governs the purchase, sale, and/or other dispositions of our securities by directors, officers, employees and certain consultants, and persons under each of their control or influence, and part-time faculty, and is designed to promote compliance with insider trading laws, rules, and regulations and applicable exchange listing requirements. A copy of our insider trading policy was filed as Exhibit 19.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. In addition, with regard to the Company's trading in its own securities, it is the Company's practice to comply with applicable securities laws and exchange listing requirements.

#### Restrictions on "Hedging"
We have adopted a policy prohibiting our directors, officers, and employees from engaging in short sales, transactions in derivative securities (including put and call options), or other forms of hedging and monetization transactions, such as zero-cost collars, equity swaps, exchange funds, and forward sale contracts, that allow the holder to limit or eliminate the risk of a decrease in the value of our securities. We have adopted this policy in order to align the interests and objectives of individuals subject to the policy with those of our stockholders.

#### Restrictions on "Pledging"
We have adopted a policy prohibiting our directors and officers from holding our securities in margin accounts, pledging our securities as collateral or maintaining an automatic rebalance feature in savings plans, deferred compensation, or deferred fee plans. This prohibition is to avoid sales of our securities on behalf of an individual related to margin calls, loan defaults, and automatic rebalances, which may occur when the individual has material nonpublic information regarding the Company.

#### Stockholder Engagement
We consider stockholder engagement to be an important corporate governance practice. Regular dialogue with stockholders not only strengthens our relationship with the financial community but also helps stockholders make informed investment decisions, evaluate our long-term financial performance, and assess our business practices. Through this engagement, we receive valuable feedback that helps inform our decisions regarding strategy, executive compensation, and corporate governance, each of which we believe is critical contributors to our long-term success.

Our investor meetings are attended by one or more members of our management team, including our Chief Executive Officer, Chief Financial Officer, and Chief Strategy and Growth Officer. Throughout 2025, management participated in numerous investor meetings across conferences, non-deal roadshows, and direct one-on-one meetings with existing and prospective investors. In November 2025, we hosted our inaugural Investor Day, where we presented our multi-year growth framework and the strategic rationale for the planned institutional combination to a broad audience of institutional investors and analysts. We also held meetings following key company updates, including earnings releases and material corporate developments.

The focus of our 2025 investor interactions spanned a wide variety of topics, including our long-term growth strategy, planned institutional combination progress and new organizational structure (APU Global and RU Health+), healthcare campus expansion plans, recent operating and financial performance, capital allocation actions, and regulatory profile.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>15</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Corporate Governance Best Practices

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **✔** | **Highly independent board** <br>▪ <br>Five of our six director nominees are independent <br>▪ <br>All Board committees are 100% independent <br>▪ <br>Active Board refreshment; four of our six non-employee directors joined the Board within the last five years | **✔** | **Board oversight of corporate responsibility efforts** |  |  |
| **✔** | **Highly independent board** <br>▪ <br>Five of our six director nominees are independent <br>▪ <br>All Board committees are 100% independent <br>▪ <br>Active Board refreshment; four of our six non-employee directors joined the Board within the last five years | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk <br>management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR)) |  |  |
| **✔** | **Annual elections of all directors**  | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk <br>management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR)) |  |  |
| **✔** | **Independent Board Chair**  | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk <br>management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR)) |  |  |
| **✔** | **Restrictions on hedging and pledging** | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk <br>management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR)) |  |  |
| **✔** | **Equity ownership guidelines**<br>▪ <br>6x annual base salary for our CEO<br>▪ <br>3x annual base salary for our CFO and 2x for all other executive officers<br>▪ <br>3x annual base retainer for non-employee directors | **Equity ownership guidelines**<br>▪ <br>6x annual base salary for our CEO<br>▪ <br>3x annual base salary for our CFO and 2x for all other executive officers<br>▪ <br>3x annual base retainer for non-employee directors | **Equity ownership guidelines**<br>▪ <br>6x annual base salary for our CEO<br>▪ <br>3x annual base salary for our CFO and 2x for all other executive officers<br>▪ <br>3x annual base retainer for non-employee directors | **✔** | **Risk management oversight** <br>▪ <br>Board has principal responsibility for risk <br>management oversight <br>▪ <br>Board regularly meets with management to receive reports <br>▪ <br>Nominating and Corporate Governance, Management Development and Compensation, and Audit Committees each have responsibility for certain risk areas as outlined under "Board's Role in Risk Oversight" (page [17](#tBRR)) |

---

#### Our Commitment to Corporate Responsibility
We believe that our intrinsic value can be measured by the impact of our activities on the communities that we serve. Our Board is responsible for overseeing and supporting our commitment to positive environmental and social impact, and our governance practices. Our NCG Committee assists the Board in this oversight, including by overseeing our strategy and activities related to corporate responsibility. We also continue to leverage a management-led committee that reports to our Chief Executive Officer and supports management's execution of our corporate responsibility efforts and development of our corporate responsibility strategy. In terms of environmental impact, APUS is a signatory to the American College & University Presidents' Climate Commitment, pursuant to which we committed to work toward carbon neutrality, inventory our emissions, integrate sustainability into our curriculum, and make related information publicly available. As an online school, APUS has an inherently lower carbon footprint than traditional brick-and-mortar universities. Both RU and HCN combine online and hybrid course offerings with conveniently located campuses reducing commutes and thereby limiting pollution. We also actively engage with a third-party environmental consultant to measure our greenhouse gas emissions and analyze our environmental impact. In addition to creating positive environmental impacts, we believe that our Company should have a positive impact on the communities in which we live and work. Our many volunteer and community service projects often emerge organically from the ideas and passions of our students and employees. To help support those efforts, we continue to provide all full-time employees with paid volunteer time off.

#### Our Commitment to Our People
Our ability to deliver on our corporate mission and to continue to transform our enterprise to focus on sustainable growth is tightly aligned with our human capital strategy. Our performance largely depends on the talents, experience, and efforts of our employees, and on our ability to foster a culture and practice of high performance, innovation, cooperation, integrity, and respect. During 2025, we continued to strengthen our executive leadership teams across APUS, RU, and HCN (each, an "institution") and at APEI. Our strong executive leadership across the enterprise is critical to our ability to deliver a quality student experience and to deliver on our business objectives. We have seen the positive impact of our strengthened executive team on our growth and transformation efforts. A strong executive team will continue to help grow our Company into the future. Throughout 2025, we saw the benefits of more of our key human capital efforts being

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>16</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
centralized. Our common talent acquisition methodology and common talent management and talent review process have allowed us to more consistently address talent needs across the enterprise. During 2025, we implemented new sourcing strategies to attract talent and centralized our faculty recruitment processes. We offer a total rewards and benefits package across the enterprise ensuring that we have a market competitive set of offerings for all employees.

We continue to partner holistically to provide a consistent, proactive approach to employee communication. Meaningful employee communication is key to driving connectivity, engagement, and efficiencies. We are committed to ensuring that all employees experience a positive and supportive work environment and that all employees and students experience a sense of belonging at APEI and our institutions.

We measure employee engagement on an ongoing basis by soliciting feedback in order to understand the views of our employees and faculty, both full-time and part-time. In 2025, we conducted a comprehensive employee engagement survey. The results from that survey, which showed notable improvement compared to prior years, are being actively used to implement programs and processes designed to enhance employee and faculty engagement and improve the overall employee experience and, therefore, the student experience.

Our strategic initiatives require our management, faculty, staff, and skilled personnel to perform at a high level and to adapt and learn new skills and capabilities. We believe that the quality of faculty is critical to the student experience and student outcomes and is therefore vital to the success of our institutions. As a result, all faculty have annual development opportunities and requirements. We continue to enhance our centralized talent and transformation team to focus on improving internal learning and development practices and succession planning to ensure that we cultivate skills needed to deliver high quality student outcomes and help grow our operations. We continue to leverage and expand the offerings in our learning management system as a tool to ensure a consistent investment in leadership capabilities across APEI.

#### Board's Role in Risk Oversight
Our management is responsible for managing risks in our business, including by developing processes to monitor and control risks. The Board views its role as one of oversight and of responsibility for setting a tone that risk management should be properly integrated with our strategy and culture. The Board focuses on understanding management's risk management processes, the effectiveness of those processes, and the way in which management proactively manages risks. The Board regularly meets with our management, particularly our Chief Executive Officer, Chief Financial Officer, Chief Innovation and Technology Officer, and General Counsel, to receive updates on how management is assessing and managing risk in particular functional areas of our business, as well as monitors risks that have been delegated to its committees. The Board and its committees also request and receive regular reports from management on particular areas of risk, such as cybersecurity and threats to technology infrastructure.

The Board's committees assist the Board in carrying out its oversight of risks, and each of the committee charters specifically address issues of risk. Pursuant to the Guidelines, the Board is expected to specifically consider risks that relate to our reputation and the general industry in which we operate, including with respect to privacy, information technology and cybersecurity, and threats to technology infrastructure. The Audit Committee assists the Board in overseeing management's development and the application of its approach for the assessment and management of risks, including strategic, operational, regulatory, information, external, and other significant non-financial risks in the business of the Company and reviews and assesses the qualitative aspects of financial reporting and our processes to manage financial and financial reporting risk. The Audit Committee regularly reports its findings to the Board.

While the Audit Committee has primary responsibility for assisting the Board with its risk oversight responsibilities, the NCG Committee and MDC Committee also assist the Board with risk oversight. The NCG Committee considers and makes recommendations on how the Board is approaching its role of risk oversight. The NCG Committee also has responsibility for oversight of corporate responsibility-related risks.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>17</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
The MDC Committee is responsible for the oversight of our human capital policies, programs, initiatives, and strategies. When establishing executive compensation and director compensation and in its role in implementing incentive compensation plans, the MDC Committee considers whether compensation practices properly take into account an appropriate risk-reward relationship or encourage unnecessary and excessive risks. The MDC Committee has concluded that our compensation policies and practices are not reasonably likely to have a material adverse effect on the Company; this conclusion has been confirmed by the Board.

The performance, reliability, and security of the networks and technology infrastructure we use or rely on is critical to our operations, our institutions' reputation, and our ability to attract and retain students. The Board regularly reviews our cybersecurity and other information technology risks, controls, and procedures, including plans to mitigate such risks and respond to any cyber incidents. The Board receives regular reports from our Chief Innovation and Technology Officer, formerly titled "Chief Technology Officer", on these and related topics, including management's approach to cybersecurity and potential investments in additional cybersecurity capabilities on a regular basis. Our Chief Innovation and Technology Officer reported to the Board at each of its regularly scheduled quarterly meetings in 2025. In 2025, the Board monitored and received quarterly briefings on the Company's cybersecurity program. The team continued to grow and strengthen the cybersecurity posture through investments in staffing, third-party service providers, and a comprehensive set of processes and policies, which further strengthens and matures our cybersecurity program.

We have determined that the Board rather than any one committee alone is currently the appropriate body for the oversight of cybersecurity risk because of the criticality and centrality of information technology to our business, and because we believe the Board should specifically consider risks related to our reputation and the general industry in which we operate, including with respect to privacy, information technology, and cybersecurity and threats to technology infrastructure. However, the Board has delegated to the Audit Committee certain oversight responsibilities with respect to our cybersecurity disclosures.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>18</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

The following table highlights the roles of the Board and each committee in risk oversight:

---

| | |
|:---|:---|
| **The Board**  | **The Board**  |
| •  | &nbsp;&nbsp;Assesses management's risk management processes, the effectiveness of those processes, and the way in which management proactively manages risks.  |
| &nbsp;&nbsp;&nbsp;&nbsp;•  | &nbsp;&nbsp;Receives and reviews regular reports provided by management, and monitors risks that have been delegated to its three standing committees.  |
| &nbsp;&nbsp;&nbsp;&nbsp;•  | &nbsp;&nbsp;Considers risks that relate to the reputation of our Company and the general industry in which we operate, including with respect to privacy, information technology and cybersecurity, and threats to technology infrastructure. |

---

---

| | | |
|:---|:---|:---|
| **Nominating and Corporate** <br>**Governance Committee** | **Audit Committee** | **Management Development &** <br>**Compensation Committee**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Considers and makes recommendations regarding how the Board approaches its role of risk oversight.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>&nbsp;&nbsp;&nbsp;&nbsp;• Assists the Board in overseeing our strategy and activities related to corporate responsibility.<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assists the Board in overseeing management's development and the application of its approach to the assessment and management of processes, the effectiveness of those processes, and management of strategic, operational, regulatory, information, external, and other significant risks.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Discusses financial and financial reporting risk exposures.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Discusses the steps management has taken to monitor and control such exposures, including our risk assessment and risk management policies.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Receives and reviews the annual report from management regarding the manner in which we are assessing and managing our exposure to financial and financial reporting risks.<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Considers whether our compensation policies and practices properly take into account an appropriate risk-reward relationship or encourage unnecessary and excessive risks.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Oversees human capital management efforts and alignment, including any related risks.<br>|

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>19</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

### COMPOSITION AND MEETINGS OF THE BOARD

### AND ITS COMMITTEES
The following table details certain basic information on our current directors, the current composition of the Board and its standing committees, and the number of meetings held during the year ended December 31, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Nominee** | **Age** | **Director** <br>**Since** | **Current**<br>**Committee**<br>**Memberships**  | **Current**<br>**Committee**<br>**Memberships**  | **Current**<br>**Committee**<br>**Memberships**  |
| **Nominee** | **Age** | **Director** <br>**Since** | **AUD** | **MDC** | **NCG**  |
| **Granetta B. Blevins, *Independent*<sup>(1)</sup>**<br>**Independent Consultant** | 67 | &nbsp;&nbsp;&nbsp;2020 | &nbsp;&nbsp;C |  | &nbsp;&nbsp;C  |
| **Michael D. Braner, *Independent*** <br>**Managing Member and Chief Compliance Officer,**<br>**325 Capital LLC** | 56 | &nbsp;&nbsp;&nbsp;2023 | &nbsp;&nbsp;X | &nbsp;&nbsp;&nbsp;X |  |
| **Anna M. Fabrega, *Independent*** <br>**Former Chief Executive Officer, Local Bounti Corp.** | 47 | &nbsp;&nbsp;&nbsp;2022 | &nbsp;&nbsp;X | &nbsp;&nbsp;&nbsp;C |  |
| **Daniel S. Pianko, *Independent*<sup>(</sup><sup>2</sup><sup>)</sup>** <br>**Co-Founder and Managing Director, Achieve Partners** | 49 | &nbsp;&nbsp;&nbsp;2020 |  |  | &nbsp;&nbsp;X  |
| **Angela K. Selden** <br>**President and Chief Executive Officer of the Company** | 60 | &nbsp;&nbsp;&nbsp;2019 |  |  |  |
| **Richard J. Statuto, *Independent*** <br>**Former President and Chief Executive Officer of Bon Secours Health System**  | 69 | &nbsp;&nbsp;&nbsp;2025 |  | &nbsp;&nbsp;&nbsp;X | &nbsp;&nbsp;X  |
| *2025 Meetings*  | Board: | 12 | &nbsp;&nbsp;5 | &nbsp;&nbsp;&nbsp;5 | &nbsp;&nbsp;7 |

---

---

| | | | |
|:---|:---|:---|:---|
| AUD | Audit Committee |  |  |
| MDC | Management Development & Compensation Committee | (1) | Audit Committee Financial Expert  |
| NCG | Nominating and Corporate Governance Committee | (2)  | Board Chair  |
| C | Committee Chair |  |  |
| X | Committee Member |  |  |

---

#### Board Independence and Leadership Structure
The Board believes, and the Guidelines require, that a substantial majority of its members must be independent directors. In addition, the respective charters of the Audit, MDC, and NCG Committees currently require that each member of such committees be independent. Consistent with Nasdaq's independence criteria, the Board has affirmatively determined that all of our directors are independent, with the exception of Ms. Selden, our President and Chief Executive Officer. Nasdaq's independence criteria include a series of objective tests, such as that the director is not an employee of the Company and has not engaged in various types of business dealings with us. In addition, as further required by Nasdaq rules, the Board has made a subjective determination as to each independent director that no relationship exists that, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations, the Board reviewed and discussed any information provided by the directors and management with regard to each director's business and personal activities that may relate to us and our management.

In accordance with the Guidelines, the independent members of the Board hold at least two "executive session" meetings each year. If the Board Chair were not an independent director, an independent chair

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>20</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
would be selected for each executive session. These meetings serve as a forum to discuss the annual evaluation of the Chief Executive Officer's performance, the annual review of the Chief Executive Officer's plan for management succession, and such other topics as the independent directors deem necessary or appropriate.

The Guidelines specify that the Board shall select its Chair based on the Board's determination of what is then in our best interests. Historically, we have split the positions of the Board Chair and Chief Executive Officer because we believe that this structure is appropriate at this time given the differences between the two roles in our management structure. We believe that an independent Chair is in our best interests and those of our stockholders and provides a strong leadership structure and sound governance foundation for working with the Board, the Company's Chief Executive Officer, and management to establish and further our strategic objectives. Our Chief Executive Officer, among other duties, is responsible for implementing the strategic direction for the Company and for the day-to-day leadership and performance of the Company, while the Board Chair, among other responsibilities, provides guidance to the Chief Executive Officer and presides over meetings of the full Board. Currently, Ms. Selden serves as our Chief Executive Officer, and Mr. Pianko serves as our Board Chair.

#### The Board of Directors and its Committees
Each Board committee consists only of directors who are not employees of the Company and who are "independent" as defined by Nasdaq rules. The Board and its committees meet regularly throughout the year, and also hold special meetings and act by written consent from time to time. The Board held a total of 12 meetings during the fiscal year ended December 31, 2025. During this time, all of our current directors attended at least 75% of the aggregate number of meetings held by the Board and all committees of the Board on which such director served. The Board does not have a formal policy with respect to Board member attendance at annual meetings of stockholders, but all members of the Board are encouraged to attend. Our 2025 Annual Meeting of Stockholders was attended by all our directors.

The Board has three standing committees: the Audit Committee; the MDC Committee; and the NCG Committee. The charters for the Audit, MDC, and NCG Committees can be accessed electronically on the "Governance — Governance & Ethics Documents" section of our corporate website, *www.apei.com*.

The Board conducts, and the NCG Committee oversees, an annual evaluation of the Board's operations and performance in order to enhance its effectiveness. Recommendations resulting from this evaluation are made by the NCG Committee to the full Board for its consideration. Each committee also conducts an annual evaluation of its own performance and charter, and makes recommendations as necessary to either management, the NCG Committee, or the full Board, as applicable, as a result of these evaluations.

#### Audit Committee
The Board has established a separately designated standing Audit Committee in accordance with Section 3(a)(58)(A) of the Exchange Act. The Audit Committee is responsible, among its other duties and responsibilities, for overseeing our accounting and financial reporting processes, the audits of our financial statements, the qualifications of our independent registered public accounting firm, and the performance of our internal audit function and our independent registered public accounting firm. The Audit Committee reviews and assesses the qualitative aspects of our financial reporting, our processes to manage financial reporting risk, and our compliance with significant applicable legal, ethical, and regulatory requirements. The Audit Committee is directly responsible for the appointment, compensation, retention, and oversight of our independent registered public accounting firm.

The current members of our Audit Committee are Ms. Blevins, who serves as chair of the Committee, Mr. Braner, and Ms. Fabrega. Each member of the Audit Committee is able to read and understand fundamental financial statements, including our balance sheet, and statements of income, comprehensive income, stockholders' equity, and cash flows.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>21</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
The Board has determined that Ms. Blevins is an "Audit Committee financial expert," as that term is defined under the SEC rules implementing Section 407 of the Sarbanes-Oxley Act of 2002. The Board has determined that each member of our Audit Committee is independent under Nasdaq's listing standards and each member of our Audit Committee is independent pursuant to Rule 10A-3 of the Exchange Act.

#### Management Development & Compensation Committee
The MDC Committee is responsible, among its other duties and responsibilities, for establishing the compensation and benefits of our Chief Executive Officer and other executive officers, monitoring compensation arrangements applicable to our Chief Executive Officer and other executive officers in light of their performance, effectiveness, and other relevant considerations, and administering and making recommendations to the Board regarding our equity and other incentive plans. In addition, the MDC Committee is responsible for succession planning for our Chief Executive Officer and other key executive officers and for overseeing our human capital management efforts, including with respect to recruitment, development, and retention. Pursuant to our Bylaws, the MDC Committee may create one or more subcommittees, each subcommittee to consist of one or more members of the MDC Committee, and may delegate any or all of its powers and authority to those subcommittees.

The current members of our MDC Committee are Ms. Fabrega, who serves as chair of the Committee, Mr. Braner, and Mr. Statuto. The Board has determined that each member of our MDC Committee meets Nasdaq's independence requirements for approval of the compensation paid to our Chief Executive Officer and other executive officers.

The MDC Committee has the sole authority to retain and terminate any compensation consultant to assist in evaluating executive officer compensation. In 2025, the MDC Committee retained Willis Towers Watson directly as an outside compensation consultant to assist in evaluating our compensation programs, as it has since 2007. The MDC Committee assessed Willis Towers Watson's independence, considering all relevant factors, including those set forth in Nasdaq rules. In connection with this assessment, the Committee considered Willis Towers Watson's work and determined that it raised no conflicts of interest. Willis Towers Watson does no work for the Company other than work that is authorized by the MDC Committee or its chairperson. The Committee used information provided to it by Willis Towers Watson in connection with making 2025 compensation determinations. Willis Towers Watson also advised the MDC Committee on the use of a peer group and applicable survey data for comparative purposes. The consultant's role in recommending the amount or form of executive compensation paid to our named executive officers during 2025 is described in the "Compensation Discussion and Analysis — Competitive Compensation — Assessing Competitive Practice" section on page [37](#tCP).

The MDC Committee considers the results of the annual advisory vote on the compensation paid to our named executive officers. See "Proposal No. 2" on page [73](#tPROP3) to review this year's proposal. In 2025, 93% of the stockholder votes cast on this proposal were voted in favor of our executive compensation. We continued our ongoing stockholder engagement program during 2025 in order to elicit further feedback and perspectives on the issues important to our stockholders.

The MDC Committee works closely with our Chief Executive Officer on compensation decisions and has delegated certain aspects of the annual incentive plans for the other executive officers, including the named executive officers, to our Chief Executive Officer. For a discussion of the role of our Chief Executive Officer in determining or recommending the executive compensation paid to our named executive officers during 2025, see the "Compensation Discussion and Analysis — Other Compensation Policies and Practices — Role of Executives in Executive Compensation Decisions" section on page [49](#tREEC). None of our other executive officers participates in any deliberations related to the setting of executive compensation.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>22</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Nominating and Corporate Governance Committee
The NCG Committee is responsible for recommending candidates for election to the Board. The Committee is also responsible, among its other duties and responsibilities, for making recommendations to the Board or otherwise acting with respect to corporate governance policies and practices, including board size and membership qualifications, recommendations with respect to director resignations tendered in the event a director fails to achieve a majority of votes cast in favor of his or her election, new director orientation, committee structure and membership, and policies and practices regarding communications with stockholders. In addition, the NCG Committee assists the Board in understanding and overseeing management's processes for the assessment and management of non-financial risks of the Company and the steps that management has taken to monitor and control exposure to such risks. The current members of our NCG Committee are Ms. Blevins, who serves as chair of the Committee, Mr. Pianko, and Mr. Statuto. The Board has determined that each member of our NCG Committee meets Nasdaq's independence requirements for directors that make director nominations.

#### Subsidiary Committees
Non-employee directors may be asked to serve in a committee role that involves service as a representative of the Board on the board of one of our wholly owned subsidiaries. During 2025, of our continuing directors, Mr. Statuto served in this role for APUS, and Mr. Pianko served in this role for RU.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>23</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### DIRECTOR NOMINATIONS AND

### COMMUNICATION WITH DIRECTORS

#### Director Nomination Process
The NCG Committee recommends, and the Board nominates, candidates to stand for election as directors. Stockholders may also nominate persons to be elected as directors. If a stockholder wishes to nominate a person for election as director, he or she must follow the procedures contained in our Bylaws and satisfy the requirements of Regulation 14A of the Exchange Act. For a stockholder's nomination of a person to stand for election as a director at an annual meeting of stockholders to be considered, our Corporate Secretary must receive such nominations at our principal executive offices not more than 120 days, and not less than 90 days, before the anniversary date of the prior year's annual meeting, except that if the annual meeting is set for a date that is not within 30 days before or 60 days after such anniversary, the nomination must be received no later than the later of the 90<sup>th</sup> day prior to such annual meeting or the close of business on the tenth day following the notice or public disclosure of the date of the meeting. Each submission must include the following information:

&nbsp;&nbsp;&nbsp;&nbsp;• the name and address of the stockholder who intends to make the nomination and the name and address of the person or persons to be nominated;

&nbsp;&nbsp;&nbsp;&nbsp;• the principal occupation or employment during the preceding five years of the person or persons to be nominated;

&nbsp;&nbsp;&nbsp;&nbsp;• the written, signed representation of each nominee that such nominee (i) consents to being named as a nominee in any Company proxy materials and to serving as a director if elected, (ii) intends to tender, promptly following such person's election or re-election, an irrevocable resignation in the form required by the incumbent directors our Bylaws, (iii) has read and agrees to adhere to our policies and guidelines applicable to directors generally, (iv) is not and will not become a party to any agreement, and has not given any commitment to, any person or entity (1) as to how such person, if elected as a director, will act or vote on any nomination or other business proposal, issue, or question that has not been disclosed to us or (2) that could limit or interfere with such person's ability to comply, if elected as a director, with such person's fiduciary duties under applicable law, and (v) is not and will not become a party to any agreement, arrangement, or understanding with any person or entity other than us with respect to any direct or indirect compensation, reimbursement, or indemnification that has not been disclosed to us in connection with such person's nomination for director or service as a director;

&nbsp;&nbsp;&nbsp;&nbsp;• a questionnaire completed and signed by such person with respect to the background and qualification of such proposed nominee and the background of any other person or entity on whose behalf the nomination is being made;

&nbsp;&nbsp;&nbsp;&nbsp;• the class or series and number of shares of the Company that are owned beneficially and of record by such stockholder;

&nbsp;&nbsp;&nbsp;&nbsp;• if such stockholder or any such beneficial owner intends to solicit proxies or votes in support of nominees other than our nominees, the information required to be included in a notice to the Company required by the SEC rules, including a statement that such person intends to solicit holders of capital stock of the Company representing at least 67% of the voting power of such shares entitled to vote on the election of directors in support of director nominees other than our nominees;

&nbsp;&nbsp;&nbsp;&nbsp;• if applicable, a description of all arrangements or understandings between the stockholder and each nominee and any other person or persons, naming such person or persons, pursuant to which the nomination is to be made by the stockholder; and

&nbsp;&nbsp;&nbsp;&nbsp;• such other information that the Board may request in its discretion.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>24</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
Each director will be elected by the vote of the majority of the votes cast with respect to that director's election, provided, however, that if, as of the tenth day preceding the date we first mail notice of the meeting for such meeting to our stockholders, the number of nominees exceeds the number of directors to be elected, which we refer to as a "Contested Election" in our Bylaws, the directors shall be elected by the vote of a plurality of the votes cast. Under plurality voting, the director nominee with the most votes for a particular seat is elected for that seat. Our Bylaws require that the Board or a committee of the Board shall not nominate any incumbent director who, as a condition to such nomination, does not submit a conditional and, in the case of an uncontested election, irrevocable letter of resignation to the Chairperson of the Board. If an incumbent nominee is not elected in an uncontested election, the NCG Committee will promptly consider such director's conditional resignation and make a recommendation to the Board regarding the resignation. Each incumbent director nominated for election to the Board at the Annual Meeting as described under "Proposal No. 1" on page [26](#tPROP1) has submitted the conditional letter of resignation as required by our Bylaws.

In the event an incumbent director fails to receive a majority of the votes cast in an election that is not a Contested Election, the NCG Committee, or such other committee designated by the Board pursuant to our Bylaws, shall make a recommendation to the Board as to whether to accept or reject the resignation of such incumbent director, or whether other action should be taken. The Board shall act on the resignation, taking into account the Committee's recommendation, and publicly disclose (by a press release and filing an appropriate disclosure with the SEC) its decision regarding the resignation and, if such resignation is rejected, the rationale behind the decision, within 90 days following certification of the election results. The Committee in making its recommendation and the Board in making its decision each may consider any factors and other information that it considers appropriate and relevant.

Additional information regarding requirements for stockholder nominations for next year's annual meeting is described in this Proxy Statement in the section titled "General Matters — Stockholder Proposals and Nominations" on page [78](#tSPN).

#### Contacting the Board of Directors
Stockholders wishing to communicate with the Board may do so by writing to the Board, the Board Chair, or the non-employee members of the Board as a group, at:

American Public Education, Inc.

303 West 3<sup>rd</sup> Avenue

Ranson, WV 25438

Attn: Corporate Secretary

Complaints or concerns relating to our accounting, internal accounting controls, or auditing matters will be referred to members of the Audit Committee. Other correspondence will be referred to the relevant individual or group. All correspondence is required to prominently display the legend "Board Communication" in order to indicate to the Corporate Secretary that it is a communication subject to our policy and will be received and processed by the Corporate Secretary's office. Each communication received by the Corporate Secretary will be copied for our files and in most cases will be promptly forwarded to the addressee. The Board has requested that certain items unrelated to the Board's duties and responsibilities be excluded from the communications so forwarded under the policy. In addition, the Corporate Secretary is not required to forward any communication that the Corporate Secretary, in good faith, determines to be frivolous, unduly hostile, threatening, illegal, or similarly unsuitable. However, the Corporate Secretary will maintain a list of each communication subject to this policy that is not forwarded and, on a quarterly basis, will deliver the list to the Board Chair. In addition, each communication subject to this policy that is not forwarded because it was determined by the Corporate Secretary to be frivolous shall nevertheless be retained in our files and made available at the request of any member of the Board to whom such communication was addressed.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>25</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### PROPOSAL NO. 1

### ELECTION OF DIRECTORS
The Board is currently comprised of six directors. Our nominees for the election of directors at the Annual Meeting include five independent non-employee directors and our Chief Executive Officer. Each director is elected to serve a one-year term, with all directors subject to annual election. At the recommendation of the NCG Committee, the Board has nominated the following persons to serve as directors for the term beginning at the Annual Meeting on May 22, 2026: Granetta B. Blevins; Michael D. Braner, Anna M. Fabrega; Daniel S. Pianko; Angela K. Selden; and Richard J. Statuto. All of the nominees are currently serving on the Board.

Proxies received in response to this solicitation will be voted FOR the election of each nominee named in this section unless otherwise stated in the proxy or in the case of a broker non-vote with respect to the proposal. Proxies submitted for the Annual Meeting can only be voted for those nominees named in this Proxy Statement. If, however, any director nominee is unable or unwilling to serve as a nominee at the time of the Annual Meeting, the persons named as proxies may vote for a substitute nominee designated by the Board, or the Board may reduce the size of the Board. Each nominee has consented to serve as a director if elected, and the Board does not believe that any nominee will be unwilling or unable to serve. Each director will hold office until his or her successor is duly elected and is qualified or until his or her earlier death, resignation, or removal.

#### Criteria for Evaluating Director Nominees
The Board provides strategic direction to the Company and oversees the performance of our business and management. The NCG Committee periodically identifies and reviews with the Board desired skills and attributes of both individual Board members and the Board overall within the context of current and future needs. Among the Committee's responsibilities is the development of general criteria, subject to approval by the full Board, for use in identifying, evaluating, and selecting qualified candidates for election or re-election to the Board. The Committee reviews the appropriate skills and characteristics required of directors in the context of the current composition of the Board, our operating requirements, and the long-term interests of our stockholders. It may use outside consultants to assist in identifying candidates. In determining whether to recommend candidates to serve on the Board, the Committee considers (i) whether candidates meet regulatory and independence requirements, (ii) the Board's overall composition in light of current and future needs, (iii) the past performance of incumbent directors, (iv) whether candidates have the qualities of integrity, judgment, acumen, and the time and ability to make a constructive contribution to the Board, and (v) each current or prospective director's public company leadership positions and other outside commitments. In reviewing the composition of the Board, the Committee considers professional skills and background, experience in relevant industries, and geographic background, and any applicable rules and regulations regarding the composition of the Board, including those of Nasdaq and the SEC. The Committee maintains a commitment to an inclusive approach with respect to the pool from which the Committee selects director candidates, and considers candidates submitted by directors and management, as well as candidates recommended by stockholders, which are evaluated in the same manner as other candidates identified to it. Final approval of director candidates is determined by the full Board.

In order to mitigate risks of director overcommitments, the Company limits the number of other public company boards that on which non-employee directors and directors who are executive officers may serve to four and two, respectively, in each case including the Board, and also limits the number of public company board audit committees on which directors may serve to three, including the Audit Committee of the Board. All of our directors are in compliance with these limitations.

As a part of our continued process of Board refreshment and succession planning, the NCG Committee and the Board regularly consider adding additional directors to the Board.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>26</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
In connection with the decision to appoint Mr. Braner to the Board in 2023, we entered into a Cooperation Agreement with 325 Capital LLC. Other than the Cooperation Agreement, which contemplated that Mr. Braner would be nominated for election to the Board at the 2023 Annual Meeting, there are no arrangements or understandings between a director and any other person pursuant to which such person was elected as director or is being nominated as a director.

The Board has determined that all of our director nominees are qualified to serve as directors of the Company. Set forth below are some of the experiences, qualifications, attributes, and skills possessed by these nominees.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Qualifications** <br>**and Experience** | **Blevins** | **Braner** | **Fabrega** | **Pianko** | **Selden** | **Statuto**  |
| *Business Strategy Experience* | •  | •  | •  | •  | •  | • |
| *Finance, Investment and Accounting Experience* | •  | •  | •  | •  | •  | • |
| *Corporate Governance Experience* | •  | •  |  | •  | •  | • |
| *Operational Experience* | •  | •  | •  | •  | •  | • |
| *Education Sector Experience* | •  |  |  | •  | •  |  |
| *Risk Management Experience* | •  | •  | •  | •  | •  | • |
| *Sales & Marketing Expertise* |  |  | •  |  | •  | • |
| *Talent Management Expertise* | •  |  | •  | •  | •  | • |
| *Technology or Cybersecurity Expertise* |  |  | •  | •  | •  |  |

---

Information for each nominee for director, including names, ages as of March 26, 2026, terms of office, principal occupations, and business experience is set forth below. In addition, for each nominee, we have included additional information regarding the experiences, qualifications, attributes, or skills that caused the NCG Committee and the Board to determine that the person should serve as a director for the Company.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>27</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

---

| | |
|:---|:---|
| **Granetta B. Blevins** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;![](ny20064163x1_gblevins1.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>*Director since June 2020* <br>• Audit Committee (Chair) <br>• Nominating and Corporate Governance Committee (Chair)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**Age:** 67<br>**Independent:** Yes | **Biography**<br>**Ms. Blevins has worked as an independent consultant/contractor since January 2000, working in a variety of capacities for non-profit and for-profit start-ups to mid-size businesses in multiple industries. From October 2018 to September 2019, Ms. Blevins served as Chief of Staff, LRNG at Southern New Hampshire University, where she was responsible for managing strategy, budget and resources for the LRNG learning platform. She also served as Chief Financial Officer and Chief of Staff of the non-profit social enterprise Collective Shift, which created the LRNG platform, from January 2015 until its acquisition by Southern New Hampshire University in October 2018. In addition, she served as Chief Financial Officer of Education Design Studio, a fund investor and business incubator for education technology start-up companies, from December 2012 until December 2019, and Chief Financial Officer of GlassLab, Inc., a non-profit that creates digital games for learning and assessment, from May 2014 to December 2016. Prior to 2000, Ms. Blevins held senior level finance and corporate planning positions with both public and privately held companies. Ms. Blevins currently serves on the Board of Trustees of Georgetown College in Georgetown, Kentucky, Chairs the Finance Committee and is a member of the Executive Committee. Ms. Blevins is also on the Kentucky Board of Community Advisors for Saint Joseph Health System, a member of CommonSpirit Health. She serves on its Executive Committee and is slated to become Chair of the Board of Community Advisors in July 2026. Ms. Blevins has previously served on and chaired boards of other non-profits and been a board member of a for-profit privately held company.** <br>**Skills and Qualifications**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant experience serving in senior management positions for a range of corporations and non-profits <br>**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Extensive experience in financial management, financial planning and analysis, strategic planning, strategy execution and governance <br>**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Expertise in the education industry, including with respect to technology**<br>|

---

---

| | |
|:---|:---|
| **Michael D. Braner** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;![](ny20064163x1_mbraner.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>*Director since March 2023* <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Audit Committee <br>• Management Development & Compensation Committee <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**Age:** 56<br>I**ndependent:** Yes | **Biography**<br>**Mr. Braner has served as a founding Managing Member and as Chief Compliance Officer at 325 Capital LLC, a long-term, significant, minority owner of small public companies, since March 2019, where he is involved in investment research and overseeing compliance. Previously, Mr. Braner served as a Partner at Sagard Capital Partners LP, pursuing a similar investment strategy to 325 Capital, from 2005 to May 2016. Prior to that, Mr. Braner served as a Partner in JB Investment Partners, an investment company he founded in 2003, from 2003 to 2004. Earlier in his career, Mr. Braner served for more than 10 years at Bain & Company Inc., a management consulting company, where he consulted large corporations and private equity investors.** <br>**Skills and Qualifications<br> • Experience in executive-level investment and business consulting**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Experience as a significant shareholder of the Company** <br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Expertise in executive leadership and corporate governance** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>28</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

---

| | |
|:---|:---|
| **Anna M. Fabrega** |  |
| ![](ny20064163x1_afabrega.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>*Director since May 2022* <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Management Development & Compensation Committee (Chair)<br>• Audit Committee <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**Age:** 47<br>**Independent:** Yes | **Biography**<br>**Ms. Fabrega served as Chief Executive Officer of Local Bounti Corp. from June 2023 to December 2023. In addition, from October 2021 to November 2022, Ms. Fabrega served as Chief Executive Officer of fresh prepared food subscription service company Freshly, LLC, after joining Freshly as Chief Commercialization Officer in January 2021. Prior to Freshly, Ms. Fabrega spent nine years in roles of increasing seniority with Amazon, most recently as Managing Director, Amazon Convenience Stores, which includes Amazon Go, Amazon's cashless convenience and grocery stores, from January 2020 through January 2021, and previously as Director, Amazon Go, from 2014 through January 2020. During her Amazon Go tenure, Ms. Fabrega helped launch Amazon Go Grocery, the first "Just Walk Out" grocery store, and scale the business to 28 stores across four cities. She earlier served as Senior Manager, Marketing and Third Party Marketplace, Sporting Goods, and General Manager, Sports and Outdoors, Amazon's $4 billion sports and outdoors business, after joining Amazon in 2011. Before Amazon, Ms. Fabrega served as a Senior Product Manager, Brand Management and Relationship Marketing, and then Senior Manager, Global Brand Strategy, at Microsoft from 2008 through 2011, Director, Brand Management and Financial Services, for Stripes Convenience Stores, a convenience store chain then owned by Susser Holdings Corporation, from 2004 through 2008, and Inventory Control Manager at J&L Industrial, an industrial distribution and supply company then owned by Kennemetal, from 2002 to 2003. Ms. Fabrega began her career in distribution and operations at McMaster-Carr Supply Company, a hardware, tools, and materials supplier, in 1999. She has served on the boards of directors of Bank OZK, a banking services provider, since May 2025, and Hippo Harvest, an agriculture company, since February 2025.**<br>**Skills and Qualifications**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Experience in marketing, including digital marketing, and business management roles <br>**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Leadership at accelerated growth and technology companies**<br>|

---

---

| | |
|:---|:---|
| **Daniel S. Pianko** | **Daniel S. Pianko** |
| &nbsp;&nbsp;&nbsp;&nbsp;![](ny20064163x1_danielpianko.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>*Director since June 2020* <br>• Nominating and Corporate Governance Committee <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**Age:** 49<br>**Independent:** Yes | **Biography**<br>**Mr. Pianko has served as Board Chair since March 2025. Mr. Pianko is the founder of and currently serves as an investor and Managing Director for Achieve Partners, since January 2019. Since April 2011, he has served as an investor and Managing Director for University Ventures, which he also founded. He also serves on the boards of directors of Education Excellence Corporation, Tiber Health, Yellowbrick Learning, and Ro Health Inc. Mr. Pianko is a frequent commentator on higher education and his insights have been featured in national media outlets including The Wall Street Journal, CNBC, TechCrunch, Inside Higher Ed, and The Chronicle of Higher Education. Prior to founding University Ventures, Mr. Pianko established a student loan fund, served as chief of staff for the public/private investments in the Philadelphia School District, and worked as a hedge fund analyst. Mr. Pianko began his career in investment banking at Goldman Sachs. He currently serves on the Board of Trustees of Harlem Village Academies.** <br>**Skills and Qualifications**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Experience as an investor in the higher education sector <br>**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Expertise related to higher education**<br>|

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>29</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

---

| | |
|:---|:---|
| **Angela K. Selden** | **Angela K. Selden** |
| &nbsp;&nbsp;&nbsp;&nbsp;![](ny20064163x1_angelaselden.jpg)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>*Director since September 2019*<br>• President and Chief Executive Officer <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**Age** 60 <br>**Independent:** No | **Biography**<br>**Ms. Selden has served as President and Chief Executive Officer and a member of the Board since September 2019. Ms. Selden previously served as Chief Executive Officer and a member of the board of DIGARC, LLC, an education technology provider to higher education institutions, from October 2016 to August 2019, continuing as a member of the board of directors until June 2021. From September 2005 until June 2013, Ms. Selden served as Chief Executive Officer and Executive Co-Chairman of Arise Virtual Solutions, Inc., a virtual workforce solutions outsourcer. Ms. Selden has also served as Chief Executive Officer of two private companies and served on a variety of private company boards. Earlier in her career, Ms. Selden spent 18 years at Accenture, including serving as the Managing Partner, leading Accenture's North American Consumer and Industrial Products group to significant growth. In addition, Ms. Selden served on the University of St. Thomas, Opus College of Business' Strategic Board of Governors from April 2012 to September 2019.** <br>**Skills and Qualifications**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Close to 25 years of leadership and management experience within the education and technology-enabled solutions industries and within private-equity and publicly traded business <br>**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Experience in business strategy, financial oversight, risk management, sales, marketing, cybersecurity and corporate governance<br>**<br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Experience delivering workforce solutions to Fortune 500 enterprises and executing large-scale business transformation programs**<br>|

---

---

| | |
|:---|:---|
| **Richard J. Statuto** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;![](ny20042073x1_rstatuto.jpg) <br>*Director since March 2025* <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>• Management Development & Compensation Committee<br>• Nominating and Corporate Governance Committee<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>**Age:** 69<br>**Independent:** Yes | **Biography**<br>**Mr. Statuto served as Chairman of the board of directors of Premier, Inc. since 2023 and was a member of the Compensation Committee and Nominating and Governance Committee until Premier was acquired in December 2025. He previously served as Chairman of the Board of Premier from May 2013, when the company went public, until August 2019. Mr. Statuto is currently an Executive Advisor for LRVHealth, a Boston-based venture capital firm, and for CoVest Partners, a Charlotte-based private equity firm. He previously served as President and Chief Executive Officer of Bon Secours Health System from 2005 until its merger with Mercy Health in 2018. Earlier in his career, he served as Chief Executive Officer of St. Joseph Health System in California from 1995 to 2004. In addition to his executive leadership roles, Mr. Statuto has served as Chairman of the Board of Trustees of the Catholic Health Association, Vice Chairman of Christus Health in Dallas, Vice Chairman of Incarnate Word Health System, Vice Chairman of CMMB, and Chairman of the American Red Cross Orange County California. He has also held board positions at Kmart, the Innovation Institute, Covenant Health System in Massachusetts, Mercy Housing, and the finance committee of the American Heart Association.** <br>**Skills and Qualifications** <br>**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Expertise in corporate governance, financial oversight, and risk management, strategic growth initiatives, and serving on finance and governance committees**<br>|

---

#### THE BOARD RECOMMENDS A VOTE FOR ELECTION OF EACH OF THE

#### SIX NOMINATED DIRECTORS.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>30</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### 2025 DIRECTOR COMPENSATION
Pursuant to our non-employee director compensation policy, directors received an annual retainer of $80,000. The chairs of the Audit, MDC, and NCG Committees were entitled to receive an additional annual retainer of $15,000, $10,000, and $8,000, respectively. The non-employee Board Chair was entitled to receive an additional annual retainer of $80,000. The Chairperson was not entitled to receive any additional annual retainers for also serving as chair of any of the Board's standing committees. Members of the Board may also be asked to serve as a representative of the Board on the board of one of our wholly owned subsidiaries and receive a flat additional retainer of $65,000 for service with respect to APUS or RU.

The annual retainers are payable in quarterly installments, and each director may, before the beginning of the applicable year, elect to receive his or her annual retainer in common stock having the same value as the portion of the annual retainer to be paid, calculated as of the close of business on the first business day of the year. In connection with our annual meeting of stockholders, our non-employee director compensation policy also provided for an annual grant to each director of restricted stock having a value of $110,000 on the grant date. Consistent with past practice, the restricted stock grant vests on the earlier of the one-year anniversary of the date of grant and immediately prior to next year's annual meeting of stockholders.

We also reimburse all directors for travel and other necessary business expenses incurred in the performance of their services for us and extend coverage to them under the directors' and officers' indemnity insurance policies.

The following table sets forth information regarding compensation earned by our non-employee directors during 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Name<sup>(1)</sup>** | **Fees** <br>**Earned or** <br>**Paid in** <br>**Cash** | **Stock** <br>**Awards<sup>(2)</sup>** | **Total**  |
| Eric C. Andersen<sup>(3)</sup> | &nbsp;&nbsp;$0  | $52413  | $52413  |
| Granetta B. Blevins | &nbsp;&nbsp;$101576  | $109971  | $211547  |
| Michael D. Braner | &nbsp;&nbsp;$80000  | $109971  | $189971  |
| Anna M. Fabrega | &nbsp;&nbsp;$87286  | $109971  | $197257  |
| James Kenigsberg<sup>(4)</sup> | &nbsp;&nbsp;$90714  | $109971  | $200685  |
| Daniel S. Pianko | &nbsp;&nbsp;$186538  | $109971  | $296510  |
| William G. Robinson<sup>(3)</sup> | &nbsp;&nbsp;$62110  | $0  | $62110  |
| Richard J. Statuto  | &nbsp;&nbsp;$92272  | $109971  | $202243 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) See the Summary Compensation Table in the "Compensation Tables and Disclosures" section of this Proxy Statement for disclosure related to Ms. Selden, who is one of our named executive officers.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The grant date fair value per share of the restricted stock awards in 2025 was $29.31 for each of the non-employee directors, each as computed in accordance with FASB ASC Topic 718.2).

&nbsp;&nbsp;&nbsp;&nbsp;(3) Service on the Board ended upon adjournment of the 2025 Annual Meeting of Stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;(4) Effective August 4, 2025, Mr. Kenigsberg was appointed Interim Chief Innovation and Technology Officer of the Company concurrent with his departure from the Board.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>31</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
As of December 31, 2025, there were no exercisable or unexercisable option awards held by our 2025 non-employee directors. The aggregate number of unvested stock awards outstanding held as of that date, unless otherwise noted, by our 2025 non-employee directors were as follows:

---

| | |
|:---|:---|
| **Name** | **Stock Awards**  |
| Granetta B. Blevins | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3752  |
| Michael D. Braner | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3752  |
| Anna M. Fabrega | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3752  |
| James Kenigsberg<sup>(1)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3752  |
| Daniel S. Pianko | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3752  |
| Richard J. Statuto  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3752 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Reflects number held as a non-employee director as of August 4, 2025, the date Mr. Kenigsberg was appointed Interim Chief Innovation and Technology Officer of the Company concurrent with his departure from the Board. On such date, Mr. Kenigsberg was granted 18,673 restricted stock units in connection with his appointment, vesting in three equal installments beginning on the anniversary of the grant date.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>32</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

### EXECUTIVE COMPENSATION

#### Compensation Discussion and Analysis
**&nbsp;&nbsp;&nbsp;&nbsp;OUR 2025 NEOS** <br>

Our named executive officers ("NEOs") for 2025 are:

---

| | | |
|:---|:---|:---|
| **Angela K. Selden**<br>**President and** <br>**Chief Executive Officer** | **Edward H. Codispoti**<br>**Executive Vice President and Chief Financial Officer** | **Nuno S. Fernandes** <br>**President, American Public University System**  |
| **Mark L. Arnold**<br>**President, Rasmussen University** | **Thomas A. Beckett**<br>**Senior Vice President,** <br>**General Counsel and Secretary** | **Richard W. Sunderland, Jr.** <br>**Former Executive Vice President and Chief Financial Officer** |

---

 **EXECUTIVE SUMMARY** <br>

This Compensation Discussion and Analysis describes our executive compensation program and decisions for 2025. This section details the compensation framework applied by the MDC Committee and, in particular, our compensation philosophy and objectives, elements of compensation, compensation decisions, and the link between executive compensation and performance.

#### 2025 Performance
&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of $648.9 million, representing growth of 3.9% year-over-year

&nbsp;&nbsp;&nbsp;&nbsp;• Net income available to common stockholders of $25.3 million, just below the high end of original guidance and representing a 152% year-over-year increase

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(1)</sup> of $85.7 million, exceeding the high end of our original guidance for 2025 and representing 19% year-over-year growth

&nbsp;&nbsp;&nbsp;&nbsp;• EPS achievement of $1.36 representing a 147% year-over-year increase

&nbsp;&nbsp;&nbsp;&nbsp;• Second consecutive year of strong shareholder returns with 75% stock price appreciation in 2025 and 124% in 2024

In 2025, we delivered strong financial performance across the enterprise. Revenue growth was achieved even with the unplanned mid-year sale of Graduate School USA ("GSUSA"), the closure of two Rasmussen campuses in Wisconsin, and government-related headwinds that affected certain subsidiary institutions. At the beginning of the year, the MDC Committee set 2025 consolidated enterprise and subsidiary institution performance targets based on our approved budgets. Prior to the July 25, 2025, sale of APEI's membership interest in GSUSA (the "GSUSA Sale"), Department of Government Efficiency ("DOGE") and other government funding actions reduced funding available for career learning and contract training at federal government agencies and led to significantly decreased GSUSA registrations and revenue. In addition, on October 1, 2025, the federal government shut down until November 12, 2025, and the Department of Defense Tuition Assistance program was temporarily suspended, which resulted in some APUS students who rely on tuition assistance as a payment source being unable to register for, or remain registered in, courses. Despite these headwinds, our strong 2025 financial performance reflected continued execution on an effective strategy designed to grow revenue and increase profitability.

APUS continues to have consistent, steady registration growth. Despite the federal government shutdown, revenue increased 1% in 2025 compared to 2024. The increase reflects continued demand from active-duty service members, veterans, and military families and highlights the strength of the military-focused franchise built by APUS.

(1) See Annex B for a reconciliation of net income to adjusted EBIDTA.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>33</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
Our nursing and healthcare institutions also delivered strong enrollment and financial growth. Continuing the trend set in the third and fourth quarters of 2024, RU enrollment increased 9% in 2025, contributing to a 14% increase in revenue to $246.2 million, and generated $4.0 million of operating income. HCN enrollment increased 12%, contributing to an 11% increase in revenue.

During 2025, we also took actions to strengthen our balance sheet, improve operating efficiency, and simplify business operations. We redeemed our Series A Senior Preferred Stock for $43.1 million, which is expected to generate approximately $6.0 million in pretax annual cash savings, and we sold two corporate buildings for approximately $23.0 million. We also completed the GSUSA Sale for $0.5 million, which is expected to generate pre-tax annual cash savings of approximately $4.0 million from the reduction in corresponding lease liability.

#### Our 2025 Executive Compensation Program
As discussed in greater detail below, the MDC Committee believes NEO compensation must reflect the overall performance of the Company and the value delivered to our stockholders. We believe our strong results for 2025 and increased payouts as a percentage of target for our NEOs under our Annual Incentive Plan ("AIP") appropriately demonstrates this link between pay and performance. Ms. Selden's total payout under our 2025 AIP represented 123% of her target opportunity, compared to 100.2% in 2024. PSUs granted in 2025 were earned by NEOs at 139%, which was above target but less than the maximum opportunity.

#### 2025 Target Compensation Mix
The charts below show the breakdown of the components of Ms. Selden's target compensation opportunity for 2025, as well as the breakdown of the average target compensation for our other NEOs, other than Mr. Codispoti, who did not participate in our 2025 AIP or receive a grant of PSUs for 2025 due to the timing of his commencement of employment with the Company, and who received a cash sign-on bonus and a sign-on RSU award. As discussed in the overview section below, the breakdown of target compensation opportunity reflects our focus on variable compensation tied to performance, with our CEO's fixed base salary representing 18% of her total target compensation opportunity, with annual and long-term incentives tied to financial performance relative to budget, strategic goals achievement, and stock price performance representing the remainder.

---

| | |
|:---|:---|
| CEO Target Compensation\* | Other NEO Target Compensation\* |
| ![](ny20064163x1_piechart05x1.jpg)<br>| ![](ny20064163x1_piechart06.jpg)<br>|

---

\* Components of table may not foot to totals shown due to rounding

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>34</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
 **COMPENSATION PROGRAM OVERVIEW** <br>

#### Compensation Program Philosophy and Objectives
Our compensation program for our NEOs is designed to attract, incentivize, retain, and reward the talent that we need to maintain and strengthen our position in career-minded adult education and to achieve our business objectives, as well as to hold our executives accountable for our actual business performance.

---

| | | |
|:---|:---|:---|
| **Elements of our Compensation Program Philosophy**  | **Elements of our Compensation Program Philosophy**  | **Elements of our Compensation Program Philosophy**  |
| **Focus on Variable Compensation** | ![](ny20007427x2_arrow.jpg)<br>| We believe in using variable cash and stock-based compensation to motivate and reward performance for our NEOs.  |
| **Focus on Corporate Goals** | ![](ny20007427x2_arrow.jpg)<br>| We strive to provide compensation that is directly related to the achievement of our corporate goals, which we measure through earnings per share, revenue, and earnings before interest, taxes, depreciation, and amortization less non-cash expenses, such as stock compensation, and other adjustments that are ordinarily consistent with our publicly reported adjusted EBITDA ("Adjusted EBITDA"), as well as critical strategic initiatives.  |
| **Carefully Monitor External Market Practices** | ![](ny20007427x2_arrow.jpg)<br>| We monitor market practices so that our programs reflect the realities of the competitive market to ensure we are paying for performance. At the same time, we must also ensure we can attract the top talent necessary to drive results through our business strategy. |

---

#### Executive Compensation Best Practices
Highlighted below are certain executive compensation practices that we employ to align executive compensation with stockholder interests and certain compensation practices that we do not employ because we do not believe they would serve our stockholders' long-term interests.

---

| | | |
|:---|:---|:---|
| **What We Do** |  | **How We Do It**  |
| **We Pay for Performance** | ![](ny20007427x2_arrow.jpg)<br>| We tie a significant portion of our executives' annual compensation opportunity to objective performance measures and continue to monitor our compensation mix to ensure the performance-based portion is consistent with that of our peers.  |
| **We Target Pay Competitively** | ![](ny20007427x2_arrow.jpg)<br>| We generally seek to target compensation within a competitive range of the market median and only deliver greater compensation when warranted by actual superior performance. Conversely, we seek to deliver lower compensation when performance results do not meet our threshold expectations. We review our compensation and performance alignment as compared to market survey data and our peers annually to understand where our programs are working and where we can continue to make improvements.  |
| **We Maintain Executive Stock Ownership Guidelines** | ![](ny20007427x2_arrow.jpg)<br>| Each of our executives is expected to own shares of our common stock with a value ranging from two to six times the executive's base salary, depending on position.  |
| **We Utilize Meaningful Vesting Conditions for Equity Awards** | ![](ny20007427x2_arrow.jpg)<br>| Equity awards, including performance-based awards, have three-year ratable vesting periods.  |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>35</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| **What We Do** |  | **How We Do It**  |
| **We Impose a "Clawback Policy"** | ![](ny20007427x2_arrow.jpg)<br>| We have an incentive compensation recoupment policy that requires us to recover erroneously awarded incentive-based compensation previously paid to certain executive officers in the event of an accounting restatement due to material noncompliance with financial reporting requirements. In addition, we can recover any performance-based cash or equity award made to any recipient where, due to an accounting restatement, performance goals were later determined not to have been achieved. We can also recover equity awards made to an employee in cases where we are required to prepare an accounting restatement due to our material noncompliance with financial reporting requirements and the restatement is the result of misconduct that resulted from the employee knowingly having engaged in that misconduct, the employee's gross negligence, or the employee knowingly or through gross negligence having failed to prevent misconduct.  |
| **We Utilize an Independent Compensation Consulting Firm** | ![](ny20007427x2_arrow.jpg)<br>| The MDC Committee utilizes Willis Towers Watson (WTW), an independent compensation consulting firm, to assist the Committee in determining compensation. |

---

---

| | | |
|:---|:---|:---|
| **What We Don't Do** |  | **How We Prohibit It**  |
| **We Don't Permit Hedging** | ![](ny20007427x2_arrow.jpg)<br>| We prohibit our directors and employees, including our NEOs, from engaging in short sales, transactions in derivative securities (including put and call options), or other forms of hedging and monetization transactions, such as zero-cost collars, equity swaps, exchange funds, and forward sale contracts, that allow the holder to limit or eliminate the risk of a decrease in the value of our securities.  |
| **We Don't Permit Pledging** | ![](ny20007427x2_arrow.jpg)<br>| We prohibit our directors and officers, including our NEOs, from holding our securities in margin accounts, pledging our securities as collateral or maintaining an automatic rebalance feature in savings plans, deferred compensation, or deferred fee plans, to avoid sales of our securities on behalf of an individual related to margin calls, loan defaults, and automatic rebalances, which may occur when the individual has material nonpublic information about us.  |
| **We Don't Offer Single-Trigger "Change of Control" Payments** | ![](ny20007427x2_arrow.jpg)<br>| For those NEOs who have employment agreements, the agreements provide that in the case of a "change of control" the NEO only receives severance payments in connection with a termination of their employment.  |
| **We Don't Provide Tax Gross-Ups** | ![](ny20007427x2_arrow.jpg)<br>| We do not provide our NEOs with tax gross-up payments for a change of control in employment agreements, or for other benefits. |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>36</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

 **COMPETITIVE COMPENSATION** <br>

Our executive compensation policies are designed to assist us in attracting and retaining qualified executives by providing competitive levels of compensation that are consistent with the executives' alternatives within the for-profit education industry and the broader market for executive talent. The MDC Committee generally intends to set each NEO's base salary, target total cash compensation (base salary plus annual cash incentives at the target performance level), and total direct compensation (which also includes equity awards) to be competitive with the 50th percentile of the survey data received from the Committee's independent consultant, with appropriate adjustments to reflect the specific situation of each NEO, including how their roles may differ from those at other companies.

---

| | |
|:---|:---|
| **50th** | The MDC Committee's intent is generally to set each NEO's base salary to be competitive with the 50th percentile of the survey data received from the Committee's independent consultant. |

---

#### Assessing Competitive Practice
For 2025, the MDC Committee continued its prior engagement of WTW as an independent consultant to the Committee, including to assist the Committee with a competitive assessment of base salary, annual incentives, long-term equity incentives, and total direct compensation. The MDC Committee assessed the independence of its consultant, considering, among other factors, the required independence factors pursuant to Nasdaq rules. Specifically, WTW provides no services to the Company or its management other than the services provided to the MDC Committee in its capacity as the MDC Committee's independent consultant on executive compensation matters, and the fees the Company pays WTW are an immaterial percentage of WTW's annual revenues. WTW affirmed that no member of the consulting team has any business or personal relationship with any member of the MDC Committee. WTW also affirmed that neither WTW nor any member of the consulting team serving the MDC Committee owns any stock of the Company. In addition, the MDC Committee evaluated the work of WTW and its conflicts of interest policies and determined that its work raised no conflict of interest, including under the applicable independence assessment set forth in Nasdaq rules. Considering all of these factors, the MDC Committee concluded WTW was independent.

For the MDC Committee's assessment of its compensation program, WTW provides comparative data that primarily includes survey data for each of the NEOs from which we compare compensation, and data from a group of publicly traded companies against which we compare compensation program practices, which we refer to as our peer group. For those executives for whom both survey data and peer group data are available, the MDC Committee uses the survey data for its primary comparisons because it believes, consistent with the advice of WTW, that the survey data is more robust and provides a better comparison for the Company than the peer group data. This is in part because peer group data is more limited and typically cannot be size-adjusted to account for revenue responsibilities.

Consistent with the advice of WTW, when reviewing compensation for executive positions, the MDC Committee generally considers compensation to be competitive if it falls within the following ranges relative to the 50th percentile of the comparative survey data:

&nbsp;&nbsp;&nbsp;&nbsp;• within 10% for base salary;

&nbsp;&nbsp;&nbsp;&nbsp;• within 15% for target total cash compensation; and

&nbsp;&nbsp;&nbsp;&nbsp;• within 20% for target total direct compensation.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>37</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Survey Data and Peer Group
For 2025 compensation decisions, WTW provided data from the following published surveys as primary sources: the *2025 WTW* General Industry Executive Compensation U.S. Survey Report and the *2025 College and University Professionals Association for Human Resources* Administrators in Higher Education Annual Survey Report. Because of the varying size of the companies included in the databases for the published surveys, WTW informed the MDC Committee that, to the extent possible, it had assessed the published survey data in the context of APEI consolidated and institution only projected fiscal 2025 revenue, as revenue responsibility is typically one of the most reliable predictors of executive compensation. The review of survey data for setting initial 2025 compensation included a competitive analysis for each of our 2025 NEOs, as well as other members of our management team. The review determined that the base salary, total cash compensation, and total direct compensation were generally within the competitive range.

While the MDC Committee uses survey data as the primary source of comparative information, we believe a peer group is still an important element of the review of the competitive market for executive talent and to compare our executive compensation design and practices to industry practices. The MDC Committee annually reviews the peer group for potential updates. For 2025, the MDC Committee, with the assistance of WTW, screened for public companies within the education services, consumer services, commercial and professional services, and software and services industry that were similar in size (revenue, net income, total assets, and number of employees), were peers of our peers, and that we had selected or proxy advisory firms had identified as our peers. As a result of this evaluation process, the MDC Committee removed 2U, Inc. due to their transition to a privately held entity in September of 2024. The 2025 peer group consisted of the following companies:

&nbsp;&nbsp;&nbsp;&nbsp;• Covista Inc. (CVSA) (formerly known as Adtalem Global Education)

&nbsp;&nbsp;&nbsp;&nbsp;• Grand Canyon Education, Inc. (LOPE)

&nbsp;&nbsp;&nbsp;&nbsp;• Laureate Education, Inc. (LAUR)

&nbsp;&nbsp;&nbsp;&nbsp;• Lincoln Educational Services Corporation (LINC)

&nbsp;&nbsp;&nbsp;&nbsp;• Perdoceo Education Corporation (PRDO)

&nbsp;&nbsp;&nbsp;&nbsp;• Strategic Education, Inc. (STRA)

&nbsp;&nbsp;&nbsp;&nbsp;• Stride, Inc. (LRN)

&nbsp;&nbsp;&nbsp;&nbsp;• Universal Technical Institute, Inc. (UTI)

The review of our peer group for setting initial 2025 compensation resulted in comparative information for Ms. Selden and Mr. Sunderland. Comparative information was not available for the remaining NEOs due to the more limited sample size of peer group data as compared to survey data; however, as discussed above, the MDC Committee uses survey data for its primary comparisons because it believes, consistent with the advice of WTW, that the survey data is more robust and provides a better comparison for the Company than the peer group data.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>38</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
 **ELEMENTS OF COMPENSATION** <br>

The compensation program for our NEOs is comprised of three core elements: base salary; annual incentive cash compensation; and long-term equity incentives.

---

| | | | |
|:---|:---|:---|:---|
| **Pay Element** | **Pay Element** | **How it Links to Performance**  | **How it Links to Performance**  |
| **BASE SALARY**  | **BASE SALARY**  | **BASE SALARY**  | **BASE SALARY**  |
| •  | Regular, fixed compensation element | •  | Generally selected to be competitive with the 50th percentile of the survey data received from the MDC Committee's independent compensation consultant  |
| •  | Reviewed annually | •  | Intended to be part of a competitive total compensation package |
| •  | Reflects each NEO's individual role and responsibility  |  |  |
| **SHORT-TERM ANNUAL INCENTIVE COMPENSATION**  | **SHORT-TERM ANNUAL INCENTIVE COMPENSATION**  | **SHORT-TERM ANNUAL INCENTIVE COMPENSATION**  | **SHORT-TERM ANNUAL INCENTIVE COMPENSATION**  |
| •  | Provides cash incentives for achieving and surpassing financial and strategic goals | • | Helps focus executives on financial, strategic, and operations plans and goals that are expected to lead to increased stockholder value  |
| •  | Offers the opportunity for NEOs to earn annual payments for achievement of Adjusted EBITDA, revenue; and satisfaction of annual institution-specific strategic goals  | •  | This focus is enhanced through above target payout opportunities, an additional incentive paid to NEOs for superior performance  |
| • | Generally structured so that target total cash (base salary plus annual incentives) is competitive with the 50th percentile of the survey data when target performance goals under the annual incentive plan are achieved |  |  |
| **LONG-TERM EQUITY INCENTIVE COMPENSATION**  | **LONG-TERM EQUITY INCENTIVE COMPENSATION**  | **LONG-TERM EQUITY INCENTIVE COMPENSATION**  | **LONG-TERM EQUITY INCENTIVE COMPENSATION**  |
| •  | Annual grants of equity awards consisting of time-based RSUs and PSUs | •  | Intended to align the interests of the NEOs with those of our stockholders  |
| • | PSUs tied to fiscal year achievement of revenue and earnings per share ("EPS") | • | Time-based vesting supports the retention of NEOs  |
| • | Provides compensation that is tied to long-term performance and that drives stockholder returns | •  | Revenue and EPS performance measures align with measures that are relevant to the achievement of our long-term strategic goals  |
| • | <br>Generally selected so that total target compensation is competitive with the 50th percentile of the survey data received from the MDC Committee's independent consultant<br>| • | The MDC Committee retains the right to adjust equity awards downward, including based on its assessment of the demonstration of leadership behaviors, transparency, fidelity to our vision and values, and commitment to a culture of compliance |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>39</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

 **2025 COMPENSATION DECISIONS**<br>

In setting base salary, annual incentive cash compensation, and long-term equity incentives for 2025, the MDC Committee considered, among other factors, the compensation levels for our NEOs in 2024, the respective performances of each of our NEOs in 2024 and a continued focus on differentiation and pay-for-impact based on a culture of performance and accountability, internal fairness and equity consistent with role, and what the Committee believed was required based on the marketplace for executive talent, including based on the survey data provided by WTW.

#### Base Salary
Base salary is an integral part of compensation for our NEOs and is generally set in January of each year, absent other factors, such as promotions or new hires with any increases effective in March, to align with the timing or annual salary increases for other employees. For 2025, the MDC Committee, in consultation with WTW, determined to increase the base salaries of certain of our continuing NEOs. In determining to provide the increases, the Committee considered the recommendation of Ms. Selden, which reflected the competitive survey data provided by WTW and each NEO's contributions to the overall strong 2024 financial performance. In determining Ms. Selden's base salary for 2025, the MDC Committee considered the overall 2024 financial performance, which exceeded full year guidance, the Company's 2024 stock performance, and that Ms. Selden's base salary had not changed since April 2022.

Mr. Codispoti's and Mr. Arnold's 2025 base salaries reflect their new hire salaries on their respective start date of October 20, 2025, and January 22, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Named Executive Officer** | **2024 Base Salary** | **2025 Base Salary** | **Percentage** <br>**Increase**  |
| **Angela K. Selden** | $795000 | $855000 | 7.55%  |
| **Edward H. Codispoti** | N/A | $530000 | N/A  |
| **Nuno S. Fernandes** | $500000 | $515000 | 3.00%  |
| **Mark L. Arnold** | N/A | $450000 | N/A  |
| **Thomas A. Beckett** | $400588 | $425625 | 6.25%  |
| **Richard W. Sunderland, Jr.** | $484500 | $496613 | 2.50% |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>40</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### 2025 Annual Incentive Plan
<u>Overall Opportunity</u>

We believe annual incentive cash compensation furthers our compensation philosophy and objectives by focusing our NEOs on performance goals that measure strategic and financial objectives. The total opportunity for annual cash incentive compensation for our NEOs under our AIP is expressed as a target percentage of base salary. The following table sets forth the threshold, target, and maximum incentives under the AIP for our NEOs, except for Mr. Codispoti, who did not participate in the AIP in 2025 due to the timing of his commencement of employment with the Company.

---

| | | | |
|:---|:---|:---|:---|
| **Named Executive Officer** | **Threshold** <br>**(50% of Target)** | **Target Incentive** <br>**(% of Base Salary)** | **Maximum** <br>**(200% of Target)**  |
| **Angela K. Selden** | 47.5% | 95% | 190%  |
| **Nuno S. Fernandes** | 32.5% | 65% | 130%  |
| **Mark L. Arnold** | 32.5% | 65% | 130%  |
| **Thomas A. Beckett** | 25.0% | 50% | 100%  |
| **Richard W. Sunderland, Jr.** | 25.0% | 50% | 100% |

---

After considering the survey data and the individual performance of the executives, the MDC Committee determined that the target AIP percentages for all continuing NEOs should remain the same for 2025.

The MDC Committee believes that the proportion of target annual incentive compensation to target total cash compensation (base salary plus target annual incentive pay) for our NEOs should be a relatively high percentage. It is also the Committee's general intent, as discussed above, that target annual incentives should be structured so that target total cash compensation is competitive with the 50th percentile of the survey data for achievement of target performance goals under the AIP. We believe this structure is appropriate because of the high level of performance that we believe is required from our executives in order for us to achieve our performance goals. We believe the high percentage of compensation tied to incentive compensation increases the focus of our NEOs on achieving our performance goals.

<u>2025 AIP Performance Measures</u>

The MDC Committee determined that performance under the NEOs' AIP should be measured based on our achievement of our financial performance and strategic goals, with financial performance measures comprising 80% of the AIP and strategic goals comprising 20% of the AIP. This split between financial and strategic reflects our belief that our NEOs should remain focused on the overall performance of the business while not losing focus on those strategic initiatives that we believe will drive long-term success. We also believe this split encourages a focus on multiple performance measures rather than focusing on one particular metric to the exclusion of others that we believe are also important to our results. For 2025, the financial performance measures included Adjusted EBITDA and subsidiary institution revenue.

*Adjusted EBITDA: The Committee selected Adjusted EBITDA as a financial performance measure because of its strong alignment with stockholder value creation. Adjusted EBITDA is a non-GAAP measure relevant to the achievement of our strategic goals and reflective of our earnings performance. Adjusted EBITDA goals and achievement were based on consolidated enterprise budgets and results for executives employed at the APEI level and, for Mr. Fernandes and Mr. Arnold, both consolidated enterprise budgets and results and their respective subsidiary institution's budgets and results.* 

*Revenue: The Committee selected revenue as the second financial performance measure in order to emphasize the importance of growth in addition to bottom-line results. For APEI participants, revenue was measured based on specific goals for APUS revenue, RU revenue, and HCN and GSUSA revenue, rather than measuring consolidated results, in order to ensure there was focus on growth at each subsidiary* 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>41</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
institution and not solely consolidated results. Given the relative size of GSUSA and HCN to the consolidated enterprise, for NEOs at the APEI level, the Committee combined the performance of these two businesses into one measure that was based on combined revenue. For APEI, the Committee retained the HCN and GSUSA revenue goal approved in January 2025 based on the full-year GSUSA revenue budget that did not account for the lost revenue opportunity after the GSUSA Sale. For Mr. Fernandes and Mr. Arnold, the revenue goal was solely based on their respective subsidiary institution's revenue.

*Strategic Goals: The Committee selected our strategic goals at the recommendation of our CEO to incent NEOs to remain focused on key initiatives that we believe will drive sustainable long-term growth and achievement of annual financial objectives. Strategic goals are intended to represent the most critical institution and enterprise-wide initiatives to position the Company for continued success.* 

The following table shows the financial performance and strategic goals for APEI-level executives and for Mr. Fernandes and Mr. Arnold expressed as a percentage of the portion of the AIP award at target that relates to financial and strategic performance.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Adjusted EBITDA Weighting*** | ***Adjusted EBITDA Weighting*** | ***Adjusted EBITDA Weighting*** | ***Revenue Weighting*** | ***Revenue Weighting*** | ***Revenue Weighting*** | ***Strategic Goals*** <br>***Weighting***  |
|  | **Company** | **APUS** | **RU** | **APUS** | **RU** | ***HCN/GSUA*** | **All NEOs**  |
| **APEI Executives** | 35% | N/A | N/A | 20% | 20% | 5% | 20%  |
| **Mr. Fernandes** | 10% | 30% | N/A | 40% | N/A | N/A | 20%  |
| **Mr. Arnold** | 10% | N/A | 30% | N/A | 40% | N/A | 20% |

---

<u>Selecting 2025 Financial Performance Goals</u>

The consolidated and institution-level Adjusted EBITDA and revenue targets used for the 2025 AIP were those included in our annual budget when approved by our Board. The AIP was established with both threshold and maximum levels of performance. In setting the threshold and maximum levels, the Committee discussed typical financial performance goal ranges with WTW, including a review of market practice.

For 2025, the MDC Committee specified that threshold performance for Adjusted EBITDA required achieving 90%, except for Mr. Arnold, and revenue required achieving 95% of the respective target goals, which the Committee determined was at a level of achievement that would require effort for the Company to achieve. The Committee determined that it was appropriate to provide an incentive at a threshold level because it would provide an annual incentive reflective of the positive performance of the Company and the contributions of our employees and NEOs. At threshold achievement, participants earn 50% of the applicable target opportunity. In addition, the Committee set the Adjusted EBITDA threshold as a gateway metric, meaning that if it were not achieved, no revenue or strategic goals payouts would be made under the AIP.

The Committee also established a maximum payout for exceptional performance, which was set at 110% of the Adjusted EBITDA target, except for Mr. Arnold as President of RU, and 105% of the revenue target, which the Committee determined was at a level of achievement that would require exceptional performance. At maximum performance achievement, participants earn 200% of the applicable target opportunity.

The Committee determined the relatively lower RU Adjusted EBITDA budget compared to APEI and APUS required a wider performance scale for Mr. Arnold to ensure meaningful above-target achievement to fund above target AIP payouts. Applying the 110% maximum Adjusted EBITDA goal used for APEI and APUS to RU would have resulted in Mr. Arnold achieving a maximum payout for RU exceeding target Adjusted EBITDA by $1M, which was below the Committee's expectations of exceptional performance. Therefore, the RU Adjusted EBITDA threshold was set at 80% and maximum was set at 140% of the Adjusted EBITDA target.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>42</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

<u>Selecting 2025 Strategic Goals</u>

Strategic goals incent NEOs to focus on key initiatives that we believe will drive sustainable long-term growth in addition to annual financial objectives. The strategic goals were recommended by Ms. Selden and approved by the Committee. Strategic goals were selected for each institution and then the strategic goals for executives at the APEI level were selected from the institution-level strategic goals, with the intention of fostering alignment among AIP participants.

For 2025, the Committee specified threshold, target, and maximum levels of achievement for each strategic goal that, if attained, would result in a payment of 50%, 100%, and 200% of the target amount, respectively, with no sliding scale adjustments for attainment between these levels.

Two 2025 strategic goals were set for each NEO participating at the APEI enterprise level, each weighted at 10% of total AIP opportunity. For those NEOs, one goal was selected from the strategic goals for the AIP participants at our two largest institutions:

&nbsp;&nbsp;&nbsp;&nbsp;• APUS: achieving a specified level of compliance with the 90/10 Rule; and

&nbsp;&nbsp;&nbsp;&nbsp;• RU: meeting budgeted total overall enrollment and total residential nursing enrollment growth targets.

For 2025, Mr. Fernandes' only strategic goal was based on achieving a specified level of compliance with the 90/10 Rule at APUS because of its relative significance and was weighted at 20% of total AIP opportunity. Mr. Arnold was subject to two strategic goals, both weighted at 10%, including strengthening NCLEX pass rates and meeting the RU goal listed above.

<u>Annual Incentive Plan Achievement and Payouts</u>

APEI-level NEOs achieved 123.4% of target payouts, while Mr. Fernandes and Mr. Arnold achieved 91.1% and 165.3% of their respective target payouts.

*Adjusted EBITDA Achievement: APEI Adjusted EBITDA achievement for 2025, which comprised 35% of AIP opportunity for APEI-level NEOs and 10% for Mr. Fernandes and Mr. Arnold, was assessed to be above target but below maximum, resulting in a payout of 164% of the APEI Adjusted EBITDA target. Mr. Fernandes earned 129% of the target for the APUS Adjusted EBITDA metric and Mr. Arnold earned 193% of the RU Adjusted EBITDA metric, which represented 30% of each of their 2025 AIP opportunities. To determine performance in 2025, the MDC Committee calculated Adjusted EBITDA by deducting from EBITDA stock-based compensation expense, professional fees for Board-approved projects, executive transition expenses, loss on assets and disposals, loss on the GSUSA Sale, and selected severance. These adjustments were consistent with the publicly reported Adjusted EBITDA except that the Committee did not exclude all of the severance expenses excluded in its public reporting when calculating AIP achievement and payouts. The Committee concluded that its adjustments used to calculated Adjusted EBITDA were consistent with its historical practice, market practices, and a culture of accountability.* 

*Revenue Achievement: APEI participants earned 124% of the revenue payout opportunity, which comprised 45% of their total target AIP opportunity. APUS and RU each accounted for 20%, and the combined HCN and GSUSA accounted for 5% of the AIP opportunity. Revenue performance resulted in payouts equal to 90% and 190% of target for the portion of total AIP opportunity subject to revenue achievement for APUS and RU revenue, respectively. HCN and GSUSA combined revenue was assessed to be below the threshold performance goal. Mr. Fernandes and Mr. Arnold earned payouts equal to 90% and 190% of target, respectively, for the 40% AIP opportunity subject to revenue achievement for APUS and RU revenue, respectively.* 

*Additional STI Pool: APUS and consolidated APEI 2025 revenue achievement was negatively impacted by federal government actions beyond management's control, including the 2025 federal government shutdown that resulted in dropped APUS course registrations and DOGE and other* 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>43</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

government funding actions that significantly reduced funding available for career learning and contract training at federal government agencies and led to decreased GSUSA registrations. In addition, the strategic decision to conduct the GSUSA Sale eliminated revenue opportunity after July 25, 2025, that had been included when setting the 2025 revenue budgets and AIP revenue financial performance goals.

The MDC Committee determined that an adjustment to the AIP funding pool was reasonable and reflective of management's successful efforts to mitigate the negative impacts of federal government actions beyond its control while continuing to deliver strong growth and stockholder returns throughout 2025. Accordingly, the Committee approved an increase to the AIP pool that was allocated proportionally to APEI and APUS AIP participants based on the percentage of their respective aggregate AIP payout, with $102,000 in the aggregate allocated to the NEOs. The additional AIP funding increased the payouts as a percentage of target from 123.4% to 128.7% for the APEI-level NEOs and from 91.1% to 101.7% for Mr. Fernandes. Mr. Arnold had minimal exposure to the revenue impact of the government shutdown and therefore was not eligible for any portion of the additional AIP funding.

No adjustments were considered by the MDC Committee for the decreased GSUSA revenue resulting from DOGE and other government funding actions and the loss of 2025 revenue opportunity after completion of the GSUSA Sale that was included when setting 2025 revenue budgets and AIP revenue financial performance goals.

*Strategic Goals Achievement: For 2025, the MDC Committee determined that the strategic RU enrollment goals were achieved at 100% of target, while the NCLEX pass rates goal was achieved at the threshold level. While APUS was in compliance with the 90/10 Rule for 2025, the level of achievement was not at a level that resulted in a payout under the AIP. Accordingly, Mr. Fernandes did not receive a strategic goal payout, and Mr. Arnold received 75% of his strategic goal payout, or 15% of his total target AIP opportunity for the strategic goals. Other NEOs achieved 50% of their strategic goal targets, or 10% of their total AIP opportunity for the achievement of strategic goals. The specific targets for RU enrollment, RU programs satisfying NCLEX benchmarks, and APUS 90/10 Rule compliance are not disclosed because they relate to information and internal forecasting of figures that are not publicly disclosed due to the proprietary nature and competitive sensitivity of that information. The method used to calculate the awards was based on actual performance.* 

The following tables show the target opportunities and payouts for each element of the AIP for each NEO, except for Mr. Codispoti, as well as total target opportunities and payouts.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  | ***Performance Achievement and Payouts for NEOs other than*** <br>***Mr. Fernandes and Mr. Arnold***  |
| **Metric** | **Weighting** | **Performance Goals (in millions)** | **Performance Goals (in millions)** | **Performance Goals (in millions)** | **Achievement** | **Achievement** | **Payout**  | **Payout**  |
| **Metric** | **Weighting** | **Threshold** | **Target** | **Maximum** | **Actual ($M)** | **% of** <br>**Target** | **Payout %** <br> | **Weighted**  |
| APEI Adjusted EBITDA | *35%* | $72.2  | $80.2  | $88.2  | $85.4  | 106.5% | 164% | 57.4%  |
| APUS Revenue | *20%* | $307.0  | $323.2  | $339.4  | $319.8  | 98.9% | 90% | 18.0%  |
| RU Revenue | *20%* | $223.9  | $235.7  | $247.5  | $246.2  | 104.7% | 190% | 38.0%  |
| HCN/GSUSA Revenue | *5%* | $104.2  | $109.7  | $115.2  | $83.0  | 75.7% | 0% | 0.0%  |
| Strategic Goals | *20%* |  |  |  |  |  | 50% | 10.0%  |
| Additional STI |  |  |  |  |  |  |  | 5.3%  |
| **TOTAL** |  |  |  |  |  |  |  | **128.7%** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>44</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  | ***Performance Achievement and Payouts for Mr. Fernandes***  |
| **Metric** | ***Weighting*** | **Performance Goals (in millions)** | **Performance Goals (in millions)** | **Performance Goals (in millions)** | **Achievement** | **Achievement** | **Payout**  | **Payout**  |
| **Metric** | ***Weighting*** | **Threshold** | **Target** | **Maximum** | **Actual ($M)** | **% of** <br>**Target** | **Payout %** <br> | **Weighted**  |
| APEI Adjusted EBITDA | *10%* | $72.2  | $80.2  | $88.2  | $85.4  | 106.5% | 164% | 16.4%  |
| APUS Adjusted EBITDA | *30%* | $86.1 | $95.7 | $105.3 | $98.5 | 102.9% | 129% | 38.7%  |
| APUS Revenue | *40%* | $307.0  | $323.2 | $339.4  | $319.8  | 98.9% | 90% | 36.0%  |
| Strategic Goals | *20%* |  |  |  |  |  | 0% | 0%  |
| Additional STI |  |  |  |  |  |  |  | 10.5%  |
| **TOTAL** |  |  |  |  |  |  |  | **101.7%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  | ***Performance Achievement and Payouts for Mr. Arnold***  |
| **Metric** | ***Weighting*** | **Performance Goals (in millions)** | **Performance Goals (in millions)** | **Performance Goals (in millions)** | **Achievement** | **Achievement** | **Payout**  | **Payout**  |
| **Metric** | ***Weighting*** | **Threshold** | **Target** | **Maximum** | **Actual ($M)** | **% of** <br>**Target** | **Payout %** <br> | **Weighted**  |
| APEI Adjusted EBITDA | *10%* | $72.2  | $80.2  | $88.2  | $85.4  | 106.5% | 164% | 16.4%  |
| RU Adjusted EBITDA | *30%* | $8.0  | $10.0  | $14.0  | $13.7  | 137.3% | 193% | 57.9%  |
| RU Revenue | *40%* | $223.9  | $235.7  | $247.5  | $246.2  | 104.4% | 190% | 76.0%  |
| Strategic Goals | *20%* |  |  |  |  |  | 75% | 15.0% |
| **TOTAL** |  |  |  |  |  |  |  | **165.3%** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***2025 AIP Payouts*** | ***2025 AIP Payouts*** | ***2025 AIP Payouts*** | ***2025 AIP Payouts*** | ***2025 AIP Payouts*** |
| **Named Executive Officer** | **Target AIP** | **Target AIP** | **Target AIP** | **2025 Payouts**  | **2025 Payouts**  |
| **Named Executive Officer** | **Annual Salary** | **% of Salary** | **Target** | **% of Target** | **Total Payout**  |
| **Angela K. Selden** | $855000 | 95% | $812250 | 128.7% | $1045315  |
| **Nuno S. Fernandes** | $515000 | 65% | $334750 | 101.7% | $340398  |
| **Mark L. Arnold<sup>(1)</sup>** | $411923 | 65% | $261105 | 165.3% | $454222  |
| **Thomas A. Beckett** | $425625 | 50% | $212812 | 128.7% | $273877  |
| **Richard W. Sunderland, Jr.** | $496613 | 50% | $248306 | 128.7% | $319555 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Prorated salary for time employed during the calendar year.

#### 2025 Equity Incentives
We believe that a significant portion of our NEOs' total compensation should be in the form of long-term equity incentive awards in order to align the priorities of the NEOs with the interests of our stockholders. To further emphasize performance and ensure that management's objectives are aligned with those of our stockholders, the 2025 annual equity awards for our continuing NEOs were split 50% as RSUs and 50% as PSUs. Consistent with historical practice, the RSUs and PSUs each vest in three equal installments on the first three anniversaries of the grant date, subject to achievement of performance metrics in the case of the PSUs.

<u>Determining 2025 Equity Award Values</u>

In determining the 2025 equity awards for the continuing NEOs other than Ms. Selden, the Committee considered the recommendation of Ms. Selden, which reflected the competitive survey data provided by WTW, the performance and impact of each NEO, and the overall strong 2024 financial and stock performance. With regard to Ms. Selden's 2025 equity award, the Committee also considered the WTW survey data and Ms. Selden's leadership in driving the 2024 financial results and stockholder returns.

The equity award values for the continuing NEOs in 2025 represented a return to market-based competitive awards. The 2024 equity award values had been generally below the competitive range provided by WTW due to the Company's 2023 financial and stock performance not meeting the Committee's expectations and the Committee's decision to preserve shares available for grants under the

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>45</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
Company's 2017 Omnibus Incentive Plan, as amended, for an additional year and instead grant to NEOs in 2024 a number of RSUs and PSUs comparable to the number of each of those units issued in 2023. In addition, the Committee further reduced the 2024 long-term equity incentive award to Ms. Selden in light of the Company's uneven performance in 2023 and her role as CEO. In 2025, as a result of the Company's solid growth and performance in 2024 and the change in the circumstances, including as a result of the increase in the Company's stock price over the course of 2024, the Committee determined that market-based competitive awards were appropriate and consistent with the Committee's focus on aligning NEO long-term incentive opportunity with overall Company performance and creating long-term stockholder value.

The size of the equity incentive awards for our NEOs was discussed at the same time the MDC Committee met to set the other elements of compensation so that all elements of compensation were set taking into account the total target compensation opportunity. In setting the equity awards, the Committee also continued to consider equitable treatment among executives but recognized that the market for competitive talent varies among executives and that it is appropriate for equity awards to vary among executives.

After determining the dollar value of equity incentive awards, the MDC Committee calculated the number of shares to be subject to the awards using a 60-day trailing average for our stock price as of a date shortly before the Committee met to approve the grants. We believe that doing so removes some of the variability that can impact awards if the Committee were to use the stock price on only one date. The 60-day trailing average stock price for the 2025 equity awards granted to continuing NEOs was $21.23.The equity award values reported in the Summary Compensation Table reflect the RSUs issued on January 31, 2025, at a grant date fair value of $21.94 per share and the PSUs issued on February 4, 2025, at a grant date fair value of $21.99 per share, calculated in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 718.

The following chart shows the value of the equity awards for each continuing NEO and also shows the resulting numbers of RSUs and of PSUs at the target level of performance.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***2025 Equity Awards***  | ***2025 Equity Awards***  | ***2025 Equity Awards***  | ***2025 Equity Awards***  | ***2025 Equity Awards***  |
| **Named Executive Officer**<br>| **Base Salary** <br>**($)** | **Calculated Value** <br>**($)** | **Value** <br>**(% of Salary)** | **RSUs** <br>**(#)** | **PSUs** <br>**(#)**  |
| **Angela K. Selden** | 855000 | 3000000 | 351% | 70655 | 70655  |
| **Nuno S. Fernandes** | 515000  | 420000  | 82% | 9892 | 9892  |
| **Mark L. Arnold** | 450000  | 320000  | 71% | 7537 | 7537  |
| **Thomas A. Beckett** | 425625  | 440000 | 103% | 10363 | 10363  |
| **Richard W. Sunderland, Jr.** | 496613  | 600000  | 121% | 14131 | 14131 |

---

<u>2025 Performance Share Unit Measures</u>

In order to reflect the importance of overall financial performance and the importance of growth for the Company, for 2025, the Committee continued to use revenue and Adjusted EPS as the performance measures for the PSUs, each weighted at 50%.

Revenue is defined as the Company's revenue calculated in accordance with accounting principles generally accepted in the United States ("GAAP") and included in the Company's financial statements. Adjusted EPS is the Company's GAAP net income per share (diluted) included in the Company's audited financial statements, provided that the calculation shall be adjusted to reflect 18.61 million budgeted shares outstanding as of February 3, 2025 and subject to adjustment for unbudgeted or unusual items, such as loss on assets and disposals, effects of acquisitions, and legal settlements.

The Committee set targets for PSUs that reflect the approved budget. The threshold payout for PSUs was established as 50% of the target level, which would be earned for achieving 95% of the revenue target

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>46</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

and 78% of the EPS target. These numbers reflected achievement that the Committee determined would require effort for the Company to achieve. The maximum payout was set at 200% of the target level, which would be earned for achieving 105% of the revenue target and 122% of the EPS target. These numbers reflected the Committee's view of exceptional performance that would create stockholder value. For levels of revenue and Adjusted EPS between the applicable dollar amounts set forth below, the percentage of the award earned would be prorated accordingly.

The Committee also retains the ability, in its subjective judgment, to reduce the level of achievement under the PSUs considering its views of an executive's overall performance, demonstration of leadership behaviors, transparency, fidelity to our vision and values, and commitment to a culture of compliance. The Committee did not exercise this discretion in 2025.

<u>2025 Performance Share Unit Performance Achievement</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **Revenue** <br>**(50% of Target Number of PSUs)** | **Revenue** <br>**(50% of Target Number of PSUs)** | **Adjusted EPS** <br>**(50% of Target Number of PSUs)**  | **Adjusted EPS** <br>**(50% of Target Number of PSUs)**  |
|  | **Earnout** <br>**(% of Target)** | **% of Budget** <br>**Amount** | **Goal** | **% of Budget** <br>**Amount** | **Goal**  |
| **Threshold** | 50% | 95% | $628.3 | 78% | $1.08  |
| **Target** | 100% | 100% | $661.3 | 100% | $1.38  |
| **Maximum** | 200% | 105% | $694.4 | 122% | $1.69  |
| ***Actual Result*** |  |  | ***$648.9*** |  | ***$1.68***  |
| **% of Target Shares Earned** |  |  | ***81.2%*** |  | ***197%*** |

---

Our 2025 revenue was $648.9 million, or approximately 98.1% of the target goal, and Adjusted EPS was $1.68, or approximately 121.7% of the target goal, resulting in 139.2% of the target PSU award being earned. For 2025, the MDC Committee adjusted reported EPS for the loss on the GSUSA Sale, severance, and loss on various assets and disposals. The Committee concluded that these adjustments were consistent with its historical practice and market practice and provided an incentive to leadership to capitalize on unbudgeted strategic opportunities. The award earned is further subject to time-based vesting in order to continue to provide a retention element and to encourage executives to focus on the long-term performance of the Company.

---

| | | | |
|:---|:---|:---|:---|
| | ***2025 PSUs Earned and Subject to Vesting***  | ***2025 PSUs Earned and Subject to Vesting***  | ***2025 PSUs Earned and Subject to Vesting***  |
| <br>**Named Executive Officer**<br>| **Target 2025** <br>**PSU Shares** | **Performance** <br>**Achievement** | **Actual 2025 PSU** <br>**Shares Earned** <br>**Subject to Vesting**  |
| Angela K. Selden | 70655 | 139.2% | 98352  |
| Nuno S. Fernandes | 9892 | 139.2% | 13770  |
| Mark L. Arnold | 7537 | 139.2% | 10492  |
| Thomas A. Beckett | 10363 | 139.2% | 14425  |
| Richard W. Sunderland, Jr. | 14131 | 139.2% | 19670 |

---

#### New CFO Sign-On Awards
In connection with his appointment to the role of our Chief Financial Officer in October 2025 and pursuant to his offer letter, Mr. Codispoti received a sign-on bonus of $70,000, subject to repayment within 12 months of Mr. Codispoti's start date in the event of termination of employment except if by the Company without cause or in the event of death or disability, and a grant of 8,477 RSUs, vesting equally over the first three grant date anniversaries. The number of shares subject to the RSU grant was based on a calculated grant value of $300,000 divided by the 60-day trailing average for our stock price as of Mr. Codispoti's appointment date, which was $35.39 per share. The calculated grant date value of

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>47</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
Mr. Codispoti's sign-on equity award equaled one-half of what his 2026 LTI award was expected to be. As a result, Mr. Codispoti's 2026 LTI award granted in February 2026 was only one-half of what it otherwise would have been. Mr. Codispoti sign-on equity award did not include PSUs because the annual performance cycle was approximately 80% complete at the time of Mr. Codispoti's appointment to CFO. However, because Mr. Codispoti's sign-on equity award consisted of RSUs, his 2026 LTI award was made solely in PSUs.

#### 2025 Say-on-Pay Vote
We consider the views of our stockholders in designing our executive compensation program and welcome feedback on our executive pay practices. In 2025, approximately 93% of the stockholder votes cast on our "say on pay" proposal were voted in favor of our executive compensation. In addition, approximately 94% of the stockholder votes were voted in favor of the proposed amendment to the Company's 2017 Omnibus Incentive Plan. We continued our ongoing stockholder engagement program during 2025 to elicit further feedback and perspectives on the issues important to our stockholders. Because the annual advisory vote occurred after our compensation was set for 2025, the results for the 2025 vote were not available to be considered prior to establishing our 2025 compensation program, but the MDC Committee considered and discussed the results prior to establishing our compensation program for 2026. See page [73](#tPROP3) for this year's say-on-pay proposal.

 **OTHER COMPENSATION POLICIES AND PRACTICES**<br>

#### Employment Agreements and Post-Termination Compensation
We entered into an employment agreement with Ms. Selden in connection with Ms. Selden's appointment as our President and Chief Executive Officer in 2019. This agreement provides Ms. Selden with severance payments upon certain terminations, including termination without cause, termination by the executive for good reason, or upon certain triggering events following a change of control. The agreement provides for certain payments in connection with a termination of her employment within 60 days prior to or 365 days following a change of control of the Company. The MDC Committee determined that entering into the employment agreement with Ms. Selden was appropriate in order to attract her to the Company and provide her with employment on terms similar to our other executives at the time and in line with what we concluded were appropriate terms for a Chief Executive Officer for a company of our size and in our industry and commensurate with her responsibilities.

In 2014, the MDC Committee authorized negotiating an employment agreement with Mr. Sunderland on substantially the same terms as the agreements with our other then-serving NEOs. The Committee determined it was appropriate to have an employment agreement with Mr. Sunderland in an effort to retain Mr. Sunderland, treat him similarly to other executives, and to ensure his agreement would be subject to post-employment non-competition and non-solicitation terms with which he otherwise would not have had to comply. The agreement provided for certain payments in connection with a termination of his employment within 180 days prior to or 365 days following a change of control of the Company. On June 13, 2024, the Company, APUS and Mr. Sunderland entered into a Transition and Release Agreement (the "Transition Agreement") providing for Mr. Sunderland's transition and the eventual cessation of his services as an employee and officer of the Company. Under the terms of the Transition Agreement, Mr. Sunderland remained an employee of the Company until February 20, 2026, the date of his departure from the Company, and the terms of the Sunderland Employment Agreement continued in full force and effect until such date. Accordingly, Mr. Sunderland was entitled to the applicable payments set forth under his employment agreement except as modified under the Transition Agreement. Mr. Sunderland's departure from the Company was deemed a termination without Cause by the Company for purposes of his employment agreement and a "Qualified Retirement" for purposes of his previously granted equity awards, which means he was entitled to full vesting of those awards, subject to satisfaction of performance conditions for outstanding performance awards.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>48</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
In 2017, at the recommendation of the MDC Committee, our Board adopted the Executive Severance Plan. The MDC Committee recommended the adoption of the Executive Severance Plan in order to provide severance benefits to Senior Vice Presidents of the Company that are designated by the MDC Committee without having to adopt individual employment or severance agreements. The MDC Committee concluded that a severance arrangement for the designated participants was appropriate in order to help retain these executives. In concluding it was appropriate to adopt the Executive Severance Plan, the MDC Committee considered practices in industry generally and among our peer group, as well as the advice of WTW. The MDC Committee also considered that the Executive Severance Plan requires, as a condition to receiving benefits, that each participant must comply with covenants not to compete with us and our affiliates and not to solicit our employees or those of our affiliates, in each case during the term of employment and for a period of 12 months thereafter. In addition, in order to receive severance benefits, a participant must agree to release all claims against us and our affiliates and their respective officers and directors.

For additional information regarding these agreements, including a quantification of benefits that would be received by these officers had termination occurred on December 31, 2025, see the section titled "Potential Payments upon Termination or Change in Control" below.

#### Non-Qualified Deferred Compensation
We maintain a non-qualified deferred compensation plan in which our executive officers are permitted to participate. The Code limits the amounts of matching contributions that we can contribute to our traditional 401(k) plan for the benefit of our executives. The deferred compensation plan provides that we will make an annual matching contribution to plan participants in an amount equal to the difference between the matching contribution that the participant would have received under our 401(k) plan if those limitations under the Code did not apply and the matching contribution that the employee actually received under our 401(k) plan. The balances in the plan are only available for investment in investment options that are also available under our 401(k) plan. We believe that it is fair to provide this plan to our executives because absent the limitations under the Code, they would have otherwise received these amounts. The plan also permits us, but does not require us to, make additional, discretionary contributions. We did not make any discretionary contributions in 2025.

#### Limited Perquisites and Tax Gross-Ups
We reimburse certain travel-related costs of certain executive officers who live at a distance from our Charles Town, West Virginia headquarters or other executive offices in order to facilitate their presence and performance of their duties at our facilities. These executive officers are taxed for these reimbursements when travel is in the ordinary course.

We did not provide a gross-up to our NEOs for any personal income taxes they incurred as a result of these benefits.

#### Role of Executives in Executive Compensation Decisions
Historically, our Chief Executive Officer has recommended to the MDC Committee each element of compensation for all executive officers other than that of the Chief Executive Officer, and the MDC Committee determines the target level of compensation for each executive officer. Our Chief Human Resources Officer provides support to Ms. Selden and the Committee, including with respect to structuring compensation arrangements during 2025.

The amount of each element of compensation for our Chief Executive Officer is determined by the MDC Committee. Our Chief Executive Officer and our Chief Human Resources Officer do not participate in deliberations relating to their own compensation. None of our other executive officers participates in any deliberations related to the setting of executive compensation.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>49</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Our Commitment to Strong Executive Compensation Practices
The Company does not currently grant awards of stock options, stock appreciation rights, or similar option-like awards as part of its annual compensation program. The Company does not time the disclosure of material non-public information, or the granting of equity awards, for the purpose of impacting the value of executive compensation.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>50</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### MANAGEMENT DEVELOPMENT & COMPENSATION

### COMMITTEE REPORT
The Management Development & Compensation Committee reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with the Company's management. Based on its review and discussions with the Company's management, the Management Development & Compensation Committee recommended that the Compensation Discussion and Analysis be included in the Company's Proxy Statement and in the Company's Annual Report on Form 10-K (including by incorporation by reference to this Proxy Statement).

Management Development & Compensation Committee

Anna M. Fabrega, Chairperson

Michael D. Braner

Richard J. Statuto

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>51</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### COMPENSATION TABLES AND DISCLOSURES

#### Summary Compensation Table

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and** <br>**Principal Position<sup>(1)</sup>** | **Year** | **Salary<sup>(2)</sup>** | **Bonus<sup>(3)</sup>** | **Stock** <br>**Awards<sup>(4)</sup>** | **Non-Equity** <br>**Incentive Plan** <br>**Compensation<sup>(5)</sup>** | **All Other** <br>**Compensation<sup>(6)</sup>** | **Total**  |
| Angela K. Selden <br>*President and Chief Executive Officer* | 2025 | $838846  | &nbsp;&nbsp;— | $3103874 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1045315  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$75573  | $5063608  |
| Angela K. Selden <br>*President and Chief Executive Officer* | 2024 | $795000  | &nbsp;&nbsp;— | $1296791  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$757055  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$60456  | $2909301  |
| Angela K. Selden <br>*President and Chief Executive Officer* | 2023 | $825577  | &nbsp;&nbsp;— | $2908441  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$423997  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$48636  | $4176074  |
| Edward H. Codispoti. <br>*Executive Vice President,* <br>*Chief Financial Officer* | 2025 | $91731 | &nbsp;&nbsp;$70000 | $318057 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2442 | $482230  |
| Nuno S. Fernandes <br>*President, American Public University System* | 2025 | $510962  | &nbsp;&nbsp;— | $434556  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$340398  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$33410  | $1319325  |
| Nuno S. Fernandes <br>*President, American Public University System* | 2024 | $493269  | &nbsp;&nbsp;— | $370300  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$199079  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$42315  | $1104963  |
| Nuno S. Fernandes <br>*President, American Public University System* | 2023 | $475000  | &nbsp;&nbsp;— | $415495  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$388270  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$36112  | $1314877  |
| Mark L. Arnold <br>*President, Rasmussen University* | 2025 | $411923  | &nbsp;&nbsp;— | $331100  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$454222  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20404  | $1217650  |
| Thomas A. Beckett <br>*Senior Vice President and General Counsel* | 2025 | $418884  | &nbsp;&nbsp;— | $455247  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$273877  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32613  | $1180621  |
| Thomas A. Beckett <br>*Senior Vice President and General Counsel* | 2024 | $394006  | &nbsp;&nbsp;— | $312110  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$200773  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$28697  | $935585  |
| Thomas A. Beckett <br>*Senior Vice President and General Counsel* | 2023 | $366407  | &nbsp;&nbsp;— | $337583  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$122038  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$21133  | $847161  |
| Richard W. Sunderland, Jr. <br>*Former Executive Vice President, Chief Financial Officer* | 2025 | $493351  | &nbsp;&nbsp;— | $620775  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$319555  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$45524  | $1479205  |
| Richard W. Sunderland, Jr. <br>*Former Executive Vice President, Chief Financial Officer* | 2024 | $481942  | &nbsp;&nbsp;— | $502550  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$242829  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$39103  | $1266425  |
| Richard W. Sunderland, Jr. <br>*Former Executive Vice President, Chief Financial Officer* | 2023 | $475000  | &nbsp;&nbsp;— | $742699  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$149483  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$34328  | $1401510 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Information is provided for 2025 only for Mr. Codispoti and Mr. Arnold because they were neither NEOs nor employees of the Company in 2024 or 2023.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Values reflect the amounts actually paid to the NEOs for each year.

&nbsp;&nbsp;&nbsp;&nbsp;(3) Reflects Mr. Codispoti's sign-on bonus of $70,000, which is subject to repayment at the Company's request if his employment with the Company terminates prior to the one-year anniversary of his start date, or October 20, 2026, for reasons other than death or disability.

&nbsp;&nbsp;&nbsp;&nbsp;(4) Amounts reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, of RSUs and PSUs, as applicable, excluding estimates of forfeiture. A discussion of the relevant assumptions used in calculating these equity awards can be found in Notes 1 and 13 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025. PSUs are valued assuming achievement at target, which was the probable outcome determined for accounting purposes at the time of grant. The target and maximum grant date values of PSUs for NEOs in 2025, except for Mr. Codispoti, who did not receive PSUs in 2025, are as follows:

---

| | | |
|:---|:---|:---|
| **Name**<br>| **Grant Date Value at** <br>**Target Performance**<br>| **Grant Date Value at** <br>**Maximum Performance** <br>|
| Angela K. Selden | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1553703 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$3107407 |
| Nuno S. Fernandes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$217525 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$435050 |
| Mark L. Arnold | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$165739 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$331477 |
| Thomas A. Beckett | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$227882 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$455765 |
| Richard W. Sunderland, Jr. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$310741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$621481 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(5) Amounts reflect payments made pursuant to our AIP based upon the achievement of performance goals established by our MDC Committee. Mr. Codispoti was not eligible to participate in the AIP in 2025 due to the timing of his start date with the Company.

&nbsp;&nbsp;&nbsp;&nbsp;(6) Amounts for 2025 include, but are not limited to, (i) $14,000 of 401(k) contribution matches made by us to Ms. Selden, Mr. Fernandes, Mr. Arnold, and Mr. Sunderland, and $13,800 to Mr. Beckett, and (ii) non-qualified deferred compensation plan matching contributions made by us of $49,836 for Ms. Selden, $14,402 for Mr. Fernandes, $10,786 for Mr. Beckett, and $15,447 for Mr. Sunderland.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>52</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### 2025 Grants of Plan-Based Awards

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name** | **Type** | **Grant Date** | **Estimated Future Payouts** <br>**Under Non-Equity Incentive** <br>**Plan Awards<sup>(1)</sup>** | **Estimated Future Payouts** <br>**Under Non-Equity Incentive** <br>**Plan Awards<sup>(1)</sup>** | **Estimated Future Payouts** <br>**Under Non-Equity Incentive** <br>**Plan Awards<sup>(1)</sup>** | **Estimated Future Payouts** <br>**Under Equity Incentive** <br>**Plan Awards<sup>(2)</sup>** | **Estimated Future Payouts** <br>**Under Equity Incentive** <br>**Plan Awards<sup>(2)</sup>** | **Estimated Future Payouts** <br>**Under Equity Incentive** <br>**Plan Awards<sup>(2)</sup>** | **All Other** <br>**Stock** <br>**Awards:** <br>**Number** <br>**of Stock** <br>**or Units<sup>(3)</sup>** | **Grant Date** <br>**Fair Value** <br>**Awards<sup>(4)</sup>**  |
| **Name** | **Type** | **Grant Date** | **Threshold** | **Target** | **Maximum** | **Threshold** | **Target** | **Maximum** | **All Other** <br>**Stock** <br>**Awards:** <br>**Number** <br>**of Stock** <br>**or Units<sup>(3)</sup>** | **Grant Date** <br>**Fair Value** <br>**Awards<sup>(4)</sup>**  |
| Angela K. Selden | RSUs | 1/30/2025 |  |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;70655 | $1550171  |
| Angela K. Selden | PSUs | 2/4/2025 |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;17664 | 70655 | &nbsp;&nbsp;141310 |  | $1553703  |
| Angela K. Selden | AIP |  | $142144 | $812250 | $1624500  |  |  |  |  |  |
| Edward H. Codispoti | RSUs | 10/20/2025 |  |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;8477 | $318057  |
| Nuno S. Fernandes | RSUs  | 1/30/2025 |  |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;9892 | $217030  |
| Nuno S. Fernandes | PSUs | 2/4/2025 |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;2473 | 9892 | &nbsp;&nbsp;19784 |  | $217525  |
| Nuno S. Fernandes | AIP |  | $16738  | $334750  | $669500  |  |  |  |  |  |
| Mark L. Arnold | RSUs | 1/30/2025 |  |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;7537 | $165362  |
| Mark L. Arnold | PSUs | 2/4/2025 |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;1884 | 7537 | &nbsp;&nbsp;15074 |  | $165739  |
| Mark L. Arnold | AIP |  | $13162  | $263250  | $526500  |  |  |  |  |  |
| Thomas A. Beckett | RSUs | 1/30/2025 |  |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;10363 | $227364  |
| Thomas A. Beckett | PSUs | 2/4/2025 |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;2591 | 10363 | &nbsp;&nbsp;20726 |  | $227882  |
| Thomas A. Beckett | AIP |  | $37242 | $212813  | $425625 |  |  |  |  |  |
| Richard W. Sunderland, Jr. | RSUs | 1/30/2025 |  |  |  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;14131 | $310034  |
| Richard W. Sunderland, Jr. | PSUs | 2/4/2025 |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;3533 | 14131 | &nbsp;&nbsp;28262 |  | $310741  |
| Richard W. Sunderland, Jr. | AIP |  | $43454 | $248306 | $496613  |  |  |  |  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) These columns show the range of possible cash payouts for 2025 performance pursuant to our AIP. Actual amounts paid out pursuant to the AIP are included in the Non-Equity Incentive Plan Compensation column of the Summary Compensation Table above. Mr. Codispoti was not eligible to participate in the AIP in 2025 due to the timing of his start date with the Company. For a discussion of the performance goals established by the MDC Committee for these awards, see the section titled "2025 Compensation Decisions — 2025 Annual Incentive Plan" in the Compensation Discussion and Analysis.

&nbsp;&nbsp;&nbsp;&nbsp;(2) These columns show the range of PSUs that could be earned based on 2025 performance pursuant to the performance-based awards granted in 2025. PSUs earned vest over a three-year period. For a discussion of the performance goals established by the MDC Committee for these awards, see the section titled "2025 Compensation Decisions — 2025 Equity Incentives" in the Compensation Discussion and Analysis.

&nbsp;&nbsp;&nbsp;&nbsp;(3) This column shows the number of RSUs granted, which vest ratably over three years.

&nbsp;&nbsp;&nbsp;&nbsp;(4) Amounts reflect the grant date fair value, computed in accordance with FASB ASC Topic 718, and will likely vary from the amount actually realized by any NEO based on a number of factors, including the number of shares that are earned and ultimately vest, the timing of vesting, the timing of any sale of shares, and the market price of our common stock at that time. PSUs are valued assuming achievement at target, which was the probable outcome determined for accounting purposes at the time of grant. For RSUs, we calculate grant date fair value by multiplying the number of shares granted by the closing market price per share of our common stock on the grant date.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>53</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Employment Agreements
For Ms. Selden and Mr. Sunderland, the amounts disclosed in the tables above are in part a result of the terms of their employment agreements. We do not have an employment agreement with the other NEOs.

*Ms. Selden's Employment Agreement. In August 2019, we entered into an employment agreement with Ms. Selden to serve as our President and Chief Executive Officer, effective September 23, 2019. The initial term of Ms. Selden's employment agreement ended on March 31, 2023, and the term automatically renews for additional one-year terms unless we give written notice of our intent not to renew at least 30 days prior to the renewal date. Pursuant to her agreement, Ms. Selden's base salary was set at $630,000 per year, subject to annual review and adjustment by our MDC Committee. Ms. Selden's employment agreement provides that she is entitled to participate in our annual incentive plan, under which she was eligible for an annual bonus of up to 90% of her base salary then in effect, and up to an additional 45% of her base salary as then in effect based upon the achievement of certain performance goals or certain "stretch" performance goals, respectively, as determined by the MDC Committee.* 

In addition to a base salary and annual bonus, Ms. Selden is entitled to receive such other benefits approved by our MDC Committee and made available to our other senior executives and to participate in plans and receive bonuses, incentive compensation and fringe benefits as we may grant or establish from time to time. Ms. Selden has agreed not to compete with us nor solicit our employees for alternative employment during the term of her agreement and for a period of two years after termination for any reason.

*Mr. Sunderland's Employment Agreement and Transition and Release Agreement. In August 2014, we entered into an employment agreement with Mr. Sunderland to serve as Executive Vice President and Chief Financial Officer (the "Sunderland Employment Agreement") that had similar provisions to the provisions of the agreement discussed above, except with respect to his position, amounts relating to his initial base salary and annual bonus, and scope of restrictive covenants. Under the Sunderland Employment Agreement, Mr. Sunderland's initial term of employment ran until March 31, 2017, and automatically renewed for additional one-year terms unless we gave written notice of our intent not to renew at least 30 days prior to the renewal date. Pursuant to his agreement, Mr. Sunderland's initial annual salary was set at $300,000, subject to annual review and adjustment by our MDC Committee. Mr. Sunderland was eligible for an annual bonus of up to 50% of his base salary then in effect and up to an additional 30% of his base salary as then in effect based upon the achievement of certain performance goals or certain "stretch" performance goals, respectively, as determined by the MDC Committee.* 

On October 20, 2025, Mr. Sunderland transitioned to a non-executive employee of the Company to assist with Mr. Codispoti's transition until his departure on February 20, 2026 (the "Separation Date"). On June 13, 2024, the Company, APUS and Mr. Sunderland entered into the Transition Agreement providing for Mr. Sunderland's transition and the eventual cessation of his services as an employee and officer of the Company. Under the terms of the Transition Agreement, Mr. Sunderland remained an active employee of the Company and the terms of the Sunderland Employment Agreement continued in full force and effect until the Separation Date. Accordingly, Mr. Sunderland was entitled to the applicable payments set forth under the Sunderland Employment Agreement except as modified under the Transition Agreement. Mr. Sunderland's departure from the Company was deemed a termination without Cause by the Company for purposes of the Sunderland Employment Agreement and a "Qualified Retirement" for purposes of his previously granted equity awards, which means he was entitled to full vesting of those awards, subject to satisfaction of performance conditions for outstanding performance awards.

The executives' base salaries for 2025 and target annual incentive compensation plan awards for 2025 are set forth in the tables above. In addition, each of the above employment agreements provides for payments upon certain terminations of the executive's employment. For a description of these termination provisions, whether or not following a change in control, and a quantification of benefits that would be received, and for Mr. Sunderland in connection with his transition, see the section titled "Potential Payments Upon Termination or Change in Control" on page [57](#tPPU).

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>54</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### 2025 Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information with respect to the outstanding equity awards at December 31, 2025, for our NEOs:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards**  | **Stock Awards**  |
| <br>**Named Executive Officer** | **Number of** <br>**Securities** <br>**Underlying** <br>**Unexercised** <br>**Options (#)** <br>**Exercisable** | **Number of** <br>**Securities** <br>**Underlying** <br>**Unexercised** <br>**Options (#)** <br>**Unexercisable** | **Options** <br>**Exercise** <br>**Price ($)** | **Options** <br>**Expiration** <br>**Date**  | **Number of** <br>**Shares or** <br>**Units of** <br>**Stock That** <br>**Have Not** <br>**Vested<sup>(1)</sup>** | **Market Value** <br>**of Shares** <br>**or Units of** <br>**Stock That** <br>**Have Not** <br>**Vested ($)<sup>(2)</sup>**  |
| Angela K. Selden | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43134 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;$23.77  | &nbsp;&nbsp;9/23/2029 | &nbsp;&nbsp;&nbsp;&nbsp;334807 | &nbsp;&nbsp;$12655705  |
| Edward H. Codispoti | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;8477 | &nbsp;&nbsp;$320431  |
| Nuno S. Fernandes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17056  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;$10.66  | &nbsp;&nbsp;8/29/2032 | &nbsp;&nbsp;&nbsp;&nbsp;61660 | &nbsp;&nbsp;$2330748  |
| Mark L. Arnold | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;18029 | &nbsp;&nbsp;$681496  |
| Thomas A. Beckett | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;56529 | &nbsp;&nbsp;$2136796  |
| Richard W. Sunderland, Jr. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;89396 | &nbsp;&nbsp;$3379169 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Includes the number of shares underlying PSUs that were earned pursuant to the achievement of the 2025 performance metrics, as adjusted. Of the number of shares shown, for the officers indicated, the following numbers of shares have vested or will vest on the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Named Executive Officer** | **Grant Date** | **Award Type** | **Vest Date** | **Number of Shares or** <br>**Units of Stock That** <br>**Have Not Vested**  |
| Angela K. Selden | 01/30/2025 | RSU | 01/30/2026 | 23552  |
| Angela K. Selden | 01/31/2024 | PSU | 01/31/2026 | 29723  |
| Angela K. Selden | 01/31/2024 | RSU | 01/31/2026 | 20428  |
| Angela K. Selden | 02/04/2025 | PSU | 02/04/2026 | 32784  |
| Angela K. Selden | 02/07/2023 | PSU | 02/07/2026 | 29352  |
| Angela K. Selden | 02/07/2023 | RSU | 02/07/2026 | 36147  |
| Angela K. Selden | 01/30/2025 | RSU | 01/30/2027 | 23552  |
| Angela K. Selden | 01/31/2024 | PSU | 01/31/2027 | 29723  |
| Angela K. Selden | 01/31/2024 | RSU | 01/31/2027 | 20428  |
| Angela K. Selden | 02/04/2025 | PSU | 02/04/2027 | 32784  |
| Angela K. Selden | 01/30/2025 | RSU | 01/30/2028 | 23551  |
| Angela K. Selden | 02/04/2025 | PSU | 02/04/2028 | 32783  |
| Edward H. Codispoti | 10/20/2025 | RSU | 10/20/2026 | 2826  |
| Edward H. Codispoti | 10/20/2025 | RSU | 10/20/2027 | 2826  |
| Edward H. Codispoti | 10/20/2025 | RSU | 10/20/2028 | 2825  |
| Nuno S. Fernandes | 01/30/2025 | RSU | 01/30/2026 | 3298  |
| Nuno S. Fernandes | 01/31/2024 | PSU | 01/31/2026 | 8488  |
| Nuno S. Fernandes | 01/31/2024 | RSU | 01/31/2026 | 5833  |
| Nuno S. Fernandes | 02/04/2025 | PSU | 02/04/2026 | 4591  |
| Nuno S. Fernandes | 02/07/2023 | PSU | 02/07/2026 | 4194  |
| Nuno S. Fernandes | 02/07/2023 | RSU | 02/07/2026 | 5164  |
| Nuno S. Fernandes | 01/30/2025 | RSU | 01/30/2027 | 3297  |
| Nuno S. Fernandes | 01/31/2024 | PSU | 01/31/2027 | 8487  |
| Nuno S. Fernandes | 01/31/2024 | RSU | 01/31/2027 | 5833  |
| Nuno S. Fernandes | 02/04/2025 | PSU | 02/04/2027 | 4589  |
| Nuno S. Fernandes | 01/30/2025 | RSU | 01/30/2028 | 3297  |
| Nuno S. Fernandes | 02/04/2025 | PSU | 02/04/2028 | 4589  |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>55</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Named Executive Officer** | **Grant Date** | **Award Type** | **Vest Date** | **Number of Shares or** <br>**Units of Stock That** <br>**Have Not Vested**  |
| Mark L. Arnold | 01/30/2025 | RSU | 01/30/2026 | 2513  |
| Mark L. Arnold | 02/04/2025 | PSU | 02/04/2026 | 3498  |
| Mark L. Arnold | 01/30/2025 | RSU | 01/30/2027 | 2512  |
| Mark L. Arnold | 02/04/2025 | PSU | 02/04/2027 | 3497  |
| Mark L. Arnold | 01/30/2025 | RSU | 01/30/2028 | 2512  |
| Mark L. Arnold | 02/04/2025 | PSU | 02/04/2028 | 3497  |
| Thomas A. Beckett | 01/30/2025 | RSU | 01/30/2026 | 3455  |
| Thomas A. Beckett | 01/31/2024 | PSU | 01/31/2026 | 7154  |
| Thomas A. Beckett | 01/31/2024 | RSU | 01/31/2026 | 4917  |
| Thomas A. Beckett | 02/04/2025 | PSU | 02/04/2026 | 4809  |
| Thomas A. Beckett | 02/07/2023 | PSU | 02/07/2026 | 3406  |
| Thomas A. Beckett | 02/07/2023 | RSU | 02/07/2026 | 4195  |
| Thomas A. Beckett | 01/30/2025 | RSU | 01/30/2027 | 3454  |
| Thomas A. Beckett | 01/31/2024 | PSU | 01/31/2027 | 7153  |
| Thomas A. Beckett | 01/31/2024 | RSU | 01/31/2027 | 4916  |
| Thomas A. Beckett | 02/04/2025 | PSU | 02/04/2027 | 4808  |
| Thomas A. Beckett | 01/30/2025 | RSU | 01/30/2028 | 3454  |
| Thomas A. Beckett | 02/04/2025 | PSU | 02/04/2028  | 4808  |
| Richard W. Sunderland, Jr. | 01/30/2025 | RSU | 01/30/2026 | 4711  |
| Richard W. Sunderland, Jr. | 01/31/2024 | PSU | 01/31/2026 | 11519  |
| Richard W. Sunderland, Jr. | 01/31/2024 | RSU | 01/31/2026 | 7917  |
| Richard W. Sunderland, Jr. | 02/04/2025 | PSU | 02/04/2026 | 6558  |
| Richard W. Sunderland, Jr. | 02/07/2023 | PSU | 02/07/2026 | 7495  |
| Richard W. Sunderland, Jr. | 02/07/2023 | RSU | 02/07/2026 | 9230  |
| Richard W. Sunderland, Jr. | 01/30/2025 | RSU | 01/30/2027 | 4710  |
| Richard W. Sunderland, Jr. | 01/31/2024 | PSU | 01/31/2027 | 11518  |
| Richard W. Sunderland, Jr. | 01/31/2024 | RSU | 01/31/2027 | 7916  |
| Richard W. Sunderland, Jr. | 02/04/2025 | PSU | 02/04/2027 | 6556  |
| Richard W. Sunderland, Jr. | 01/30/2025 | RSU | 01/30/2028 | 4710  |
| Richard W. Sunderland, Jr. | 02/04/2025 | PSU | 02/04/2028 | 6556 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(2) The market value of the shares of common stock that have not vested is based on the closing price of our common stock on Nasdaq on December 31, 2025 (the last trading day of 2025), $37.80.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>56</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### Option Exercises and Stock Vested
The following table sets forth information with respect to option exercises by our NEOs during 2025 and shares of restricted stock held by our NEOs that vested during 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Option Awards** | **Option Awards** | **Stock Awards**  | **Stock Awards**  |
| <br>**Named Executive Officer** | **Number of Shares** <br>**Acquired on** <br>**Exercise (#)** | **Value Realized** <br>**on Exercise ($)<sup>(1)</sup>** | **Number of Shares** <br>**Acquired on** <br>**Vesting (#)** | **Value Realized** <br>**on Vesting ($)<sup>(2)</sup>**  |
| Angela K. Selden | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;141076 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$3055098  |
| Edward H. Codispoti | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—  |
| Nuno S. Fernandes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$133650 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31836 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$753226  |
| Mark L. Arnold | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—  |
| Thomas A. Beckett | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23139 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$497977  |
| Richard W. Sunderland, Jr. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;42877 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$925061 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The value realized on exercise is based on the difference between the exercise price of the option and the closing price of our common stock on Nasdaq on the day of exercise, multiplied by the number of shares acquired.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The value realized on vesting is based on the closing price of our common stock on Nasdaq on the day of vesting multiplied by the number of shares acquired

#### Non-qualified Deferred Compensation
The following table sets forth information with respect to each defined contribution or other plan that provides for the deferral of compensation on a basis that is not tax-qualified during 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Registrant** <br>**Contributions for** <br>**Last FY<sup>(1)</sup>** | **Aggregate** <br>**Earnings** <br>**in Last FY<sup>(2)</sup>** | **Aggregate** <br>**Balance** <br>**at Last FYE<sup>(3)</sup>**  |
| Angela K. Selden | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$49836 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$34744 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$285582  |
| Nuno S. Fernandes | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$14402 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$5947 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$51591  |
| Mark L. Arnold | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1922 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1992  |
| Thomas A. Beckett | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$10786 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$7840 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$73609  |
| Richard W. Sunderland, Jr. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$15447 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$23612 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$182523 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Includes amounts contributed by the Company in 2025 with respect to 2025 as matching contributions. All amounts are reported in the Summary Compensation Table on page [52](#tSCT) .

&nbsp;&nbsp;&nbsp;&nbsp;(2) Amounts reflected in this column include changes in plan values during 2025, as well as any dividends and interest earned by the plan participant with regard to the investment funds chosen by such participant during the fiscal year.

&nbsp;&nbsp;&nbsp;&nbsp;(3) All amounts have been reported in the Summary Compensation Table or in previous years.

#### Potential Payments Upon Termination or Change in Control
The employment agreements for Ms. Selden and Mr. Sunderland described beginning on page [54](#tNDSC), include provisions providing for payments to them in the event of certain terminations of their respective employment.

The other NEOs do not have employment agreements but are covered by our Executive Severance Plan.

***Termination for cause, without good reason or by reason of death. In the event that Ms. Selden's employment is or Mr. Sunderland's employment was terminated by us for "cause," by the executive without "good reason," or by reason of death (each of "cause" and "good reason" as defined below), we will or would pay to each of them or their estate, as the case may be, (i) his or her full base salary through the date***

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>57</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
of termination, (ii) any previously deferred and unpaid compensation and any unpaid accrued vacation pay, and (iii) any earned, but unpaid, amounts the executive is entitled to as of the date of termination in connection with any fringe benefits or under any of our incentive compensation plans or programs, including the annual incentive bonus.

In the event that Mr. Codispoti's, Mr. Beckett's, Mr. Fernandes', or Mr. Arnold's service to the Company is terminated by us for "cause," by the executive without "good reason," or by reason of death (each of "cause" and "good reason" as defined below), we will pay him or his estate, as the case may be, (i) his full base salary through the date of termination, (ii) any unpaid accrued vacation pay and unreimbursed business expenses accrued through the date of termination, (iii) any benefits provided under our employment benefit plans upon or following a termination of employment (together, the "Accrued Amounts"), and (iv) the bonus, if any, earned with respect to the calendar year ending on or preceding the termination date, to the extent not previously paid (the "Earned Bonus").

***Termination by reason of disability. If Mr. Sunderland's employment was terminated by reason of disability, we would have been required to pay to him, in a lump sum within 30 days of the date of termination, an amount equal to (i) his base salary through the date of termination, (ii) his annual incentive bonus, to the extent the Company and Mr. Sunderland's were then satisfying applicable performance targets, adjusted for the short period through the date of termination, for such bonus, prorated for the period of Mr. Sunderland's service during the applicable year, and (iii) any previously deferred and unpaid compensation and unpaid accrued vacation pay (together, the "Accrued Obligations"). In addition, subject to Mr. Sunderland's timely execution of a release of claims, we would further have been required to pay to Mr. Sunderland's an amount equal to the sum of (i) Mr. Sunderland's annual base salary paid in installments in accordance with our normal payroll practices for a period of 18 months (the "Salary Continuation Payments") and (ii) Mr. Sunderland's annual incentive bonus, to the extent the Company and Mr. Sunderland were then satisfying applicable performance targets, adjusted for the short period, after the date of termination to the end of the calendar year for such bonus and as to the remainder of the 18-month period following the date of termination (the "Bonus Period"), if net income increased from the same period in the prior year and the performance targets established for the successor executive were being satisfied for that period, paid in installments in accordance with our normal payroll practices over the Bonus Period, and the second within 60 days after the end of the Bonus Period (the "Bonus Continuation Payments").***

If Ms. Selden's employment is terminated by reason of disability, we are required to pay to her, (i) in a lump sum within 30 days of the date of termination, an amount equal to the Accrued Obligations, (ii) an amount equal to two times Ms. Selden's annual base salary paid in installments in accordance with our normal payroll practices for a period of 24 months (the "Selden Salary Continuation Payments"), and (iii) an amount equal to two times Ms. Selden's annual incentive bonus, to the extent the Company and the executive were then satisfying applicable performance targets, adjusted for the short period, after the date of termination to the end of the calendar year for such bonus and as to the remainder of the 24-month period following the date of termination (the "Selden Bonus Period"), if net income increased from the same period in the prior year and paid in two installments, one within 60 days after the end of the year in which the termination occurred, and the second within 60 days after the end of the Selden Bonus Period (the "Selden Bonus Continuation Payments"), in the case of (ii) and (iii), subject to Ms. Selden's timely release of claims.

These payments shall be reduced by the sum of the amounts, if any, payable to the executive at or prior to the time of any payment under our disability benefit plans and which amounts were not previously applied to reduce any payment, all in a manner that complies with Section 409A of the Code.

If Mr. Beckett's, Mr. Fernandes', Mr. Arnold's or Mr. Codispoti's employment is terminated by reason of disability, we are required pursuant to the terms of the Executive Severance Plan to pay to the executive the Accrued Amounts and Earned Bonus.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>58</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

***Termination other than for cause or disability or for good reason. In the event that we terminate Ms. Selden's or would have terminated Mr. Sunderland's employment other than for cause or disability or they terminate their employment for good reason, we are or would have been required to pay, or provide, to the executive (subject to the NEO's timely execution of a release of claims in respect of all but the first item below), as applicable:***

&nbsp;&nbsp;&nbsp;&nbsp;• in a lump sum within 30 days of the date of termination, the Accrued Obligations;

&nbsp;&nbsp;&nbsp;&nbsp;• the Salary Continuation Payments or the Selden Salary Continuation Payments, as applicable;

&nbsp;&nbsp;&nbsp;&nbsp;• the Bonus Continuation Payments or the Selden Bonus Continuation Payments, as applicable; and

&nbsp;&nbsp;&nbsp;&nbsp;• for a period of 24 months following the date of termination (for Ms. Selden) or 12 months following the date of termination (for Mr. Sunderland) or for any longer period provided for under the terms of the appropriate plan, program, practice or policy, a continuation of benefits to the executive and/or his or her family at a level and in an amount that is at least equal to that which would have been provided by us to them had the executive continued his employment, provided, however, that we may elect to pay the executive a payment equal to 24 or 12 months' premiums (as applicable) under our benefit plans in lieu of the continuation of such benefits, and provided, further, that if the executive becomes reemployed with another employer and is eligible to receive any of the benefits that had been provided by us, then the benefits we provide shall be secondary; and to the extent not otherwise paid or provided, for a period of 24 months following the date of termination (for Ms. Selden) or 12 months following the date of termination (for Mr. Sunderland), any other amounts or benefits required to be paid or provided or which the executive is eligible to receive under any of our other existing benefit plans; provided, however, if Ms. Selden terminates her employment after we have delivered to her a written notice of intent not to renew, or a notice of Nonrenewal Termination (as defined in Ms. Selden's employment agreement), prior to the beginning of a change in control termination period (as defined in Ms. Selden's employment agreement), then the Selden Salary Continuation Payments shall be for a period of 18 months, the Selden Bonus Continuation Payments shall be equal to 1.5 times the Annual Bonus, and the continuation of benefits shall apply for only 18 months.

In the event that Ms. Selden's employment is terminated by the Company without cause or by her for good reason, Ms. Selden will become vested in a prorated portion of each of her then-unvested outstanding equity awards, determined by multiplying the number of shares of our common stock scheduled to vest at the vesting date immediately following her termination of employment by a fraction, the numerator of which is the number of days following the last vesting date (or the grant date if no portion of the award has vested) that she was employed and the denominator of which is the number of days from the last vesting date or the grant date, as applicable, to the date the next tranche of such outstanding equity award would have vested, rounded to the nearest whole share, subject, however, in the case of performance-vesting awards to the attainment of the applicable performance criteria.

In the event that we terminate Mr. Codispoti's, Mr. Beckett's, Mr. Fernandes', or Mr. Arnold's employment other than for cause or disability or they terminate their employment for good reason, we are required to pay, or provide, to the executive (subject to the executive's timely execution of a release of claims and other certain restrictive covenants): (i) the Accrued Amounts; (ii) the Earned Bonus; (iii) an amount equal to his base salary in effect immediately prior to the date of termination plus the product of (x) the annual cash bonus that would have been earned for the entire calendar year in which the date of termination occurs based on the actual level of achievement of any Company performance goals for such year and the higher of the actual or target level of achievement of any individual performance goals for such year; and (y) a fraction, the numerator of which is the number of days the executive was employed by the Company during the calendar year in which the date of termination occurs and the denominator of which is the number of days in such year, paid on the date that annual bonuses are paid to our executives or the 61<sup>st</sup> day following the date of termination; and (iv) any amount, determined in the sole discretion of the MDC

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>59</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

Committee, equal to 12 times the difference between (x) the monthly COBRA premium paid by the executive for group health plan coverage and (y) the monthly premium amount paid by the executive immediately prior to the date of termination for the same coverage, payable in a single lump sum on the 61<sup>st</sup> day following the date of termination.

*Mr. Sunderland's Transition and Release Agreement. On October 20, 2025, Mr. Sunderland transitioned to a non-executive employee of the Company to assist with Mr. Codispoti's transition until his departure effective on February 20, 2026. As discussed above, pursuant to the Transition Agreement, Mr. Sunderland was entitled to the applicable payments set forth under the Sunderland Employment Agreement. Mr. Sunderland's separation was deemed a termination without Cause by the Company for purposes of the Sunderland Employment Agreement which provided for salary continuation and payments equal to his target bonus for a period of eighteen months and continuation of benefits for a period of twelve months. For the purpose of his previously granted equity award, Mr. Sunderland's termination is a "Qualified Retirement", which means he is be entitled to full vesting of those awards, subject to satisfaction of performance conditions for outstanding performance awards.* 

***Termination following a change of control. If within 60 days prior to or one year after a change in control (as defined below), we terminate Ms. Selden's employment or if within 180 days after a change of control or we terminated Mr. Sunderland's employment, other than for cause or disability or the executive terminates his or her employment for good reason, we are required to pay, or provide, to the executive (subject to the NEO's timely execution of a release of claims in respect of all but the first item below):***

&nbsp;&nbsp;&nbsp;&nbsp;• in a lump sum within 30 days of the effective date of termination, the Accrued Obligations;

&nbsp;&nbsp;&nbsp;&nbsp;• an amount equal to the sum of (i) two times the executive's annual base salary and (ii) two times the executive's annual incentive bonus, to the extent the Company and the executive were then satisfying applicable performance targets, adjusted for the short period, in a lump sum within 60 days of the effective date of termination;

&nbsp;&nbsp;&nbsp;&nbsp;• for a period of 24 months following the date of termination (for Ms. Selden) or 12 months following the date of termination (for Mr. Sunderland) or for any longer period provided for under the terms of the appropriate plan, program, practice, or policy, a continuation of benefits to the executive and/or his or her family at a level and in an amount that is at least equal to that which would have been provided by us to them had the executive continued his or her employment, provided, however, that we may elect to pay the executive a payment equal to 24 or 12 months' (as applicable) premiums under our benefit plans in lieu of the continuation of such benefits, and provided, further, that if the executive becomes reemployed with another employer and is eligible to receive any of the benefits that had been provided by us, then the benefits we provide shall be secondary; and

&nbsp;&nbsp;&nbsp;&nbsp;• to the extent not otherwise paid or provided, for a period of 24 months following the date of termination (for Ms. Selden) or 12 months following the date of termination (Mr. Sunderland), any other amounts or benefits required to be paid or provided or which the executive is eligible to receive under any of our other existing benefit schemes.

In the event that any amounts payable or benefits to be provided to the executive under the employment agreement or otherwise would be nondeductible to us by reason of Section 280G of the Code and would subject the executive to the excise tax imposed by Section 4999 of the Code, then such payments and/or benefits will be reduced to the extent necessary so that such payments or benefits will no longer be ineligible for deduction by reason of Section 280G of the Code or subject to the excise tax imposed by Section 4999 of the Code unless the executive would receive at least $50,000 more on a net after-tax basis if such payments and benefits were not reduced.

If within six months after a change of control, we terminate Mr. Codispoti's, Mr. Beckett's, Mr. Fernandes', or Mr. Arnold's employment without cause or the executive terminates his employment for

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>60</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

good reason (as defined below), the executive shall be entitled to receive the Accrued Amounts and the Earned Bonus. In addition, we are required to pay to the executive (subject to the executive's timely execution of a release of claims and other certain restrictive covenants):

&nbsp;&nbsp;&nbsp;&nbsp;• an amount equal to the 1.5 times the sum of the base salary in effect, plus the executive's target annual bonus for the year in which the date of termination occurs, payable in a single lump sum on the 61<sup>st</sup> day following the date of termination; and

&nbsp;&nbsp;&nbsp;&nbsp;• an amount, determined in the sole discretion of the Committee, equal to 18 times the difference between (x) the monthly COBRA premium paid by the executive for group health plan coverage for the executive, and (y) the monthly premium amount paid by the executive immediately prior to the date of termination for the same coverage, payable in a single lump sum on the 61<sup>st</sup> day following the date of termination.

***Acceleration of equity awards upon termination for death, for disability or following a change of control. Under Ms. Selden's or Mr. Sunderland's employment agreements, all equity awards granted to the NEO under any of our equity incentive plans that are outstanding immediately prior to the following events will vest and become fully exercisable as follows: (i) upon termination of the executive's employment by the executive's death; (ii) upon our termination of the executive's employment for disability; or (iii) upon termination of the executive's employment, in the 12-month period following a change of control, or in the 60-day period prior to or one year period after a change of control, in the case of Ms. Selden (a) by us for any reason other than for disability or cause, or for no reason at all, or (b) by the executive for good reason in the 12-month period following a change of control. However, for purposes of clauses (i) and (ii) above, any equity awards that are subject to performance conditions for a performance period not yet completed will be deemed to be vested and exercisable in a pro-rated amount equivalent to the portion of the performance period that has passed and assuming achievement of the performance conditions for that period at the "target" level, and, for purposes of clause (iii) above, any equity awards that are subject to performance conditions for a performance period not yet completed will be deemed to be vested and exercisable in full at the "target" level.***

The Executive Severance Plan does not affect the term of any outstanding equity awards. In the event Mr. Codispoti's, Mr. Beckett's, Mr. Fernandes', or Mr. Arnold's employment is terminated, the treatment of any outstanding equity awards is determined in accordance with the terms of the Company equity plan or plans under which they were granted and any applicable award agreements. The 2017 Omnibus Incentive Plan provides that equity awards will vest in full upon the termination of an awardee without cause within one year of a change in control in which the awards are assumed, continued, or substituted.

#### Terms defined in employment agreements. For purposes of Ms. Selden's and Mr. Sunderland's employment agreements, the following definitions apply:
"Cause" means:

&nbsp;&nbsp;&nbsp;&nbsp;• refusal by the executive to follow a lawful written order of the Chair of our Board, the Board, or for Mr. Sunderland, our President and Chief Executive Officer;

&nbsp;&nbsp;&nbsp;&nbsp;• the executive's engagement in conduct materially injurious to us or our reputation;

&nbsp;&nbsp;&nbsp;&nbsp;• dishonesty of a material nature that relates to the performance of the executive's duties under his or her employment agreement;

&nbsp;&nbsp;&nbsp;&nbsp;• the executive's conviction for any crime involving moral turpitude or any felony; or

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>61</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
&nbsp;&nbsp;&nbsp;&nbsp;• the executive's continued failure to perform his or her duties under his or her employment agreement (except due to the executive's incapacity as a result of physical or mental illness) to the satisfaction of the Board for a period of at least 30 consecutive days after written notice is delivered to the executive specifically identifying the manner in which the NEO has failed to perform his or her duties.

"Change of control" generally means:

&nbsp;&nbsp;&nbsp;&nbsp;• our dissolution or liquidation, or a merger, consolidation, or reorganization of us with one or more other entities in which we are not the surviving entity;

&nbsp;&nbsp;&nbsp;&nbsp;• a sale of substantially all of our assets to another person or entity; or

&nbsp;&nbsp;&nbsp;&nbsp;• any transaction (including without limitation a merger or reorganization in which we are the surviving entity) which results in any person or entity owning 50% or more of the combined voting power of all classes of our stock.

"Good reason" generally means:

&nbsp;&nbsp;&nbsp;&nbsp;• the assignment to the executive of duties inconsistent in any material respect with the NEO's position as set forth in, or in accordance with, his or her employment agreement, excluding an isolated, insubstantial, and inadvertent action that we remedy promptly after receipt of notice from the executive;

&nbsp;&nbsp;&nbsp;&nbsp;• any material failure by us to comply with any provisions of the executive's employment agreement, excluding an isolated, insubstantial, and inadvertent failure that we remedy promptly after receipt of notice from the executive;

&nbsp;&nbsp;&nbsp;&nbsp;• there is a change of control and the executive does not continue in his or her position, or any other office he or she holds at the time of the transaction, of the most senior resulting entity succeeding to our business;

&nbsp;&nbsp;&nbsp;&nbsp;• any material failure by us to require any successor or any party that acquires control of us, whether directly or indirectly, by purchase, merger, consolidation or otherwise, or all or substantially all of our business and/or assets to assume expressly and agree to perform the executive's employment agreement in the same manner and to the same extent;

&nbsp;&nbsp;&nbsp;&nbsp;• with respect only to Ms. Selden, any material reduction in her base salary or annual bonus opportunity;

&nbsp;&nbsp;&nbsp;&nbsp;• with respect only to Ms. Selden, after her initial relocation, any requirement that her primary workplace be located more than 50 miles from our current headquarters; and

&nbsp;&nbsp;&nbsp;&nbsp;• with respect only to Ms. Selden, her election to terminate employment after the end of the term or any renewal term if we have delivered to her a written notice of intent not to renew.

None of the foregoing constitute good reason if the executive consents in writing to such event, and none of the foregoing constitute good reason unless the executive provides notice to us within 90 days of the initial existence of such grounds and we fail to cure the asserted grounds for good reason within 30 days of receipt of such notice from the executive. In order to terminate his or her employment for good reason, the executive must terminate employment within 30 days of the end of the cure period if the breach has not been cured.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>62</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

***Terms defined in the Executive Severance Plan. For purposes of the Executive Severance Plan, which currently only applies to Mr. Codispoti, Mr. Beckett, Mr. Fernandes, and Mr. Arnold, the following definitions apply:***

"Cause" means:

&nbsp;&nbsp;&nbsp;&nbsp;• gross negligence or willful misconduct in connection with the performance of duties;

&nbsp;&nbsp;&nbsp;&nbsp;• conviction of, or pleading guilty or nolo contendere to, a criminal offense (other than minor traffic offenses); or

&nbsp;&nbsp;&nbsp;&nbsp;• material breach of any term of any employment, consulting or other services, confidentiality, intellectual property, or non-competition agreements, if any, between such executive and the Company or an affiliate.

"Change of control" generally means:

&nbsp;&nbsp;&nbsp;&nbsp;• the dissolution or liquidation of the Company or a merger, consolidation, or reorganization of the Company with one or more other entities in which the Company is not the surviving entity;

&nbsp;&nbsp;&nbsp;&nbsp;• a sale of substantially all of the assets of the Company to another person (within the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act); or

&nbsp;&nbsp;&nbsp;&nbsp;• any transaction (including without limitation a merger or reorganization in which the Company is the surviving entity) which results in any person owning 50% or more of the combined voting power of all classes of common stock of the Company.

"Good reason" generally means:

&nbsp;&nbsp;&nbsp;&nbsp;• a material diminution in the executive's authority, duties, or responsibilities;

&nbsp;&nbsp;&nbsp;&nbsp;• a material reduction in the executive's base salary; or

&nbsp;&nbsp;&nbsp;&nbsp;• a material change in the geographic location at which the executive must perform services, including a required relocation of the executive's principal place of employment of more than 50 miles.

***Equity Retirement Policy. In July 2016, the MDC Committee approved the Equity Retirement Policy, effective January 1, 2017. The Equity Retirement Policy provides for accelerated vesting upon a "Qualified Retirement" of any (i) time-based awards and (ii) subject to the achievement of the applicable performance measure, performance-based awards, that were granted at least one year prior to the date of the Qualified Retirement. A "Qualified Retirement" is when an employee has a separation from service other than for cause, has reached an age of 62 years, and has provided at least 10 years of continuous service to the Company as of and through the date of their separation from service.***

Mr. Sunderland was the only NEO eligible for the Equity Retirement Policy in 2025.

***Payment and Benefit Estimates. The table below reflects the potential termination or change in control payments pursuant to the employment agreements and arrangements described above, calculated as though the applicable triggering event occurred, (i.e. the NEO's employment was terminated, or the applicable change in control occurred) on December 31, 2025 (the last trading day of 2025), using the closing price of our common stock on Nasdaq of $37.80 on December 31, 2025. As discussed in the narrative above, upon termination for cause or by the NEO without good reason, the NEO is generally only***

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>63</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

entitled to receive amounts they are owed as of the termination date (*e.g.*, salary, benefits, and, in limited cases, any previously earned, but unpaid, annual incentive compensation). These accrued amounts are described in the narrative above, and we have not included these earned, but unpaid amounts, in the termination events included in the table below.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Aggregate** <br>**Severance** <br>**Pay<sup>(1)</sup>** <br>**$** | **Accelerated** <br>**Vesting of** <br>**Equity** <br>**Awards** <br>**$** | **Welfare** <br>**Benefits** <br>**Continuation** <br>**$** | **Total** <br>**$**  |
| **Angela K. Selden** |  |  |  |  |
| Termination by Reason of Disability | $3334500  | $8386081  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$0 | $11720581  |
| Termination other than for Cause or Disability or by Executive for Good Reason | $3334500  | $8386081  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$69735 | $11790316  |
| Termination other than for Cause, Disability, or death, or by executive for Good Reason within sixty days before or one year after a Change in Control | $3334500  | $12655705  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$69735 | $16059940  |
| Nonrenewal of employment agreement by Company prior to a Change in Control | $2500875  | $12655705  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$52301 | $15208881  |
| Termination by Reason of Death |  | $8386081  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $8386081  |
| **Edward H. Codispoti** |  |  |  |  |
| Termination without Cause or by Executive for Good Reason | $795000  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $795000  |
| Termination without Cause or by Executive for Good Reason within six months of a Change in Control | $1060000  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $1060000  |
| Termination without Cause within one year of a Change in Control in which awards are assumed, continued, or substituted |  | $320431  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $320431  |
| **Nuno S. Fernandes** |  |  |  |  |
| Termination without Cause or by Executive for Good Reason | $849750  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$10247  | $859997  |
| Termination without Cause or by Executive for Good Reason within six months of a Change in Control | $1107250  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$15370  | $1122620  |
| Termination without Cause within one year of a Change in Control in which awards are assumed, continued, or substituted |  | $2330748  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $2330748  |
| **Mark L. Arnold** |  |  |  |  |
| Termination without Cause or by Executive for Good Reason | $742500  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$29208  | $771708  |
| Termination without Cause or by Executive for Good Reason within six months of a Change in Control | $967500  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$43812  | $1011312  |
| Termination without Cause within one year of a Change in Control in which awards are assumed, continued, or substituted |  | $681496  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $681496  |
| **Thomas A. Beckett** |  |  |  |  |
| Termination without Cause or by Executive for Good Reason | $638437  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$27671  | $666108  |
| Termination without Cause or by Executive for Good Reason within six months of a Change in Control | $851250  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$41506  | $892756  |
| Termination without Cause within one year of a Change in Control in which awards are assumed, continued, or substituted |  | $2136796  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $2136796  |
| **Richard W. Sunderland, Jr.<sup>(2)</sup>** |  |  |  |  |
| Termination by Reason of Disability | $1117378  | $3379169  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | $4496547  |
| By Company other than for Cause or Disability or the by executive for Good Reason  | $1117378  | $3379169  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$24721  | $4521268  |
| Termination other than for Cause or Disability or by Executive for Good Reason within 180 days of a Change in Control | $1489838  | $3379169  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$24721  | $4893728  |
| Termination other than for Cause within between 180 days and 12 months of a Change in Control in which outstanding Awards are being assumed, continued, or substituted for |  | $3379169  |  | $3379169  |
| Termination by Reason of Death |  |  |  |  |
| Termination by executive other than cause due to Retirement |  | $3379169  |  | $3379169 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) We have assumed for purposes of calculating the aggregate severance pay that (a) our financial performance and, if applicable, the NEO's successor's performance would be sufficient for the NEO to receive the maximum payout and (b) in the case of a termination due to Disability, amounts are not reduced by any payment under our disability benefit plans.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Mr. Sunderland departed from the Company, effective February 20, 2026. Under the terms of the Sunderland Employment Agreement and Transition Agreement, Mr. Sunderland's departure was deemed a termination without Cause by the Company and a "Qualified Retirement" for purposes of his previously granted equity awards.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>64</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### CEO Pay Ratio
As required by the Dodd-Frank Wall Street Reform and Consumer Protection Act, we are presenting the ratio of our Chief Executive Officer's annual total compensation to our median employee's annual total compensation.

In order to identify our median employee for purposes of calculating the ratio, we retained the 2024 median employee that was determined as reported in our payroll system for our 5,792 employees other than our Chief Executive Officer as of November 1, 2024, and then annualized the total compensation of all permanent employees that were employed for less than the full year. There were no any changes to the employee population or employee compensation arrangements that the Company reasonably believed resulted in a significant change in its pay ratio disclosure.

As set forth in the Summary Compensation Table in this Proxy Statement, the 2025 annual total compensation as determined under Item 402 of Regulation S-K for our Chief Executive Officer was $5,063,608. The 2025 annual total compensation for our median employee, who is a part-time faculty member at APUS, was $34,846. The ratio of our Chief Executive Officer's annual total compensation to our median employee's total compensation for 2025 is approximately 145 to 1. This ratio was determined using reasonable estimates as permitted by the SEC's rules and should not be used as a comparison with pay ratios disclosed by other companies.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>65</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Pay Versus Performance
In accordance with SEC rules, this section provides information with respect to Compensation Actually Paid ("CAP") to our NEOs and Company performance. This information does not necessarily align with how the Company, or the MDC Committee views the link between the Company's performance and its NEO's pay. CAP is an SEC-defined term and neither CAP nor the amount reported in the Summary Compensation Table ("SCT") necessarily reflect the amounts earned, received, or realized by the NEOs. Unvested awards remain subject to vesting conditions and fluctuations in value based on changes in the price of our common stock, and the ultimate value realized by our NEOs from unvested equity awards will not be determined until the awards vest. In addition, a significant portion of CAP relates to changes in fair value of unvested awards over the course of each year. For a more detailed discussion of how we view our executive compensation structure, including alignment with our performance, see the Compensation Discussion and Analysis ("CD&A").

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Summary** <br>**Compensation** <br>**Table Total for** <br>**CEO<sup>(1)</sup>** | **Compensation** <br>**Actually Paid** <br>**to CEO<sup>(34)</sup>** | **Average** <br>**Summary** <br>**Compensation** <br>**Table Total for** <br>**Other NEOs<sup>(2)</sup>** | **Average** <br>**Compensation** <br>**Actually Paid** <br>**to Other** <br>**NEOs<sup>(34)</sup>** | **Value of Initial Fixed** <br>**$100 Investment** <br>**Based on<sup>(5)</sup>** | **Value of Initial Fixed** <br>**$100 Investment** <br>**Based on<sup>(5)</sup>** | **Net** <br>**Income (in** <br>**millions)<sup>(6)</sup>** | ***Revenue*** <br>***(in millions)<sup>(7)</sup>***  |
| **Year** | **Summary** <br>**Compensation** <br>**Table Total for** <br>**CEO<sup>(1)</sup>** | **Compensation** <br>**Actually Paid** <br>**to CEO<sup>(34)</sup>** | **Average** <br>**Summary** <br>**Compensation** <br>**Table Total for** <br>**Other NEOs<sup>(2)</sup>** | **Average** <br>**Compensation** <br>**Actually Paid** <br>**to Other** <br>**NEOs<sup>(34)</sup>** | **Total** <br>**Shareholder** <br>**Return** | **Peer Group** <br>**Total** <br>**Shareholder** <br>**Return** | **Net** <br>**Income (in** <br>**millions)<sup>(6)</sup>** | ***Revenue*** <br>***(in millions)<sup>(7)</sup>***  |
| 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$5063608  | &nbsp;&nbsp;&nbsp;&nbsp;$11051255  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1135806  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1957715  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$124 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$25.3  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$648.9  |
| 2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2909301  | &nbsp;&nbsp;&nbsp;&nbsp;$6901739  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1064125  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2025656  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$71 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$190 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$10.1  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$624.6  |
| 2023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4176075  | &nbsp;&nbsp;&nbsp;&nbsp;$2982535  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1056661  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$778190  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$142 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;($53.3) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$600.5  |
| 2022 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$3359173  | &nbsp;&nbsp;&nbsp;&nbsp;$826912  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$864041  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$345804  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$40 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$105 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;($115.0) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$606.3  |
| 2021 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2994052  | &nbsp;&nbsp;&nbsp;&nbsp;$1963734  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$953983  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$673074  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$73 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$85 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$17.8  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$418.8 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Ms. Selden was the CEO for each of the covered years.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The other NEOs for each covered year were: In 2025, Mr. Codispoti, Mr. Fernandes, Mr. Arnold, Mr. Beckett, and Mr. Sunderland; in 2024, Mr. Sunderland, Mr. Beckett, Mr. Fernandes, and Mr. MacGibbon; in 2023, Mr. Sunderland, Mr. Beckett, Mr. Fernandes, Mr. MacGibbon, and Mr. Tognola; in 2022, Mr. Sunderland, Mr. Beckett, Mr. Wilkins, Mr. Tognola, Mr. Dyberg, and Mr. Slagle; and in 2021, Mr. Sunderland, Mr. Beckett, Dr. Dyke, Mr. Dyberg, and Dr. Smith.

&nbsp;&nbsp;&nbsp;&nbsp;(3) The following tables disclose the amounts deducted from and added to SCT total compensation for the applicable year pursuant to Item 402(v) of Regulation S-K to determine CAP:

*Adjustments made to NEO SCT to calculate CAP* 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **Reported SCT total** | **minus reported** <br>**value of equity awards** | **plus, equity award** <br>**adjustments** | **equals CAP**  |
| ***<u>CEO</u>*** |  |  |  |  |
| **2025** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$5063608  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;($3103874) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9091521  | $11051255  |
| ***<u>Other NEOs</u>*** | ***<u>Other NEOs</u>*** | ***<u>Other NEOs</u>*** | ***<u>Other NEOs</u>*** | ***<u>Other NEOs</u>*** |
| **2025** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1135806  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;($431947) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1253856  | $1957715 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>66</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
&nbsp;&nbsp;&nbsp;&nbsp;(4) Adjustments made to NEO equity awards

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **Year-end FMV** <br>**awards** <br>**granted during** <br>**the year** | **Year over year** <br>**FMV change of** <br>**outstanding and** <br>**unvested** <br>**awards as of** <br>**year end** | **Year over year** <br>**FMV change of** <br>**awards granted** <br>**in prior years** <br>**that vested** <br>**during the year** | **Total equity** <br>**award** <br>**adjustments**  |
| **<u>CEO</u>** | **<u>CEO</u>** | **<u>CEO</u>** | **<u>CEO</u>** | **<u>CEO</u>** |
| **2025** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$6388456  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$12088  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2690978  | &nbsp;&nbsp;&nbsp;$9091521  |
| **<u>Other NEOs</u>** | **<u>Other NEOs</u>** | **<u>Other NEOs</u>** | **<u>Other NEOs</u>** | **<u>Other NEOs</u>** |
| **2025** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$822202  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$24804  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$406850  | &nbsp;&nbsp;&nbsp;$1253856 |

---

&nbsp;&nbsp;&nbsp;&nbsp;• Fair market value ("FMV") used to determine the equity award adjustments is consistent with the calculations used to account for share-based payments in the Company's financial statements in accordance with GAAP, although the assumptions are materially different from those disclosed with respect to valuation at the time of grant including:

&nbsp;&nbsp;&nbsp;&nbsp;• **RSUs:** The FMV of RSU awards was calculated using the closing price of our common stock as of the last day of the applicable year or on the date of vesting, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;• **PSUs:** The number of "earned" units was calculated by multiplying the target units by the applicable performance achievement percentage for a given year. The FMV of PSU awards was calculated using the closing price of our common stock as of the last day of the applicable year or on the date of vesting, as applicable, multiplied by the number of "earned" units.

&nbsp;&nbsp;&nbsp;&nbsp;• **Stock Option Awards:** Option awards use a model consistent with the fair value methodology used to account for share-based payments in the Company's financial statements in accordance with GAAP. The FMV value of the options was estimated using the Black-Scholes option pricing model that reflect for each award and valuation date, adjustments for expected volatility, risk-free interest rate, dividend yield, and expected term.

&nbsp;&nbsp;&nbsp;&nbsp;(5) Reflects Total Shareholder Return ("TSR") for the Company and the Company's customized peer group of companies as reported in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Historical stock performance is not necessarily indicative of future stock performance.

&nbsp;&nbsp;&nbsp;&nbsp;(6) Represents the amount of net income reflected in our audited financial statements for each applicable fiscal year. For the purposes of this table, "net income" represents "net income available to common stockholders" as reported in the Company's financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;(7) SEC rules require us to designate a "company-selected measure" that in our assessment represents the most important financial performance measure (other than TSR, stock price, or net income) used by the Company to link the CAP of our NEOs, for the most recently completed fiscal year, to our performance. We selected revenue as the most important financial performance measurement due to the alignment with the Company's long-term strategic goals, including its direct linkage to enrollments. Revenue is defined as the Company's GAAP revenue as reported.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>67</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### Relationship Between CAP and Company and Peer Group TSR
The following graph compares the CAP to our CEO and the average CAP to our Other NEOs to our cumulative TSR and also compares our cumulative TSR and 2025 Annual Report customized peer group cumulative TSR. The cumulative TSR amounts in the graph assume an initial investment of $100 on December 31, 2020.

![](ny20064163x1_pvpchart1x1.jpg)

#### Relationship Between CAP and Company Financial Measures CAP versus Net Income
The following graph compares the CAP to our CEO and the average CAP to our Other NEOs to net income.

![](ny20064163x1_pvpchart2x2.jpg)

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>68</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### CAP versus Revenue
The following graph compares the CAP to our CEO and the average CAP to our Other NEOs to revenue.

![](ny20064163x1_pvpchart3x2.jpg)

#### Most Important Performance Measures
The Company's 2025 short-term annual incentive cash and long-term equity incentive compensation plans included the three measures listed below that the MDC Committee considers to be the most important measures to link CAP to Company performance. The order of the table below does not reflect any ranking of importance. Additional details regarding the 2025 incentive plan performance measures, including performance targets, payout opportunities, and weighting of each measure by NEO are further described in Compensation Discussion and Analysis within the sections titled "2025 Compensation Decisions — 2025 Annual Incentive Plan" and "2025 Compensation Decisions — 2025 Equity Incentives".

---

| |
|:---|
| **2025 Most Important Performance Measures**  |
| Revenue (financial)  |
| EPS (financial)  |
| Adjusted EBITDA (financial) |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>69</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

#### Equity Compensation Plan Information
The following table summarizes our equity compensation plan information as of December 31, 2025. All equity compensation plans have been approved by Company stockholders.

---

| | | | |
|:---|:---|:---|:---|
| **Plan** | **Number of** <br>**securities** <br>**to be** <br>**issued** <br>**upon** <br>**exercise of** <br>**outstanding** <br>**options** <br>(a) | **Weighted-** <br>**average** <br>**exercise** <br>**price of** <br>**outstanding** <br>**options** <br>(b) | **Number of** <br>**securities** <br>**Remaining** <br>**available for** <br>**Future**<br>**issuance** <br>**under equity**<br>**compensation** <br>**Plans** <br>**(excluding** <br>**securities** <br>**reflected** <br>**in column (a)** <br>(c)  |
| Equity compensation plans approved by Company stockholders | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75655 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$18.04 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1481989  |
| Equity compensation plans not approved by Company stockholders | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—  |
| Total | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75655 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$18.04 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1481989 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>70</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### PROPOSAL NO. 2

### ADVISORY VOTE ON THE COMPENSATION PAID TO

### OUR NAMED EXECUTIVE OFFICERS
We are seeking stockholder input on the compensation paid to our named executive officers as disclosed in this Proxy Statement. We have determined to hold this vote annually. The Board and the MDC Committee actively monitor our executive compensation practices in light of the industry in which we operate and the marketplace for talent in which we compete. We believe that the supply of qualified executive talent is limited and have designed our compensation programs to help us attract and retain qualified candidates by offering compensation that is competitive within the for-profit education industry and the broader market for executive talent.

As described in the Compensation Discussion and Analysis beginning on page [33](#tCDA) of this Proxy Statement, our executive compensation program is designed to provide competitive levels of compensation that are based on performance metrics, reflect the level of capability and effort required to achieve our corporate goals, and to reward our executives for the achievement of strategic, operational, and financial success. By paying for performance, we believe that we align the interests of our executive officers with those of our stockholders. We also believe that an effective executive compensation program can assist us in attracting, incentivizing, retaining, and rewarding the talent that we need to maintain and strengthen our position in career-minded adult education and to achieve our business objectives.

To achieve these objectives, we adhere to the following principles:

&nbsp;&nbsp;&nbsp;&nbsp;• compensation should be directly related to achievement of our corporate goals as measured through individual management objectives and through enrollment and earnings results;

&nbsp;&nbsp;&nbsp;&nbsp;• an emphasis on equity-based compensation aligns the long-term interests of executive officers and stockholders; and

&nbsp;&nbsp;&nbsp;&nbsp;• NEO compensation must be evaluated against opportunities offered by companies that are similar to, and competitive with, us in the market for executive talent.

Our executive compensation program also includes features specifically intended to align the interests of our NEOs with those of our stockholders, such as:

&nbsp;&nbsp;&nbsp;&nbsp;• each of our executives is expected to own shares of our common stock with a value ranging from two to six times the executive's base salary, depending on position; and

&nbsp;&nbsp;&nbsp;&nbsp;• we make use of equity awards with a value that is contingent on our long-term performance.

We believe our executive compensation program achieves our compensation principles, properly aligns the interests of our NEOs and our stockholders and is deserving of stockholder support. We believe that stockholders should also consider the following when determining whether to approve the compensation paid to our NEOs as presented in this Proxy Statement:

&nbsp;&nbsp;&nbsp;&nbsp;• the MDC Committee utilizes Willis Towers Watson, an independent compensation consulting firm, to assist the Committee in determining compensation;

&nbsp;&nbsp;&nbsp;&nbsp;• our NEOs are prohibited from engaging in short sales, transactions in derivative securities (including put and call options), or other forms of hedging and monetization transactions, such as zero-cost collars, equity swaps;

&nbsp;&nbsp;&nbsp;&nbsp;• exchange funds and forward sale contracts, that allow the holder to limit or eliminate the risk of a decrease in the value of our securities;

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>71</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
&nbsp;&nbsp;&nbsp;&nbsp;• our equity awards have been granted with three-year minimum vesting periods, and our equity plans prohibit repricing or replacement of outstanding option awards;

&nbsp;&nbsp;&nbsp;&nbsp;• upon a "change of control," the NEOs only receive severance payments in connection with a termination of their employment; and

&nbsp;&nbsp;&nbsp;&nbsp;• employment agreements with our NEOs do not include tax-gross up payments in connection with a "change of control."

For these reasons, the Board recommends that stockholders vote in favor of the following resolution:

"RESOLVED, that the compensation paid to the American Public Education, Inc. named executive officers, as disclosed in the Company's Proxy Statement for the 2026 Annual Meeting of Stockholders pursuant to the rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, compensation tables and any other related disclosure, is hereby APPROVED."

The vote is advisory and is not binding on the Company, the Board, or the MDC Committee. However, the MDC Committee expects to take into account the outcome of the vote as it continues to consider our executive compensation program.

#### THE BOARD RECOMMENDS A VOTE FOR THE APPROVAL OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>72</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### PROPOSAL NO. 3

### RATIFICATION OF APPOINTMENT OF

### INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We are asking our stockholders to ratify the Audit Committee's appointment of Deloitte as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

Deloitte has audited our consolidated financial statements since 2018, when we engaged Deloitte after reviewing proposals from several independent registered public accounting firms as part of a competitive review process that we undertook that year. The Audit Committee has again selected Deloitte as our independent registered accounting firm for the year ended December 31, 2026, and believes that the retention of Deloitte for the 2026 fiscal year is in the best interests of the Company and our stockholders.

The Audit Committee has ultimate authority and responsibility for the appointment, termination, compensation, evaluation, and oversight of our independent registered public accounting firm and annually evaluates the performance of our independent registered public accounting firm. The Audit Committee also evaluates and approves the selection of the lead engagement partner.

Although ratification is not required by our Bylaws or otherwise, the Board is submitting the appointment of Deloitte to our stockholders for ratification as a matter of good corporate practice. If the appointment is not ratified, the Audit Committee will consider whether it is appropriate to select another registered public accounting firm. Even if the appointment is ratified, the Audit Committee in its discretion may select a different registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and our stockholders.

Representatives of Deloitte are expected to be present at the Annual Meeting. They will be given an opportunity to make a statement at the meeting if they desire to do so, and they will be available to respond to appropriate questions.

**THE BOARD RECOMMENDS A VOTE FOR RATIFICATION OF THE APPOINTMENT OF DELOITTE AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.** 

#### Principal Accountant Fees and Services
We regularly review the services and fees of our independent accountants. These services and fees are also reviewed by the Audit Committee on an annual basis. The following table summarizes the aggregate fees billed or expected to be billed by Deloitte for the fiscal years ended December 31, 2024 and 2025.

---

| | | |
|:---|:---|:---|
| **Fee Category** | **2024** | **2025**  |
| Audit Fees | $1712275 | $1599191  |
| Audit-Related Fees |  | $35000  |
| Tax Fees | $264000 | $282595  |
| All Other Fees |  | 2028  |
| Total Fees | $1976275 | $1918814 |

---

*Audit Fees. Consist of fees billed for professional services rendered for the audit of our annual financial statements, the review of financial statements included in our Quarterly Reports on Form 10-Q, and services provided in connection with statutory and regulatory filings or engagements.* 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>73</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
*Audit-Related Fees. Consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under "Audit Fees," including due diligence, accounting consultations, and audits-related to potential acquisitions, which, for 2025, included registration statement-related fees.* 

*Tax Fees. Consist of fees billed for tax compliance, tax advice, and tax planning services and include fees for tax return preparation.* 

*All Other Fees. Consist of all other products and services provided by the independent registered public accounting firm that are not reflected in any of the previous categories, and in 2025, include subscriptions to Deloitte's online accounting research and tools.* 

In 2025, all fees paid to Deloitte were pre-approved pursuant to the policy described below.

#### Audit Committee's Pre-Approval Policies and Procedures
The Audit Committee reviews with Deloitte and management the plan and scope of Deloitte's proposed annual financial audit and quarterly reviews, including the procedures to be utilized and Deloitte's compensation. The Audit Committee also pre-approves all auditing services, internal control related services, and permitted non-audit services (including the fees and terms thereof) to be performed for us by Deloitte, subject to the *de minimis* exception for non-audit services that are approved by the Audit Committee prior to the completion of an audit. None of the Deloitte services in 2024 and 2025 were approved by the Audit Committee pursuant to the *de minimis* exception. The Audit Committee may delegate pre-approval authority to one or more members of the Audit Committee consistent with applicable law and listing standards, provided that the decisions of such Audit Committee member or members must be presented to the full Audit Committee at its next scheduled meeting.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>74</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### AUDIT COMMITTEE REPORT
Each of the Audit Committee members is independent under the applicable SEC and Nasdaq rules and our corporate governance principles. The Audit Committee operates under a written charter adopted by the Board, which is available in the "Governance — Governance & Ethics Documents" section of our corporate website, *www.apei.com*. The Audit Committee reviews the charter and proposes necessary changes to the Board on an annual basis.

During the fiscal year ended December 31, 2025, the Audit Committee fulfilled its duties and responsibilities generally as outlined in its charter. The Audit Committee has:

&nbsp;&nbsp;&nbsp;&nbsp;• reviewed and discussed with management our audited financial statements as of and for the fiscal year ended December 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;• discussed with Deloitte, the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the "PCAOB") and the SEC; and

&nbsp;&nbsp;&nbsp;&nbsp;• received the written disclosures and the letter from Deloitte required under the applicable requirements of the PCAOB regarding the independent auditors' communications with the Audit Committee concerning independence and discussed with Deloitte its independence.

Based on the review and discussions referenced above, the Audit Committee recommended to the Board that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 for filing with the SEC.

In connection with the appointment, compensation, retention, and oversight of the independent auditor, the Audit Committee annually reviews the qualifications, performance, and independence of the independent auditor, and lead engagement partner, and assures the regular rotation of the lead engagement partner as required. In doing so, the Audit Committee considers a number of factors including, but not limited to quality of services provided, technical expertise and knowledge of the industry, effective communication, objectivity, and the likely impact of changing the independent auditor. The Audit Committee also considers whether the non-audit services provided by Deloitte are compatible with maintaining Deloitte's independence.

The Audit Committee has appointed Deloitte as our independent registered public accounting firm for fiscal year 2026 and recommended the appointment be submitted for ratification by stockholders.

Audit Committee

Granetta B. Blevins, Chairperson

Michael D. Braner

Anna M. Fabrega

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>75</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### BENEFICIAL OWNERSHIP OF COMMON STOCK
The following table sets forth certain information as of March 26, 2026 (unless otherwise specified), with respect to the beneficial ownership of our common stock by each person who is known to own beneficially more than 5% of the outstanding shares of common stock, each person currently serving as a director, each nominee for director, each NEO (as set forth in the Summary Compensation Table on page [52](#tSCT), and all directors and executive officers as a group.

---

| | | |
|:---|:---|:---|
| **Name of Beneficial Owner** | **Shares of** <br>**Common** <br>**Stock** <br>**Beneficially** <br>**Owned<sup>(1)</sup>** | **Percentage of** <br>**Class**  |
| **More than 5% Stockholders<sup>(2)</sup>**<br>|  |  |
| Divisadero Street Capital Management, LP<sup>(3)</sup> | 1671558 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.1%  |
| 325 Capital LLC<sup>(4)</sup> | 1206977 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6%  |
| BlackRock, Inc.<sup>(5)</sup> | 1202326 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5%  |
| Renaissance Technologies LLC<sup>(6)</sup> | 962920 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2%  |
| No Street GP LP<sup>(7)</sup> | 925000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.0%  |
| **Directors, Director Nominees and Named Executive Officers**<br>|  |  |
| Mark L. Arnold | 4040 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Thomas A. Beckett | 28301 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Granetta B. Blevins | 57945 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Michael D. Braner<sup>(8)</sup> | 1206977 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6%  |
| Edward H. Codispoti |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Anna M. Fabrega | 31296 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Nuno S. Fernandes<sup>(9)</sup> | 62781 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Daniel S. Pianko | 31197 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Angela K. Selden<sup>(10)</sup> | 462264 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5%  |
| Richard J. Statuto | 4640 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| Richard W. Sunderland, Jr. | 101789 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\*  |
| **All of our directors and executive officers as a group (13 persons)<sup>(11)</sup>** | 1945221 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.6% |

---

\* Represents beneficial ownership of less than 1%.

(1) Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Except where indicated otherwise, and subject to community property laws where applicable, the persons named in the table above have sole voting and sole investment power with respect to all shares of common stock shown as beneficially owned by them. As of March 27, 2026, there were 18,411,154 shares of common stock outstanding.

(2) Based solely on a Schedule 13G filed by The Vanguard Group, Inc. ("Vanguard") on January 30, 2026, Vanguard previously beneficially owned 1,138,861 shares of common stock and had shared voting power with respect to 148,541 shares and shared dispositive power with respect to 1,138,861 shares. Subsequently, in a Schedule 13G/A filed on March 26, 2026, Vanguard reported that due to an internal realignment it no longer has, or is deemed to have, beneficial ownership over Company securities beneficially owned by various Vanguard subsidiaries and/or business divisions. Vanguard also reported that certain subsidiaries or business divisions that formerly had, or were deemed to have, beneficial ownership with Vanguard, will report beneficial ownership separately (on a disaggregated basis).

(3) Based solely on a 13G/A filed Divisadero Street Capital Management, LP, William Zolezzi, Divisadero Street Partners, L.P., Divisadero Street Partners GP, LLC, and Divisadero Street Capital, LLC on February 13, 2026. Each reporting person's address is 3480 Main Highway, Suite 204 Miami, Florida 33133. Each of the reporting persons have shared voting and dispositive power with respect to the shares.

(4) Based on a Schedule 13D/A filed by 325 Capital Master Fund LP ("325 Master Fund") and 325 Capital GP, LLC ("325 Capital GP"); and 325 Capital LLC ("325"), Michael Braner, Daniel Friedberg, and Anil Shrivastava (collectively, the "325 Capital Investors") on March 20, 2026 and on a Form 4 filed by the 325 Capital Investors on March 23, 2026. 325 Capital Master Fund LP ("325 Master Fund") directly beneficially owns 347,498 of these shares. As the investment manager to 325 Master Fund and certain separately managed accounts (the "SMAs"), 325 may be deemed to

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>76</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
beneficially own the shares directly owned by 325 Master Fund and 836,234 shares of common stock held in the SMAs. The address for the 325 Capital Investors and 325 Capital GP is 757 Third Avenue, 20th Floor, New York, New York 10017. The address for 325 Master Fund is 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands. 325 Master Fund, 325 Capital GP, and each of the 325 Capital Investors have shared voting and dispositive power with respect to these shares.

(5) Based solely on a Schedule 13G/A filed by BlackRock, Inc. ("BlackRock") on April 17, 2025. BlackRock, in its capacity as a parent holding company or control person for various subsidiaries, may be deemed to beneficially own the indicated shares and has sole voting power with respect to 1,181,300 of the shares and sole dispositive power with respect to 1,202,326 of the shares. BlackRock reported its beneficial ownership on behalf of itself and the following direct and indirect subsidiaries and affiliates: BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC. The stockholders' address is 50 Hudson Yards, New York, NY 10002.

(6) Based solely on a Schedule 13G filed by Renaissance Technologies LLC ("Renaissance") and Renaissance Technologies Holdings Corporation ("Renaissance Holdings") on November 12, 2024. Each of Renaissance and Renaissance Holdings Corporation have sole voting and dispositive power with respect to the shares. The address of Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation is 800 Third Avenue, New York, New York 10022.

(7) Based solely on a Schedule 13G filed by No Street GP LP ("No Street") on February 17, 2026. No Street has sole voting and dispositive power with respect to the shares. The address of No Street is 505 Montgomery Street, Suite 1250, San Francisco, California 94111.

(8) As a Managing Member of 325, Mr. Braner may be deemed to beneficially own the shares owned by 325 Master Fund and the shares held in the SMAs. Mr. Braner's address is c/o 325 Capital LLC, 757 Third Avenue, 20th Floor, New York, New York 10017.

(9) Includes 17,056 shares of common stock subject to outstanding options that are exercisable within 60 days of March 26, 2026.

(10) Includes 43,134 shares of common stock subject to outstanding options that are exercisable within 60 days of March 26, 2026.

(11) Includes 60,190 shares of common stock subject to outstanding options that are exercisable within 60 days of March 26, 2026.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>77</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

### GENERAL MATTERS

#### Availability of Certain Documents
A copy of our 2025 Annual Report has been posted on the Internet along with this Proxy Statement to all stockholders entitled to notice of and to vote at the Annual Meeting. The Annual Report is not incorporated into this Proxy Statement and is not considered proxy-soliciting material. Upon written request, we will mail without charge a copy of the Annual Report, including exhibits. Please send a written request to our Corporate Secretary at:

American Public Education, Inc.

303 West 3<sup>rd</sup> Avenue,

Ranson, West Virginia 25438

Attention: Corporate Secretary

The charters for our Audit, MDC, and NCG Committees, as well as the Guidelines and the Code of Conduct, are in the Governance section of our corporate website, *www.apei.com*, and are also available in print without charge upon written request to our Corporate Secretary at the address above. The information on our corporate website is not incorporated by reference into this Proxy Statement.

Stockholders residing in the same household who hold their stock through a bank or broker may receive only one set of proxy materials in accordance with a notice sent earlier by their bank or broker. This practice will continue unless instructions to the contrary are received by the bank or broker from one or more of the stockholders within the household. We will promptly deliver a separate copy of the proxy materials to such stockholders upon receipt of a written or oral request to our Corporate Secretary at the address above, by e-mailing corpsecretary@apei.com, or by calling (304) 724-3730.

If you hold your shares in "street name" and reside in a household that received only one copy of the proxy materials, you can request to receive a separate copy in the future by following the instructions sent by your bank or broker. If your household is receiving multiple copies of the proxy materials, you may request that only a single set of materials be sent by following the instructions sent by your bank or broker.

#### Stockholder Proposals and Nominations
***Stockholder Proposals to be Considered for Inclusion in our Proxy Materials. As required by SEC rules, in order to be considered for inclusion in next year's proxy statement, stockholder proposals must be received by our Corporate Secretary at our principal executive offices not less than 120 calendar days before the anniversary of the date this Proxy Statement is released to stockholders in connection with the previous year's annual meeting, which is no later than December 11, 2026.***

***Stockholder Nominations and Proposals to be Brought Before an Annual Meeting. Our Bylaws provide that, for stockholder nominations to the Board or other proposals to be considered at an annual meeting, the stockholder must have given timely notice thereof in writing to the Corporate Secretary at American Public Education, Inc., 303 West 3<sup>rd</sup> Avenue, Ranson, West Virginia 25438, Attn: Corporate Secretary. To be timely for our 2027 Annual Meeting of Stockholders (the "2027 Annual Meeting"), the stockholder's notice must be delivered to or mailed and received by us not more than 120 days, and not less than 90 days, before the anniversary date of the preceding annual meeting, except that if the annual meeting is set for a date that is not within 30 days before or 60 days after such anniversary date, we must receive the notice no later than the later of the 90th day prior to such annual meeting or the close of business on the tenth day following the day on which we provide notice or public disclosure of the date of the meeting. Assuming the date of our 2027 Annual Meeting is not so advanced or delayed, stockholders who wish to make a nomination or proposal at the 2027 Annual Meeting, including if they intend to solicit proxies in support of director nominees other than our nominees pursuant to Rule 14a-19 under the***

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>78</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
Exchange Act, must notify us no earlier than January 22, 2027 and no later than February 21, 2027. Such notice must provide the information required by our Bylaws with respect to each matter the stockholder proposes to bring before the 2027 Annual Meeting, including the information required by Rule 14a-19 under the Exchange Act, if applicable.

#### Other Matters
As of the date of this Proxy Statement, the Board does not intend to present any matters other than those described herein at the Annual Meeting and is unaware of any matters to be presented by other parties. If other matters are properly brought before the meeting for action by the stockholders, proxies will be voted in accordance with the recommendation of the Board or, in the absence of such a recommendation, in accordance with the judgment of the proxy holder.

---

| |
|:---|
| By Order of the Board of Directors,  |
| ![](sig_tbeckett.jpg)<br>|
| Thomas A. Beckett  |
| Senior Vice President, General Counsel and Secretary |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>79</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### Annex A

#### CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Proxy Statement contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are based on current expectations, forecasts, assumptions and other information available to the Company as of the date hereof. Forward-looking statements involve inherent risks and uncertainties, include statements regarding the Company's expectations, beliefs, intentions or strategies regarding the future, including with respect to business, financial, operational, and governance matters and can be identified by forward-looking words such as "anticipate," "believe," "can," "could," "continue," "estimate," "expect," "future," "goal," "intend," "may," "plan," "potential," "should," "will," and "would" or similar words. The Company's actual results, performance or events may differ materially from these forward-looking statements made or implied due to a number of risks and uncertainties relating to the Company's business, including: the Company's failure to comply with regulatory and accrediting agency requirements, including the "90/10 Rule", and to maintain institutional accreditation and the impacts of any actions the Company may take to prevent or correct such failure; the effect of broader economic and market conditions on the students we serve; the impact, timing, projected benefits, and terms of the planned combination of APUS, RU, and HCN into one consolidated institution; changes in the postsecondary education regulatory environment as a result of U.S. federal elections, including any changes by or as a result of actions of the current administration to the operations of the Department of Education or changes to or the elimination or implementation of laws, regulations, standards, policies, and practices; potential or actual government shutdowns, including the U.S federal government shutdown in the fourth quarter of 2025; uncertainties in the estimated impact of the shutdown on the Company and its prospective and current students, and the Company's inability to mitigate these impacts; government budget and federal workforce uncertainty; the Company's dependence on the effectiveness of its ability to attract students who persist in its institutions' programs; the Company's loss of eligibility to participate in Title IV programs or ability to process Title IV financial aid; the loss or disruption of the Company's ability to receive funds under Title IV or tuition assistance programs or the reduction, elimination, or suspension of federal funds, and the risks and uncertainties discussed in the Company's Annual Report on Form 10-K for fiscal year ended December 31, 2025, as well as the Company's other filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update any forward-looking statements made in this Proxy Statement, whether as a result of new information, future events or circumstances, or otherwise, except as required by law.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>A-1</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**

### Annex B

#### GAAP NET INCOME AVAILABLE TO COMMON STOCKHOLDERS TO ADJUSTED EBITDA:
The following table sets forth the reconciliation of the Company's reported GAAP net income available to common stockholders to the calculation of adjusted EBITDA for the years ended December 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **Year Ended Dec. 31,**  | **Year Ended Dec. 31,**  |
| *(in thousands)* | **2025** | **2024**  |
| Net income available to common stockholders | &nbsp;&nbsp;&nbsp;$25305 | &nbsp;&nbsp;&nbsp;$10057  |
| Preferred stock dividends | &nbsp;&nbsp;&nbsp;2751 | &nbsp;&nbsp;&nbsp;6056  |
| Loss on redemption of preferred stock | &nbsp;&nbsp;&nbsp;3501 | &nbsp;&nbsp;&nbsp;—  |
| Net income | &nbsp;&nbsp;&nbsp;$31557 | &nbsp;&nbsp;&nbsp;$16113  |
| Income tax expense | &nbsp;&nbsp;&nbsp;12148 | &nbsp;&nbsp;&nbsp;10419  |
| Interest expense, net | &nbsp;&nbsp;&nbsp;4230 | &nbsp;&nbsp;&nbsp;2127  |
| Equity investment loss | &nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;4407  |
| Depreciation and amortization | &nbsp;&nbsp;&nbsp;16148 | &nbsp;&nbsp;&nbsp;19303  |
| **EBITDA** | &nbsp;&nbsp;&nbsp;64083 | &nbsp;&nbsp;&nbsp;52369  |
| Loss on leases | &nbsp;&nbsp;&nbsp;77 | &nbsp;&nbsp;&nbsp;3715  |
| Loss on assets held for sale | &nbsp;&nbsp;&nbsp;1527 | &nbsp;&nbsp;&nbsp;1618  |
| Loss on sale of subsidiary | &nbsp;&nbsp;&nbsp;3362 | &nbsp;&nbsp;&nbsp;-  |
| Other professional fees | &nbsp;&nbsp;&nbsp;3733 | &nbsp;&nbsp;&nbsp;2217  |
| Stock compensation | &nbsp;&nbsp;&nbsp;8352 | &nbsp;&nbsp;&nbsp;7668  |
| Loss on disposals of long-lived assets | &nbsp;&nbsp;&nbsp;444 | &nbsp;&nbsp;&nbsp;383  |
| Transition services costs | &nbsp;&nbsp;&nbsp;821 | &nbsp;&nbsp;&nbsp;3798  |
| Severance expense | &nbsp;&nbsp;&nbsp;3327 | &nbsp;&nbsp;&nbsp;530  |
| **Adjusted EBITDA** | &nbsp;&nbsp;&nbsp;$85,726\* | &nbsp;&nbsp;&nbsp;$72298 |

---

\* For purposes of calculating the AIP achievement and payouts, the MDC Committee did not exclude selected severance of $0.3 million, resulting in adjusted EBITDA for such purposes of $85.4 million.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;![](logo_apeiv5x1.jpg)<br><sup>B-1</sup><br>| POWERING PURPOSE<br>POTENTIAL AND <br>PROSPERITY |

---

------

#### **TABLE OF CONTENTS**
![](ny20064163x1_bcovx1.jpg)

------

![](ny20064163x1-pc_1.jpg)

------

![](ny20064163x1-pc_2.jpg)